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The interaction of microbes with dendritic cells (DCs) is likely to have an enormous 
impact on the initiation of the immune response against a pathogen.  In this study, we compared 
the interaction of Mycobacterium tuberculosis with murine bone marrow derived DCs and 
macrophages in vitro.  M. tuberculosis grew equally well within non-activated DCs and MØ.  
Activation of DCs and MØ with IFN-γ and LPS inhibited the growth of the intracellular bacteria 
in an NOS2-dependent fashion.  However, while this activation enabled MØ to kill the 
intracellular bacteria, the M. tuberculosis  bacilli within activated DCs were not killed.  Thus, 
DC could restrict the growth of the intracellular mycobacteria, but were less efficient than 
macrophages at eliminating the infection.  These results may have implications for priming 
immune responses to M. tuberculosis.  In addition, they suggest that DCs may serve as a 
reservoir for M. tuberculosis in tissues, including lymph nodes and lungs.  
 Dendritic cells (DC) possess anti-microbial mechanisms that may play a role in M. 
tuberculosis infection.  Activated DC and MØ produce a comparable amount of reactive nitrogen 
intermediates, as measured by nitrite production but our data indicate that nitric oxide production 
is not directly responsible for the differences in the ability of DC and MØ to kill M. tuberculosis.  
Activated DC have the capacity to produce greater quantities of reactive oxygen intermediate 
(ROI) than activated MØ.  The higher levels of ROI in infected DC may affect the formation of 
different reactive nitrogen intermediate (RNI) species, such as peroxynitrite, and alter the lethal 
effect on M. tuberculosis. In addition DC may not able to acidify their phagosomal compartment, 
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where the bacilli reside, to the same degree as macrophages.  This may contribute to the 
ineffectiveness of their anti-microbial compounds. 
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Introduction 
Epidemiology of M. tuberculosis infection  
 The disease tuberculosis is caused by the bacterium Mycobacterium tuberculosis, which 
is a highly infectious organism transmitted via aerosol.  In 1999 the World Health Organization 
(WHO) estimated that M. tuberculosis caused 8 million new cases of tuberculosis and 1.8 million 
deaths (1).  Until the early 1800s tuberculosis was one of the leading causes of death in Europe 
and the Americas, however improved living conditions as well as the start of successful 
chemotherapy led to a decrease in mortality rates (1).  This disease persisted in developing 
countries where it is still responsible for 25% of the avoidable deaths among adults and a leading 
cause of death among young women (1).  A recent epidemiological study estimated that 
approximately 1.8 billion persons, which is one third of the world’s population, are infected with 
M. tuberculosis (1).  This number will increase with the expanding population, inadequate 
treatment and health care, civil disturbances, and importantly, the human immunodeficiency 
virus (HIV) pandemic.   
 Tuberculosis is most prevalent in developing countries that harbor both 95% of the 
world’s M. tuberculosis infection (2) and 90% of the global HIV infections.  HIV causes 
acquired immunodeficiency syndrome (AIDS) and has emerged as one of the greatest risk 
factors for the development of active tuberculosis in persons co-infected with both M. 
tuberculosis and HIV (2) (3).  AIDS increases the risk of progressing to tuberculosis that results 
in death (4).  Indeed, tuberculosis was reported to be the leading cause of death among HIV 
patients in 1999 (1). M. tuberculosis infection may accelerate HIV replication; viral recovery 
from lungs of HIV-infected patients increased following the development of tuberculosis and 
returned to baseline following successful anti-tuberculosis chemotherapy (5).  The correlation 
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with M. tuberculosis infection and HIV replication rate may result from immune activation 
accompanying tuberculosis (6).  HIV and tuberculosis together result in much socioeconomic 
hardships for those who are afflicted and this contributes to a global financial burden (1).  The 
World Health Organization uses a measure of disease burden called a DALY, Disability-
Adjusted Life Year.  DALYs express the years lived with a disability, adjusted for by the 
severity, and the years of lost life due to premature death (1).  HIV and tuberculosis together 
accounted for 7% of all DALYs in 1998.   
 If diagnosed, tuberculosis can be treated successfully with a combination of several 
antibiotics.  However, the antibiotic regimen is long- six to twelve months- and the high level of 
non-compliance among patients encourages the development of multi-drug resistant strains of M. 
tuberculosis (MDR-Tb).  In New York City, 33% of tuberculosis strains recovered in 1992 were 
resistant to one drug and 19% were resistant to two or more drugs (7).  In Asia and Eastern 
European countries there has been an increase in MDR-Tb (1), (8), (9).  The World Health 
Organization developed the Directly Observed Treatment- Short-course (DOTS) strategy in the 
early 1990s in the Western Pacific to help improve treatment.  Under DOTS, patients take the 
antibiotics under direct supervision to help reduce non-compliance and subsequent drug-resistant 
strains.  DOTs is now in use in 28 countries and treats 35% of all cases (1).  Recently this 
strategy is being used in New York City where non-compliance, as well as MDR-Tb, is high.  
When properly administered, DOTS has achieved up to a 90% cure rate (1) but many developing 
countries lack the resources to properly implement it.  Insufficient treatment programs have 
resulted in drug-resistant rates in excess of 30% in some developing nations (10).  For instance, 
the prison system in Russia gave prisoners partial antibiotic treatments for tuberculosis, which 
resulted in a very high number of drug resistant strains in the prison system (40%) and 
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subsequently a doubling (3-6%) of MDR-Tb in civilian Russia (11).  In light of the complex 
nature of M. tuberculosis and the increasing number of HIV infected people, an increase of 
MDR-Tb strains and cases, a rapid expansion of third world’s population, increasing elderly 
population and numerous cases of reactivation, this disease demands a considerable amount of 
attention, both medical and research, now and in the future. 
 Currently, no effective vaccine is available.  A vaccine made from an attenuated strain of 
Mycobacterium bovis, bacillus Calmette-Guérin (BCG), remains the sole vaccine against 
tuberculosis but its efficacy is variable and has been estimated to range from 0 to 80% effective 
(12).  The only way to eliminate the spread of M. tuberculosis is to develop a protective and 
reliable vaccine.   Recently, DNA vaccines based on the antigen 85 complex (13) or the 65 kD 
heat shock protein (hsp) of M. tuberculosis (14) have provided partial protection against a 
challenge with virulent M. tuberculosis in mice.  DC infected with BCG, or M. tuberculosis have 
been shown to confer protection to challenge with M. tuberculosis in a murine model (15).  A 
greater understanding of the immune response is necessary in order to develop a vaccine that will 
confer complete protection from infection and, hopefully, from reactivation of a pre-existing 
infection. 
 
Characteristics of Mycobacterium tuberculosis 
 
Mycobacteria have a straight or curved rod morphology and exist either singly or in 
clusters.  Mycobacterium tuberculosis is a facultative intracellular aerobic pathogen that resides 
primarily in macrophages of many mammalian hosts such as human and cattle.  M. tuberculosis 
is a particularly slow growing bacterium and divides once every 18-24 hours.  Therefore it takes 
between 18-21 days to view visible colonies on solid medium, which slows down research of this 
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organism.  The cell wall of M. tuberculosis has an unusually high lipid content and has many 
components which are unique to mycobacteria, such as cord factor which causes the bacilli to 
clump in cell culture and again impose a problem in experimental infections (12). 
 The cellular envelope of M. tuberculosis consists of a plasma membrane and a highly 
unusual cell wall.  The plasma membrane consists of a classical bilayer structure.  The elaborate 
distinctive features of the mycobacterial cell walls include the lipoarabinomannan (LAM) (16), 
lipomannan, mycolyl-arabinogalactan, phosphatidyl-myo-inositol mannoside, sulfatide, cord 
factor, and other acylated trehaloses, phenolic glycolipids, lipoligosaccharides, and other 
attenuated lipids (12).   Many of these have been shown to be involved in the virulence and 
pathogenesis of this bacillus (12).  LAM, a predominant component of the cell wall, is a 
virulence factor for M. tuberculosis, and activates macrophages and scavenges reactive oxygen 
intermediates (17).  When LAM is mannosylated there is a loss of virulence (18).  The most 
common characteristic of the cell wall is peptidolglycan that is surrounded by covalently linked 
phospohdiester bonded arabinogalactan with mycolic acids attached to it.  The arabinogalactan 
and mycolic acid complex is a strong immunogen (19). 
 An important feature of the mycobacterial cell wall is the integrity of the outer matrix 
mycolyl-arabinogalactan and the integrity of the capsular lipids (20) that keeps the cell wall very 
rigid, highly organized, and very densely packed with lipids.  Due to the unique composition and 
high lipid density of the cell wall, mycobacteria can be detected by an acid fast staining 
technique.  In this technique the bacteria retain the primary dye after decolorization with an acid 
alcohol, carbol fushsin, due to the high lipid content of the cell wall and mycobacteria are 
referred to as acid fast (12). It has been hypothesized that this unique cell wall ensures the 
survival and replication of the bacteria in vivo.  The cell wall structures may help evade 
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complement-mediated lysis, prevent anti-microbial mechanisms within the macrophages, and 
downregulate a successful immune response (12)  
Mycobacterium tuberculosis Virulence and Disease Pathogenesis 
 The development of tuberculosis from infection may be viewed as a series of battles 
between the host defenses and the bacilli (12).  The development of the disease tuberculosis can 
occur decades after infection and the bacterium is very complex which makes it very hard for the 
host to eliminate and sometimes control M. tuberculosis.  M. tuberculosis infection can result 
from the inhalation of as few as 10-50 bacilli that are swallowed up by alveolar macrophages.  
M. tuberculosis can gain entry into human macrophages, their host cell,  by utilizing a wide array 
of receptors depending on whether or not the bacilli are opsonized with complement, antibodies 
or surfactant-A (reviewed in (21)).  Putative receptors include complement receptors-1, 3 and 4, 
the macrophage mannose receptor, class A scavenger receptors, CD-14, Fcγ receptors and 
surfactant-A receptors (reviewed in (21)).  It may be possible that all the invading bacilli are 
killed immediately within the macrophages, thereby preventing infection.  There is no direct 
evidence that this scenario occurs, although it is generally believed that certain people are 
resistant to infection; these persons, who are often health care workers, are repeatedly exposed to 
M. tuberculosis but do not convert to PPD+ or develop tuberculosis.  However, it is unclear how 
common this is. If the bacilli do survive within the alveolar macrophages, they replicate and 
invade the lymphatics and bloodstream, spreading throughout the body, often seeding the apical 
lung segments and may lead to disease.  Other organs also may become infected resulting in 
extrapulmonary tuberculosis, most commonly arising in the lymphatics, pleura, bones, 
genitourinary tract, and meninges of the central nervous system (CNS).  Both human (22) and 
murine (23) dendritic cells can internalize M. tuberculosis and these migratory cells may play a 
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role in dissemination of the bacteria to lymphoid organs.  An infected person may control the 
initial infection, but it is believed that the infection is generally not eliminated.  However, control 
of the infection with no symptoms is the most common outcome of infection, and this is referred 
to as latent tuberculosis. A person with latent tuberculosis may reactivate, even after many years, 
under a variety of conditions such as HIV, malnutrition, age, or steroid use.  However, more 
commonly, the infected person never develops disease. It is not fully understood how or why 
reactivation occurs or whether the bacilli are dormant or proliferating during this period (12).   
  Approximately 5-10% of primary infections progress to active pulmonary tuberculosis; 
in which a lesion will generally be visible upon chest radiograph.  In tuberculosis, the tubercle 
bacilli induce the formation of characteristic granulomas in the lungs or other infected organ. 
These lesions consist of central macrophages that become enlarged or “epithelioid” surrounded 
by lymphocytic cells and fibrocytes.  In humans, these epithelioid macrophages may fuse to form 
multinucleated giant cells.  As the disease progresses, the granulomas increase in size, become 
necrotic and create pathology of the affected organ.  In pulmonary tuberculosis, the patient 
becomes highly contagious as lungs expel debris containing bacilli in tiny droplets whenever the 
patient coughs, sneezes, or even speaks.  These granulomas are a delicate balance between the 
struggle for the host’s immune response to control the bacterial growth and the bacteria’s desire 
to persist in this harsh environment.  Ironically, the damage sustained to the host results at least 
in part from the products of the immune system (12). 
 
Macrophage Effector Functions 
 It has long been known that macrophages possess anti-microbial functions (24), (25), 
(26).  Mononuclear phagocytes, such as macrophages, constitute a potent anti-microbial 
component of the cell-mediated immune response (12).  The best characterized effector 
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mechanisms include phagosome-lysosome fusion, the reactive oxygen intermediate (ROI) burst, 
and the production of reactive nitrogen intermediates (RNI) by an L-arginine-dependent pathway 
(12).  M. tuberculosis is equipped with several features that increase its chances of survival 
within macrophages. 
 
Phagolysosome-Fusion 
 Once ingested by a phagocytic cell an intracellular pathogen is sequestered away in a 
membrane bound phagosome unless they have mechanisms to escape out of the phagosome and 
into the cytoplasm (27), where they will be processed for MHC class I presentation.  It is an 
advantage for a microbe to hide in the phagosome, however the organism must be able to either 
prevent lysosomal fusion or acidification.  The phagosome progresses through the endocytic 
pathway, characterized by the acquisition of small GTPase proteins, Rabs, which regulate 
endosomal membrane trafficking (28), until it fuses with the lysosome.  The lysosome is a very 
complex organelle that contains hydrolytic enzymes that can degrade a wide variety of 
macromolecules, including microbes.  These enzymes function best at an acidic pH and therefore 
the lysosome maintains a pH of 4.5-5.5 (29).  This environment is maintained by ATPase proton 
pumps in the vacuole (30).  The fusion of the phagosome to the lysosome is a dynamic process 
since it involves the maturation of the phagosome. M. tuberculosis and M. avium can inhibit both 
phagosome acidification and phagosome-lysosome fusion (30), (31).  If M. tuberculosis is within 
these conditions of the phagosome-lysosome it can be killed (32).  Studies have shown that M. 
tuberculosis arrests the phagosome maturation at the early endosome stage, which expresses Rab 
5, and this results in the phagosome being unable to proceed to fuse with the lysosome (33).  M. 
tuberculosis- or M. avium-infected cells have been shown to exclude the ATPase proton pump 
from the phagosome, which would also prevent acidification (30), (31). Although M. avium 
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appears to have many similarities to M. tuberculosis in the way that it resides within the 
phagosome, there are many differences between these bacteria, which result in altered disease 
pathogenesis.  M. avium only can cause disease in immunocompromised people.  
 Recent data from studies using BCG suggest that this inhibition may result from the 
internalization of cholesterol into the macrophage that occurs when mycobacteria enter through 
cholesterol-rich domains of the macrophage cell membrane (34).  This cholesterol co-localizes 
with the mycobacteria in the phagosome and may cause retention by the phagosome of 
tryptophan-aspartate-containing coat protein (TACO), preventing phagosome-lysosome fusion 
(34), (35).   In vitro studies have suggested that M. tuberculosis can generate copious amounts of 
ammonia in cultures which could be responsible for preventing phagosome-lysosome fusion as it 
affects lysosome trafficking and alkalinizes the intracellular environment of the lysosome (36).  
Two enzymes which contribute to ammonia metabolism have been investigated, urease and 
glutamine synthetase. Glutamine synthetase has actually been shown to be released from 
monocytes during infection with M. tuberculosis.  It is released from virulent species in cultures, 
such as M. tuberculosis and M. bovis but not from non-pathogenic strains such as M. smegmatis 
(37), (38).  Overall there is substantial evidence that M. tuberculosis can block phagosome-
lysosome fusion so that it can reside within the macrophage.  However, upon activation there is 
some phagosome-lysosome fusion resulting in bacterial death. 
 
Reactive Oxygen Intermediates 
 The production of reactive oxygen intermediates (ROI), or the respiratory burst, plays a 
significant role against microbes, such as Salmonella species (39).  The importance of ROI is 
demonstrated by the frequent uncontrolled infections seen in chronic granulomatous patients. 
These patients  have a defect in NADPH oxidase complex, a critical respiratory burst enzyme 
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complex, therefore they cannot produce ROI (40, 41).  The role that ROI play in M. tuberculosis 
infection is controversial. ROI were shown to kill M. microti, which at first led researchers to 
believe they may kill M. tuberculosis.  However, evidence supported quite the opposite.  A major 
mycobacterial cell wall component, lipoarabinomannan (LAM), was effective at scavenging ROI 
generated by the respiratory burst of infected macrophages (18).  It was also shown that ROI can 
inhibit protein kinase C which downregulates the respiratory burst (18).  Tubercle bacilli also 
produce both superoxide dismutase (42) and catalase (43) that may interfere with toxic oxygen 
radical production.  Other mycobacterial components such as sulfatides and phenolglycolipid I 
(PGL-1) have also been suggested to interfere with ROI-dependent anti-microbial mechanisms 
within macrophages (18).  M. tuberculosis could also evade the respiratory burst by avoiding 
binding to macrophage receptors, such as Fc receptors, but instead use complement receptors.  
M. tuberculosis has been shown to use CR3 to enter into macrophages (44), (45).  A macrophage 
line which is deficient in ROI production was shown to be able to control the infection the same 
as wild-type controls suggesting that ROI are not required to control infection in vitro(46). 
 However, other studies support a role for ROI in control of M. tuberculosis infection.  
Hydrogen peroxide generated by cytokine-activated macrophages was shown to have 
mycobactericidal effects (47).  Infection of phox-/- mice, which are deficient in NADPH oxidase 
complex, were initially more susceptible to M. tuberculosis infection (40), (41).  Humans with 
chronic granulomatous disease are more susceptible to tuberculosis (48). In addition, ROI may 
form other compounds, such as peroxynitrite or peroxynitrous acid, which have been shown to 
kill some mycobacterial species (49).   
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Reactive Nitrogen Intermediates  
 Phagocytic cells, such as macrophages and more recently DC, have been shown to 
produce nitric oxide (NO) and other reactive nitrogen intermediates (RNI) via the NOS2 enzyme 
using L-arginine as a substrate.  NOS2 is induced by interferon-γ (IFN-γ) and a second signal 
such as tumor necrosis factor (TNF-α) or bacterial products such as LPS or LAM (50), (51), 
(52), (23), (53), (54), (55). NO is highly reactive, has a very short life, and can quickly be 
oxidized to form nitrite, NO2-, a more stable compound.  In an acidic environment, such as the 
phagolysosome, chemical reactions can generate many RNI species such NO2, HNO2, N2O3, and 
in conjunction with ROI can form peroxynitrite (ONOO-) and peroxynitrous acid (HOONO) 
(56).  
 Nitric oxide production within macrophages has major anti-microbial mechanisms (52), 
(57), (50), (51).  RNI can inflict damage to the bacterium by modifying DNA, proteins, and 
lipids (51), (57).  In the murine system, toxic nitrogen compounds have been shown to play a 
role in protection in both an acute and a chronic M. tuberculosis infection (58), (59).  NOS2-
derived RNI are the only clearly demonstrated mycobacterial effector function in macrophages 
(60), (46), (61), (62), (23).  Activated (IFN-γ + LPS or TNF-α) macrophages  (cell lines and 
murine bone-marrow derived macrophages) can routinely kill 50% of intracellular M. 
tuberculosis which is not enough to clear infection (46), (23), (62), (18).  However, macrophages 
derived from NOS2-deficient mice do not kill M. tuberculosis, nor do wild type bone-marrow 
macrophages which have been treated with an NOS2 inhibitor such as aminoguanidine (AG) or 
NG-monomethyl-L-arginine (NMMA) (58), (46).  Mice given AG or NMMA to block RNI 
synthesis succumbed to infection with M. tuberculosis in acute and chronic infection models (46) 
(63).  NOS2 gene-disrupted mice died after infection with M. tuberculosis (64) (65).  These 
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studies clearly demonstrate that NOS2 is essential to control of M. tuberculosis infection in mice 
in vivo.  There are also data suggesting a role of NOS2 in humans.  A high level of NOS2 
expression was seen in bronchial lavage macrophages from patient’s with active tuberculosis 
(66), (67).  In one study patients with tuberculosis exhaled more nitric oxide (67).  More 
macrophages obtained from tuberculosis patients expressed NOS2 as compared to normal non-
diseased people (66).  Despite the toxicity of these RNI compounds, only 50% of the 
intracellular M. tuberculosis is killed in murine derived macrophages and cell lines.  It is yet to 
be determined if and how much M. tuberculosis is killed within human macrophages.  Thus, 
while this is a very important mechanism for protection, other critical factors which remain to be 
identified.  
 
Peroxynitrite 
  Peroxynitrite, as described above, is a strong oxidant produced by macrophages and 
neutrophils (68). Peroxynitrite is highly bactericidal for many bacteria including Escherichia 
coli, and Salmonella (69), (39).  Peroxynitrite has a longer half-life and is better at killing in a 
low pH, such as found in the phagolysosome (56).  Peroxynitrite is formed from NO and the ROI 
superanion (02-), which are produced simultaneously in macrophages (56).  The equation for this 
reaction is NO. + . 02-  = ONNO-.  It was believed that peroxynitrite production may contribute to 
the RNI-dependent killing of M. tuberculosis.  However, one study demonstrated that M. 
tuberculosis is actually highly resistant to very large quantities of peroxynitrite (49).  In this 
study, clinical strains as well as laboratory strains of virulent M. tuberculosis were highly 
resistant to peroxynitrite in a cell-free system, whereas non-pathogenic and non-virulent species 
or strains, such as M. smegmatis and BCG (avirulent M. bovis) were susceptible (49).  All of 
these species and strains were susceptible to nitric oxide and nitride oxide killing, which 
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suggested that virulent strains of mycobacteria have evolved to avoid peroxynitrite killing.  
These bacilli have recently been reported to exhibit peroxynitrite reductase activity that may 
allow it to convert toxic peroxynitrite to nitrate (70).    
 
Toll-Like- Receptors 
 The discovery of Toll-Like Receptors (TLR) in vertebrates has provided a link between 
innate immunity and adaptive immunity (71), (72),(73), (74), (75), (76), (77), and (78). Toll was 
first identified as being responsible for protecting Drosophila against fungal infections (79).  
Subsequently their link to adaptive immunity was shown. Toll receptors provide a signal for NF-
κB-mediated cytokine cascades involved in anti-microbial mechanisms (80) and TLR likely play 
a role in regulating M. tuberculosis infections.  The immunogenic properties of 19 k-Da 
mycobacterial lipoprotein were shown to be dependent on TLR-2 (81) (157).  M. tuberculosis 
was shown to activate either TLR-2 or TLR-4 in vitro and in a CD14 independent manner (82). 
Importantly many of the immunogenic compounds such as LAM and mycolylarabinogalactan-
peptidoglycan complex, and various mycobacterial lipids have been shown to signal through 
either TLR2, TLR4, or both (82).  Recently, Modlin, et. al. reported that M. tuberculosis induced 
nitric oxide production via signaling through TLR (83).  NO production is an important anti-
microbial mechanism for M. tuberculosis infection.  It will be of interest to determine whether 
and how this contributes to not only macrophage activation, but DC activation as well since DC 
express TLR, but not substantial levels of CD14 (84).  Lipopeptides, which include bacteria 
products, were shown to stimulate dendritic cell maturation through TLR2 (85).  As well it may 
be speculated that difference in the levels of TLR on DC versus macrophages may contribute to 
different levels of cytokine expression. 
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Immune Responses to Mycobacterium tuberculosis 
A murine mouse model has been used to investigate both the acute and latent infection of 
M. tuberculosis since Koch first discovered the bacteria (12).  This system has demonstrated that 
cell-mediated immunity that is dependent upon the production of inflammatory cytokines, is 
important for protection from disease.  IFN-γ from T cells activate macrophages to produce RNI 
that can kill M. tuberculosis.  Many of these components have been shown to be necessary for 
resistance in humans as well.  Ironically, the same immune responses that are critical for 
protection are also partially responsible for the disease-associated pathology and longevity of  
infection. The following section details the various components of the immune response to M. 
tuberculosis. 
 
Interleukin 12 
 To control M. tuberculosis infection, a Type 1 T cell response must be generated, as in 
the case of most intracellular infections.  Macrophage and DCs produce IL-12 in response to M. 
tuberculosis infection leading to the development of a TH1 response and IFN-γ production (23), 
(86), (14), (87), (88).  Exogenous administration of therapeutic IL-12 and the finding of 
susceptibility in of IL-12p40 gene deficient mice strongly support an important role for this 
cytokine in the protective immune response against M. tuberculosis (89),(90).  In absence of IL-
12 production, lower levels of IFN-γ production were generated upon bacterial challenge; which 
probably contributed to the susceptibility of the IL-12 deficient mice to the infection.  Human 
cases of disseminated BCG or M. avium infections have been linked to mutations in genes 
encoding the IL-12 receptor.  These patients are deficient in T cell production of IFN-γ 
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production (91).  Vaccination in conjunction with IL-12 DNA has been reported to reduce the 
bacterial load in M. tuberculosis in chronically infected mice (92). 
 
Interferon−γ 
 IFN-γ is a critical cytokine involved in the control of M. tuberculosis infections.  IFN-γ is 
produced by CD4+ and CD8+ T cells in M. tuberculosis infection.  NK cells are another source of 
IFN-γ,  but they have not been shown to directly to produce this cytokine in response to M. 
tuberculosis (93), (94), (95), (96), (97).  Mice with a genetic deficiency for IFN-γ are the most 
susceptible to infection with virulent M. tuberculosis and have a mean survival time of only 14 
days (98), (99).  Notably there was also less NOS2 production in these mice indicating that 
macrophage activation was defective,  contributing to the susceptibility of IFN-γ knockout mice. 
However, this is not the only critical factor since NOS2 gene-disrupted mice have a mean 
survival time which is twice as long as IFN-γ-/- mice (98), (50).  The importance of this cytokine 
is also confirmed in humans who have a mutation in their IFN-γ receptor and this was associated 
with a heightened susceptibility to mycobacterial infections (100),(101).  IFN-γ have been 
detected in the granulomas of patients and their T cells have been shown to produce IFN-γ in 
response to challenge with M. tuberculosis (102), (103).  Although this is evidence for the direct 
importance of IFN-γ  in human, the activation of human macrophages with simple addition of 
IFN-γ  is not sufficient to kill M. tuberculosis  in vitro (104).   Ηowever, macrophages harvested 
from tuberculosis patient express NOS2 indicating that they have been activated in vivo (66), 
(67).  This suggests that in vitro systems  have not been able to sufficiently mimic what happens 
in vivo.  In essence, we have not identified how to properly activate human macrophages to 
produce RNI.  Some studies have shown that IFN-γ is depressed in the serum of patients with 
 27 
tuberculosis.  It has even been suggested that M. tuberculosis or its components inhibit 
macrophages to respond to IFN-γ by inhibiting STAT1-dependant signaling (105). 
 
Tumor Necrosis Factor α 
 TNF-α is required for the control of an acute M. tuberculosis infection.  TNF-α is 
secreted from DC and macrophages in response to M. tuberculosis infection (88), (86), (23), 
(14).  Mice deficient in TNF-α or the 55-kDa TNF receptor succumb more quickly to M. 
tuberculosis infection (106), (107).  Again, these mice have a high bacterial burden compared to 
wild-type controls.  TNF-α acts as a necessary second signal (in addition to IFN-γ) to activate 
macrophages to produce RNI (108), (109), (61). NOS2 expression is delayed in the TNFRp55-/- 
mice but not in TNF-α-/- mice (106).  Overall, the role of TNF-α in a M. tuberculosis infection 
is complex since it appears to contributes to both protection and pathology (110). 
 
Interleukin-10: 
  IL-10 is an anti-inflammatory cytokine, which is produced by macrophages and T cells, 
leading to downregulation of IL-12 and consequently IFN-γ secretion by T cell and macrophages 
activation.  Inhibition of IL-10 can help reverse the suppression of T cell proliferation in vitro by 
macrophages isolated from human tuberculosis patients (111).  IL-10 has been shown to directly 
inhibit APC functions and T cell responses to mycobacteria infection (112). Although these 
results suggest IL-10 can counteract the ability of IFN-α to activate of macrophages, IL-10-/- 
knock-out mice were not shown to be more resistant to infection with M. tuberculosis (113).  The 
role for IL-10 in M. tuberculosis infection is still not very well understood.  Murine DC infected 
with M. tuberculosis do not produce IL-10 and therefore the deactivation of DC may come from 
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other cytokines, such as TGF-β (23).  In other systems, TH1-polarized DC in the presence of IL-
10 or TGF-β induced TH-2 like responses (84). 
Cell Mediated Immunity: 
 Protection against M. tuberculosis is dependent on the development of a TH1 response.  
Since this bacteria resides intracellularly in macrophages and DC, an antibody response is not 
helpful, but T cell effector functions and macrophage activation can facilitate the elimination of 
the bacteria from within the cell.  Both CD4+ and CD8+ T cells have been shown to play 
important roles in regulating the infection. 
 
CD4+ T cells: 
  CD4+ cells are the most prevalent in the CMI toward M. tuberculosis and this is not 
surprising, since mycobacterial antigens can be processed intracellularly and then be presented 
by MHC II molecules.  The necessity for CD4+ T cells in bacterial resistance has been 
demonstrated in the murine system using antibody depletion (114), adoptive transfer systems 
(115), (116), and mice deficient in MHC II and CD4+ (15), (117).  The mean survival time for 
CD4-/- mice infected with M. tuberculosis is 60 days and the MST for MHC II-/- is 40 days 
whereas wild type mice will not die from the infection.  There is a heavy recruitment of CD4+ T 
cells to the lungs after IV infection with M. tuberculosis (116).  In humans, the necessity for 
CD4+ T cells to help control infection is shown by the rapid acceleration of tuberculosis in HIV+ 
patients who have a loss of CD4+cells (118).  The predominant role for CD4+ T cells in 
protection is believed to be their production of IFN−γ, which will help activate macrophages to 
kill M. tuberculosis.  However, this may not be the sole function for CD4+ T cells in these 
infections.  For instance CD8+ T cells have been shown to contribute substantial amounts of IFN-
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γ in CD4-/- cells (117), however this did not prevent the mice from ultimately succumbing to the 
infection.  Also in this study NOS2 levels returned to normal after several weeks.  These data 
demonstrate an IFN-γ and NOS2 independent mechanism that plays a dominant role in 
protection from disease.  This has led to the investigation of other pathways by which CD4+ T 
cells may protect against infection.  Possible pathways which are still under active investigation 
include the perforin and granulysin, FAS-L or TNF-α lytic and apoptosis pathways (119), the 
interaction of CD40-CD40L between CD4+ T cells and to enhance APC function (120), (121), 
(122), as well the ability of CD4+ T cells to provide help to CD8+ cells that may mediate a 
cytolytic response (Serbina, et. al. Journal of Immunology, in press).   
 
CD8+ T cells 
The contribution of CD8+ T cells in infection has been debated for a long time.  At the 
crux of this debate is whether M. tuberculosis is ever found outside the phagosome (i.e. 
cytoplasm) where it could be processed for MHC I presentation.  Although it still has not been 
exhaustively determined as to how mycobacterial antigens are presented to the immune system, 
CD8+ T cells that are specific for mycobacterial antigens have been isolated from both infected 
humans and mice.  CD8+ T cells have also been shown to accumulate in the lungs after M. 
tuberculosis infection in mice.  These cells can produce IFN-γ and lyse infected macrophages 
(97), (123), (93), (124).  Earlier studies with mice deficient in the genes for β2-microglobulin, 
TAP, MHC I, and CD8+ have shown that these mice exhibit heightened susceptibility to M. 
tuberculosis infection,  and therefore CD8+ T cells must contribute to protection (125), (126), 
(127).  There have been recent data that MHC-I restricted CD8+ T cells can recognize several 
antigens including some heat shock proteins (128).  H2-M3-restricted CD8+ T cells specific for 
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N-formyl peptides of M. tuberculosis have been reported to produce IFN-γ and lyse infected 
macrophages (129).  CD1 molecules are structurally similar to MHC class I molecules but have 
differences in their binding groove which allow for the binding and presentation of lipids and 
glycolipids instead of protein antigens (130).  Therefore they are believed to serve as important 
presentation complexes for mycobacterial antigens, and indeed, this has been shown for many 
mycobacterial lipids including LAM (131).  However the actual role of T cell in response to 
these complexes in infection has been unclear. 
Mechanisms by which mycobacteria could be processed for MHC I presentation have 
been recently suggested.  Mice without CD1d were not more susceptible to infection (126), 
(127).  Since DC have recently been shown to be important APC in a M. tuberculosis infection 
and they express CD1, this may be relevant to protection.  It has been reported that 
mycobacterial bacilli were found outside of the phagosome several days post-infection (132).  
Other evidence shows that mycobacteria can make a pore in the phagosomal membrane that 
envelops them, allowing for the mycobacterial antigens to gain access to the cytoplasm (133).  
Increasing evidence supports the role for CD8+ T cell in preventing  tuberculosis infections but a 
debate remains as to the exact mechanisms by which this occurs. 
Indeed the roles of both CD4+ and CD8+ may be multi-faceted and the two cell types 
likely collaborate in the generation of protective cellular immunity.  Therefore understanding 
how to activate both T cell types in a vaccine is probably crucial to generating protection and 
long term memory.  
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Dendritic Cells  
 The high degree of specificity displayed by T and B lymphocytes in recognition of 
antigens is achieved with the help of antigen presenting cells (APCs), particularly, DC.  DC are 
bone-marrow derived cells of the hematopoietic lineage which are potent APC.  DCs have both 
an immature and mature stage.  Immature DC are highly phagocytic and serve as scavengers for 
debris and pathogens.  After stimulation with cyokines, T cell interaction or bacterial stimulus, 
the DC reach a mature stage, in which they dramatically enhance their antigen presenting 
functions.  In the mature stage, DC upregulate not only important cell surface markers for T cell 
interaction, but adhesion molecules, and chemokine receptors.  These allow DC to migrate from 
the site of infection to the draining lymph nodes in order to stimulate naïve T cells. DC are 
scattered throughout the body and are observed at various portals for infection (84).  In the lung, 
DC are found in the interstitium and the airways (134).   
Historically it was believed that alveolar macrophages were the dominant APC in the 
lung, however resident macrophages are not very migratory from the site of infection. Alveolar 
macrophages have also been shown to be poor APCs (135), (136), (137) whereas DC and 
interstitial macrophages in the lung were shown to be efficient APCs (138), (139).  Alveolar 
macrophages have been demonstrated to be suppressive to T cells (140), (141), (142), (143).  
There is also data suggesting that mice in which the alveolar macrophages were depleted are 
protected during pulmonary tuberculosis (144).  When alveolar macrophages are depleted in 
mice by liposome-encapsulated dichloromethylene diphosphonate (AM- mice) given 
intranasally, they are then completely protected from death after M. tuberculosis.  Bacterial 
burdens in the lungs of these mice were significantly reduced.  Granuloma formation were not 
observed,  but increased numbers of activated T cells, as well as increases in pulmonary 
polymorphonuclear cells (144) infection were seen and are critical to control this infection.  In 
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general, pulmonary macrophages do not provide assistance for T cell mitogen responses (140). 
In a study where DC and alveolar macrophages were injected intratracheally into rats, the DC 
could migrate to the lymph nodes whereas the alveolar macrophages appeared to be unable to 
pass through the epithelium (145).   Holt et al. have shown that pulmonary DC traffic from the 
lung to the draining lymph nodes to present inhaled antigens to T cells after bacterial infection 
(140).  In response to M. tuberculosis infection DCs shift to an antigen presenting phenotype 
(22), (23) and can stimulate T cells from the spleens and lungs of infected mice in vitro (23), (97) 
and in the lung of infected mice (14).  M. tuberculosis-infected DC have been observed in-vivo in 
infected mice (146).  
DC also contribute to the elimination of M. tuberculosis by the secretion of cytokines and 
creating an optimal environment for immune activation.  DC produce IL-12 in response to M. 
tuberculosis infection and IL-12 production is critical to drive a TH-1 response necessary to fight 
infection.  IL-12 production is responsible for activating T cells to produce IFN-γ.  IFN-γ 
production activates both macrophages and DC to produce RNI that will prevent the growth of 
M. tuberculosis. Murine and human DC secrete TNF-α, IL-6, IL-1α, and IL-1β which contribute 
to the inflammatory response and cell migration (14), (23), (22), (147), (148).  DC express 
CD40L and studies have shown the CD40 stimulated BCG-infected mice express high level of 
the chemokines MIP-α/β which are potent chemotactant signals for DC and neutrophils in mice 
(149). CD40 cross-linking on DCs has also been shown to lead to the secretion of high level of 
IL-12 (150), (151).  DC express Toll Like Receptors (TLR) which when stimulated with 
mycobacterial antigens can upregulate NF-κB regulated cytokines, such as IL-1 and TNF-α. 
TLRs on CD8α+ DC have been shown to induce IL-12 production in response to E. coli (84).  
DC use TLR to discriminate different microbes and stimulate either a TH1 or TH2 response (84).  
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 DC can present non-protein antigens to T cells via non-classical MHC class I molecules, 
CD1.  Thus far CD1 presentation has not been shown to have an affect on conferring protection 
in an M. tuberculosis infection, even though there is clear evidence that LAM is presented by 
CD1b and other mycobacterial lipids are presented by CD1a and CD1d (130).  However, mice 
do not have CD1 Group 1 antigens, so the importance of T cells restricted by CD1a, b, c is 
difficult to test. DC infected with BCG and M. tuberculosis induced modest protection in mice 
after challenge, which confirms the importance of DC in initiating a protective immune response 
(14). DC may also play a role in downmodulating the immune response, which in a M. 
tuberculosis infection, can cause considerable damage.  DC may participate in this 
downmodulation by B7 engaging CTLA-4 on activated T cells which inhibits the T cells 
proliferation.  APCs express B7-H1 that can engage inducible co-stimulatory receptors on T cells 
and induce IL-10 (reviewed in (152)).  It is believed that tolerance may be induced by immature 
DC phagocytosing apoptotic cells and then being unable to stimulate T cells (153).  
DC  may also function as effector cells .  DC were shown to produce NO (23), (55), (53), 
(54). NO produced by DC may play a role in autoimmune disease such as Multiple Sclerosis 
(MS).  In the mouse model of this disease, experimental allergic encephalomyelitis (EAE) the 
NO produced by the DCs caused apoptosis of the autoreactive T cells (53). NO production may 
not always be advantageous for the host.  In one study with M. avium it was suggested that the 
NO produced from macrophages did not kill M. avium and downregulated a TH1 response which 
helped the bacteria subvert the immune response (154).  Overall, DC may benefit the host by 
exhibiting anti-microbial mechanisms that protect them from being overwhelmed and killed 
during an infection.  In addition these mechanism may enhance their APC function since the DC 
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may retain live bacteria and retain the ability to stimulate T cells in a pathogen-specific manner 
(155).   
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Hypothesis and Specific Aims 
  My hypothesis is that DC are crucial for the initiation of a protective immune response in 
M. tuberculosis.  We hypothesize that they are infected in the lungs, migrate from the lungs to 
the draining lymph nodes to prime naive T cells, which will return to the lung to establish 
protective immunity. DC at the site of infection can also contribute to the immune response by 
secreting inflammatory cytokines.  We also hypothesize that DC will have effector functions that 
enable them to participate in control of M. tuberculosis infection.  
The basis for the initiation of the immune response which leads to protection in the 
majority of immunocompetent people infected with M. tuberculosis is not well understood.  
Although 1.8 million people are believed to be infected, only approximately 10% of 
immunocompetent people will present with active tuberculosis.  Therefore, in immunocompetent 
people a successful protective immune response is usually mounted.  A cell-mediated immune 
(CMI) response is necessary for adequate protection. However, alveolar macrophages have not 
been shown to generate a strong CMI; in fact they may be suppressive for T cells.  DC are potent 
antigen presenting cells (APC) and play critical roles in many infections and have been shown to 
play a role in eliciting T cell responses to airway pathogens. DC can secrete cytokines which 
favor a Type 1 T cell response necessary for the control of M. tuberculosis.  We investigated 
these and other roles DC play in M. tuberculosis infection and compared these roles to that of the 
macrophage, which is the known host cell for M. tuberculosis. We also examined the 
intracellular environment of DC to try to identify mechanisms which would be effective against 
M. tuberculosis.  These mechanisms may help to control the bacterial burden and also aid in the 
APC ability of the DC.  Our goal was to identify the unique role that DC play in this infection.  
 
The specific aims for this project are detailed below: 
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1.  Examine whether murine DC are infected and mature in response to M. tuberculosis 
infection: 
 
The infection of murine bone-marrow derived DC was examined and compared to 
macrophages.  Various markers of maturation in the DC, such as cell surface expression, 
cytokine production, and phagocytic ability were examined.  The antigen presenting 
ability of DC and macrophages cells was compared by examining the proliferation of T 
cells.  These data provide us with information about the ability of these cells to initiate a 
cell mediated immune response. 
 
2.  Examine the anti-mycobacterial mechanism in DC: 
We monitored the intracellular proliferation and growth of M. tuberculosis in untreated 
and IFN-γ + LPS-activated DC and macrophages. We investigated the production of RNI 
and the effect of these RNI on the intracellular growth of M. tuberculosis. These studies 
indicated that DC have anti-mycobacteriostatic effects which are NOS2 dependent.   
 
3.  Investigate the mechanism underlying the differences in bacterial killing between activated 
DC and macrophages. 
 
M. tuberculosis grew equally well within non-activated DCs and macrophage.  Activation 
of DCs and macrophages with IFN-γ and LPS inhibited the growth of the intracellular 
bacteria in an NOS2-dependent fashion.  However, while this activation enabled 
macrophages to kill the intracellular bacteria, the M. tuberculosis bacilli within activated 
DCs were not killed.  We examined the production other anti-microbial compounds, such 
as ROI, peroxynitrite, pH levels, intracellular compartmentalization of M. tuberculosis 
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within activated DC and macrophages to determine whether these contributed to the 
differences seen in killing.   
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CHAPTER 1 
Interaction of Dendritic Cells with Mycobacterium tuberculosis 
 
 
 
 
 
 
This chapter has been modified from: 
Bodnar, K. A., N. V. Serbina, and J. L. Flynn. Fate of Mycobacterium tuberculosis within Murine Dendritic Cells.  
Infection and Immunity.  69.  2:800-809. 
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Introduction 
It has been established that T cells provide protection against M. tuberculosis [reviewed 
in (156)] and there are studies supporting roles for both CD4+ and CD8+ T cells (15, 115, 117, 
125, 126, 157).  How precisely cell-mediated immunity is generated in a Mycobacterium 
tuberculosis infection is not known.  The interaction between DC and Mycobacterium 
tuberculosis may provide insight into how the protective immune response is generated.  
Macrophages, as well as DC, are monocyte derived cells which are phagocytic and can present 
antigens.  M. tuberculosis resides and multiplies within macrophages, which can be activated by 
IFN-γ and other signals to control the infection.   
The interactions between DCs and pathogens are of prime importance in establishing an 
appropriate immune response.  It has been demonstrated that DCs internalize various microbes 
(22, 158-165).  We reported previously that human peripheral blood-derived DCs phagocytose 
M. tuberculosis and subsequently display a phenotype consistent with that of a mature DC (22).  
Recently it has been reported that a murine DC cell line also can be infected with M. 
tuberculosis, which results in a mature phenotype with secretion of inflammatory cytokines (14).  
The initiation of a protective immune response depends on the interaction of antigen presenting 
cells (APC) and naïve T cells, which occurs in lymphoid organs, including lymph nodes.  
Dendritic cells (DCs) are considered to be the most potent APC and play a crucial role in the 
initiation of an adaptive immune response. Following phagocytosis of an antigen (such as a 
bacterium), mannose and Fc receptors on DCs are downregulated, while adhesion, antigen 
presenting, and co-stimulatory molecules for T cells are upregulated, resulting in a mature DC 
(140, 166). The murine model of tuberculosis has provided considerable insight about immune 
responses to M. tuberculosis.  In this study we extend the findings from our human DC studies to 
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the mouse system.  We present data indicating that the responses of DCs and MØ to M. 
tuberculosis infection differ and show that DC can prime an immune response which is 
protective against M. tuberculosis, one that is superior to that primed from macrophages.  This 
may have implications for the immune response against this microbe, as well as for the 
persistence of bacilli in the host.  
Materials and Methods 
Mice: 
Adult female (8-10) week old C57BL/6 mice (Jackson Laboratories, Bar Harbor, ME) 
were used.  NOS2-/- mice on a C57BL/6 background were generated by MacMicking, et al. (64) 
and kindly provided by Dr. Timothy Billiar (University of Pittsburgh School of Medicine).  All 
mice were maintained in a specific pathogen-free Biosafety Level 3 facility.   
  
Culture and purification of DC and ΜØ: 
DCs and MØ were generated from the bone marrow cells of C57BL/6 mice.  Briefly, 
cells were extracted from the femur and tibia bones of mice in DMEM medium.  For the MØ 
cultures, cells were washed twice in DMEM and 2.5 X 106 cells were plated in LabTek PS petri 
dishes (Fisher Scientific, Pittsburgh PA) in 25 ml DMEM supplemented with 10% certified FBS, 
1mM sodium pyruvate, 2mM L-glutamine (Life Technologies, Grand Island, NY), and 33% 
supernatant from L-cells fibroblasts cultured for 5-6 days.  All reagents were LPS-free and no 
antibiotics were used.  Medium was changed on day 3.  On day 5, adherent cells were washed 
twice with ice-cold PBS (Life Technologies, Grand Island, NY), incubated for 20 minutes on ice, 
and harvested using cell scrapers (Becton Dickinson Labware, Lincoln Park, NJ).  Cell 
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concentration was adjusted to 1.0 x 106 cells/ml and cells were placed in Teflon jars (1 ml) 
(Savillex, Minnetonka, MN) or aliquoted into a 96 well plate (200µl/well) for infection.  
 
For DC cultures, bone marrow cells were centrifuged at 1200 rpm for 7 minutes, and red 
blood cells were lysed with NH4Cl/Tris solution.  T cells (CD4+ and CD8+) were removed using 
Low-Tox–M rabbit complement (Accurate Chemical and Scientific Corporation, Westbury, NY) 
after incubation with anti-CD4 antibody (GK1.5 10µg/1 x 107 cells) and anti-CD8 antibody 
hybridoma supernatant (anti-CD8α, clone 83−15−5).  Cell concentration was adjusted to 1 x 106 
cells/ml and adherent cells were depleted by overnight culture in DC medium containing 
DMEM, 2 mM L-glutamine, and heat inactivated 5% mouse serum (Sigma, St. Louis, MO).  The 
non-adherent cells were cultured at 0.25 x 106 cells/ml in 24-well plates (Costar, Cambridge, 
MA) in DC medium containing 1000 Units/ml of rm-GM-CSF and rmIL-4 (Schering-Plough, 
Kenilworth, NH and kindly provided by Dr. Walter Storkus).  At day 5 cells, non-adherent cells, 
were harvested, adjusted to 1.0 x 106 cells/ml in DC media containing rmGM-CSF (1000 U/ml) 
and either dispersed into a 24 well plate (1 ml/well) or aliquoted into a 96 well plate (200µl/well) 
for infection.  
 
Bacteria 
M. tuberculosis strain Erdman (obtained from the Trudeau Institute, Saranac Lake, NY) 
was passed through mice, grown once in liquid (7H9 Middlebrook, Difco) medium, and frozen 
in aliquots at –800C.  Aliquots were used to start cultures at a concentration of 2.5 x 106 /ml in 
7H9 medium; bacteria were grown in 5% CO2 at 37oC.  Cultures were used at day 6 or 7 to infect 
cells. The bacteria were washed and resuspended in DC or ΜØ media, sonicated 10s in a cup-
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horn sonicator, then added to the cell cultures after estimation of bacterial numbers based on 
previous experience.  Enumeration of viable bacteria to confirm MOI was by plating for viable 
CFU on 7H10 Middlebrook medium and incubated for 18 days at 37 oC with 5% humidified 
CO2.  
 
Cytospins of DCs and MØ 
After culture for 5 days, 1 X 104 DCs and MØ in 40% FBS in RPMI medium were spun 
at 600 RPMs onto a glass slide in a Cytospin 3 centrifuge (Pittsburgh, PA).  The slides were 
airdried, fixed in acetone, then stained with a Diffquick staining kit (Sigma, St. Louis, MO). 
 
Infection of DCs and MØ 
After culture for 5 days, DCs (at 1 x 106/ml in DC media + rmGM-CSF, without IL-4) 
were infected in 24 or 96 well plates with M. tuberculosis at an estimated MOI of 3-5.  After 12 
hours, unincorporated bacteria were removed by pelleting the DCs at low speed (<1000 rpm) and 
reculturing with fresh media. In some experiments, MØ were cultured and infected in 96 well 
plates; monolayers were washed to remove extracellular bacteria and fresh medium was added.  
In experiments involving quantitative cultures of intracellular bacterial growth, stasis or killing, 
the MOI was reduced to 1 and extracellular bacteria were removed after 4 hours.  To estimate the 
percentage of infected cells for each experiment, DCs and MØ were either airdried on poly-L-
lysine coated slides or grown in parallel in glass culture well slides (Nalgene) and fixed in 1% 
paraformaldehyde at each time point.  Slides were stained by the Kinyoun method for acid–fast 
bacteria.  For phenotypic assays, DCs and MØ were cultured for an additional 48 hours. 
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Transmission electron microscopy 
Uninfected and M. tuberculosis-infected DCs were cultured as described above for 72 
hours post-infection. Cells (4 x 105) were gently pelleted at 2000 rpm for 2 minutes in microfuge 
tubes, washed twice in PBS, and then fixed in 1.5% paraformaldehyde and 1.0% glutaraldehyde 
in PBS.  Cells were post-fixed in 1% osmium tetroxide in PBS, dehydrated through a graded 
series of alcohols and embedded in Epon (Energy Beam Sciences, Agawam, MA).  Thin (60nm) 
sections were cut using a Reichert Ultracut S (Leica, Deerborn, MI), mounted on 200 mesh 
copper grids, counterstained with 2% aqueous uranyl acetate for 7 minutes and 1% aqueous lead 
nitrate for 2 minutes, and observed using a JEOL 1210 transmission electron microscope 
(Peabody, MA). 
 
Flow cytometry analysis of cell surface markers 
DCs and MØ were obtained and infected as described above.  Approximately 2-5 x 105 
were aliquoted into tubes and stained for surface markers using antibodies against MHC class I 
(PE-conjugated anti mouse H2Db clone KH95 with control Balb/c IgG2b), MHC Class II (FITC 
anti-mouse I-Ab clone AF6-120.1 with control mouse IgG2κ), ICAM-1 (FITC anti-mouse CD54 
clone 3E2 with control hamster IgG), B7.1 (FITC anti-mouse CD80 clone 16-10A1 with control 
hamster IgG), B7.2 (FITC anti-mouse CD86 clone GL-1 with control rat IgG2), and CD14 (PE 
anti-mouse clone rm C5-3 with control PE rat IgG1) in  PBS containing 20% mouse serum, 0.1% 
BSA, and 0.1% sodium azide (FACS buffer) for 30 minutes at 4oC.  All antibodies were used at 
0.2 µg/106 cells and obtained from PharMingen (San Diego, CA).  Cells were fixed in 2% 
paraformaldehyde for 4-15 hours and analyzed by flow cytometry (FACSCaliber) using Lysis II 
 44 
(acquisition) and Cell Quest (analysis) software (Becton-Dickinson Immunocytometry Systems, 
San Jose, CA). 
Phagocytosis assay 
 
Infected or control bone marrow derived DC and macrophages were harvested from 
culture and resuspended at 4 X 105/ml in DMEM medium and kept on ice. Eight microliters of 
FITC-latex conjugated beads of 3-micron diameter (Polysciences, Warrington, PA) were added 
to the cells and mixed well.  The cells were incubated with the beads for 2 hr at 370C or 40C.  The 
cells were washed five times after incubation with ice cold FACS medium then fixed for 1 hr 
with 1% formaldehyde before analysis by flow cytometry (FACScan; Becton Dickinson). 
 
Cytokine production 
Supernatants from control and M. tuberculosis-infected DCs and MØ cultures were 
harvested post-infection, filtered (0.2 µM filters), and stored at –800C.  ELISA antibody pairs 
were used to detect IL-10 (JES5-SXC1 and JES5-2A5), IL-12p70 heterodimer (C15.6 and 
C17.15) (BIOSOURCE International, Camarillo, CA), TNF-α (MP6-XT22 and MP6-XT3) 
(Pharmingen, San Diego, CA) in the supernatants. Recombinant cytokines (Pharmingen, San 
Diego, CA and Genetics Institiute, Cambridge, MA) were used to generate standard curves.  The 
ELISAs were performed according to Pharmingen’s protocol.   
 
RNAse protection assay (RPA) 
Determination of the levels of mRNA for the genes of interest at various time intervals 
after the infection was performed using a multiprobe RNAse assay system (Pharmingen, San 
Diego, CA). Total RNA, extracted from DC and MØ, cultured and uninfected or infected with 
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M. tuberculosis as detailed before, using Trizol reagent (Life Technology, Grand Island, NY).  
The extracted RNA was subjected to RPA according to manufacturer's instructions. Protected 
[32P]UTP-labeled probes were resolved on a 6% polyacrylamide gel and analyzed by 
autoradiography.  Cytokine analysis was performed using custom made probe sets specific for 
NOS2, IL-12p40, IL-1α, IL-1β, IFN−γ, and IL-10 (mck3) and IL-4, IL2p40, TNF-α, IFN-γ, IL-
1α, and IL1β (mck2Β). The expression of specific genes was quantified densitometrically 
(Image Quant, Molecular Dynamics, Sunnyvale, CA) relative to the abundance of housekeeping 
genes glyceraldehyde-3-phosphate dehydrogenase (GAPDH) or L32. 
 
T cell proliferation and cytokine production assays 
DCs and MØ uninfected or infected (MOI 4) as described before for 24 hours then plated 
in triplicate in 96-well U-bottom plates (Corning Incorporated, Corning, NY) at various 
concentrations to achieve 1:20–1:100 APC:T cell ratio in RPMI 1640 medium (Life 
Technologies, Grand Island, NY) containing 10% certified FBS, 1mM sodium pyruvate, 2mM L-
glutamine, 25mM HEPES (Life Technologies, Grand Island, NY) and 50 µM 2-ME (Sigma, St. 
Louis, MO).  As a source of sensitized T cells, spleens were obtained from C57BL/6 mice 
infected for 4-5 weeks and single cell suspensions were obtained by crushing the spleens in cell 
strainers (Becton Dickinson Labware, Lincoln Park, NJ). Red blood cells were lysed with 
NH4Cl/Tris solution, and cells were washed twice. MØ were depleted by adherence on plastic 
Petri dishes for 2 h at 37°C. In some experiments, B cells were depleted by adherence on anti-
IgG/anti-IgM Ab coated plates (Zymed Laboratories, Inc., San Francisco, CA).  Lymphocyte-
enriched splenocytes were added at 2-4 x 105 cells/well and cultured with different APC for 3 
days. Proliferation of T cells in medium alone served as a baseline. As a positive control, cells 
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were stimulated with ConA (Boehringer Mannheim Corporation, Indianapolis, IN) at 5 µg/ml.  
Cells were pulsed for the final 12-18 h of culture with 1 µCi/well [3H] thymidine (Amersham 
Life Sciences, Inc., Arlington Heights, IL) and the incorporation of radioactivity was measured 
by counting cell lysates on filters in scintillation counter. The stimulation index was determined 
by (cpm T cell + infected APC/cpm T cells + uninfected APC). Culture supernatants were 
harvested after 3 days of culture and IFN-γ production was measured by sandwich ELISA using 
antibodies R4-A62 and XMG1.2 (biotinylated) (Pharmingen, San Diego, CA), according to the 
manufacturer’s protocol. Recombinant murine IFN-γ used to generate a standard curve was a gift 
from Genentech (San Francisco, CA). 
 
Statistics 
For statistical analysis of samples, paired and  unpaired student t tests were used (Instat, 
v. 2.03, GraphPad Software, San Diego, CA and StatView, Abacus Concepts, Berkeley, CA).  P 
values <0.05 were considered significant. 
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Results 
Murine bone-marrow derived DCs have a different morphology from that of murine bone-
marrow macrophages. 
The bone-marrow generates pleuripotent hematopoietic stem cells which produce 
lymphocyte and monocyte lineages.  These hematopoietic cells give rise to lymphocytes, such as 
T cells and B cells; monocytes, which include professional antigen presenting cells, such as 
macrophages and DCs; as well as granulocytes, natural killer cells, esonophil, and basophil.  M. 
tuberculosis infects macrophages and this study examined their ability to affect another 
monocytic derived APC, the dendritic cell (DC). Although these two cell types are derived from 
the same precursors, macrophages and DCs become very discreet and distinct cell types due to 
the different growth factors they encounter as monocytes.  The maturation of DC is characterized 
by many surface markers changes such as antigen presenting molecules, MHC class II, MHC 
class I; T cell co-stimulatory molecules, B7.1, B7.2, CD-40; and adhesion molecules such as 
ICAM-1, LFA-3.  There is also a decrease in phagocytosis and receptors, such as FcR and 
mannose receptors (167).  These changes are visualized by flow cytometry as described in the 
next section.   
In addition to these changes there is also a morphological change to the DC after it 
transitions from a monocyte and this different than the morphology of a macrophage.  DCs have 
a veiled appearance and cytoplasmic processes that can extend far out from cell.  DCs have a 
high cytoplasm to nuclei ratio (168). A simple stain and light microscopy can reveal these 
morphological differences.  We generated immature murine DC by culture of bone-marrow cells 
for five days in LPS-free media supplemented with 5% mouse serum, rmGM-CSF and rmIL-4.  
Murine macrophages were generated from the bone-marrow cells and cultured in media 
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supplemented with 10% fetal bovine serum, sodium pyruvate, glutamine, and supernatant of L-
cells, which provide the growth factors for macrophages.  These cells were harvested and spun 
onto a glass spin by a cytospin procedure then stained and viewed with a light microscope (Fig. 
1).  The cytospins show the unique appearance of the DC with the long processes (Fig 1A), 
whereas the macrophage cytoplasm is elongated and stretched it does not have any processes 
(Fig 1B).  We can isolate both macrophages and DC from the murine bone-marrow and use these 
in our study to compare what M. tuberculosis does to these cells and in the next chapter we show 
what happens to the bacteria within these untreated and activated cells. 
 
Infection of murine DCs with M. tuberculosis. 
Immature DCs are highly phagocytic and readily take up various microbes, whereas 
mature DCs lose their phagocytic ability (168, 169).  The DCs we generate in autologous serum 
with LPS-free reagents and medium have a very immature phenotype as judged by cell surface 
molecule expression low expression of MHC class II, B7.1, B7.2, and moderate expression of 
ICAM (Figure 1), morphology, and a high phagocytic ability, as determined by the uptake of 
FITC-labeled beads (Figure 2).  Therefore, these DCs should readily take up bacteria.  MØ were 
also derived from bone-marrow precursors and were shown to also have a high phagocytic 
ability (Figure 2) and are known to be readily infected with M. tuberculosis (170).  The DCs and 
MØ were infected with M. tuberculosis at an estimated multiple of infection (MOI) of 3-5 for 12 
hours.   The use of a higher MOI (5-10) resulted in a higher percentage of infected cells or more 
bacteria per cell, but was associated with a loss of cell viability.  To confirm the mycobacteria 
were internalized, infected DCs were examined using transmission electron microscopy (Figure 
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2).  M. tuberculosis bacilli were observed within vacuoles of the DCs and multiple bacilli were 
often present within the cell.  Bacteria free in the cytoplasm were not observed.   
 
Murine DC can be infected with M. tuberculosis and was comparable to the infection of MØ.   
Infection of DC resulted in 50-70% of the cells infected, as judged by staining for acid 
fast bacilli and this is comparable to infection of macrophages (Figure 3).  Human-peripheral 
blood derived DC (MDDC) were compared to human-peripheral blood derived macrophages 
(MDM) and the MDDC were suggested to be more active in the phagocytosis of M. tuberculosis 
which resulted in a slightly higher infection and slightly more bacilli per cell then macrophages 
(147).  We observe very similar infection in vitro with the murine-derived cells.  It was reported 
that human derived DCs infected with M. tuberculosis at an MOI of 2.5 results in 63% of the 
cells infected, which is compared to the murine DCs.  As well higher MOI resulted in 93% of the 
DC infected but caused a large amount of cell death (148).  Lung derived DC have been show by 
acid fast staining to be infected in vitro with M. tuberculosis (146).  However, these were not 
directly compared to alveolar macrophages.  This data show that there maybe another reservoir 
for M. tuberculosis other than the macrophage. 
 
Murine DCs and MØ respond differently to M. tuberculosis infection. 
We previously reported that M. tuberculosis infection of human PBMC-derived DCs 
resulted in phenotypic maturation of the cells.  To confirm a similar effect on murine DCs, we 
examined cell surface marker expression following M. tuberculosis infection of murine bone-
marrow derived DCs and MØ by flow cytometry.  The DCs generated from bone marrow were 
cultured in mouse serum and have a very immature phenotype.  DCs infected with M.  
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Figure 1.  Morphology of bone-marrow derived DC compared to macrophages.  
 
Cytospins of bone-marrow derived (A) DC and (B) macrophages cultured as described in 
Material and Methods were stained with Diffquick (Sigma, St. Louis, MO).   
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Figure 2.  Immature murine DCs internalize live M. tuberculosis.  
 
DCs infected with M. tuberculosis were fixed, embedded, sectioned, and examined by 
transmission electron microscopy (EM).  Arrows indicated M. tuberculosis.  The micrograph 
shown is representative of 25 individual cells observed. 
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Figure 3.  Murine DC can be infected with M. tuberculosis and was comparable to the infection 
of MØ.  
 
DCs and MØ were cultured with live M. tuberculosis for 12 hours.  DC and MØ were allowed to 
adhere to glass culture well slides, fixed in paraformaldehyde, and stained for acid-fast bacilli by 
the Kinyoun (cold) method (mycobacterium stain red).  A.  DC infected with M. tuberculosis and 
B. MØ infected with M. tuberculosis. 
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Figure 4.  Cell surface phenotype of DCs infected with M. tuberculosis.  
 
Purified bone marrow-derived DC and MØ were infected with M. tuberculosis or uninfected and 
harvested 48 hours post-infection.  The cells were stained for IAb - FITC conjugated (MHC class 
II) with mouse IgG2a, CD54-FITC (ICAM) and CD80-FITC (B7.1) with hamster IgG,  CD86-
FITC (B7.2) with rat IgG2a, and CD-14-PE with rat IgG antibodies, fixed, and analyzed by 
FACS analysis. Top row, MØ; bottom row, DC; dotted line, IgG control; thin gray line, 
uninfected cells; thick black line, M. tuberculosis-infected cells.  A representative experiment of 
10 independent experiments is shown.   
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tuberculosis showed a consistent upregulation in expression of cell surface molecules ICAM, 
B7.2, and B7.1, as compared to uninfected cells (Figure 4, Table 1), suggesting a shift to a more 
mature phenotype.  Although the MØ express MHC Class I and II, B7.1, B7.2, and ICAM-1, 
these were not generally upregulated following infection with M. tuberculosis.  The MØ express 
high levels of CD14, a receptor for LPS, which is highly expressed on macrophages.  Whereas 
the DCs only express a small amount of CD14, which appears to be slightly upregulated upon 
infection and this has been described elsewhere (Figure 4, Table1) (171).  The morphology of 
both population of cells is changed post-infection (Fig. 5) although the surface marker expression 
of MØ does not change much.  
Immature DCs are quite phagocytic, but this is reduced upon maturation (172, 173).  We 
compared the effect of M. tuberculosis infection on the phagocytic potential of murine DC and 
macrophages using FITC-labeled 3 micron labeled latex beads (Figure 6).  Upon infection, DCs 
had reduced phagocytic ability at 37°C compared to uninfected DC (lower MFI and percent 
gated).  In contrast, no change in phagocytic potential of macrophages was observed following 
infection (Figure 6). These data suggest that M. tuberculosis infection results in maturation of 
DCs, confirming the results obtained with human DCs (22) and to that of other infections (174). 
 
Inflammatory cytokines induced by M. tuberculosis infection of DCs. 
Macrophages infected with M. tuberculosis secrete inflammatory cytokines, which can 
influence cytokine production by T cells (175).  The production of cytokines by DCs during  
priming of T cells in the lymph node is likely to affect the initiation of an immune response 
against an infection.  IL-10, IL-12, and TNF-α secretion by M. tuberculosis-infected DC and MØ 
culture were measured.  IL-12 was detectable by 12 hrs in M. tuberculosis-infected DCs and as  
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Figure 5.  Cell size and density of DCs and macrophages infected with M. tu
 
Purified bone marrow-derived DC and MØ were infected with M. tubercul
harvested 48 hours post-infection.  The cells were stained, fixed, and
analysis.  The forward versus side scatter plots show that both the DC and 
changes after infection. 
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osis or uninfected and 
 analyzed by FACS 
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 MACROPHAGE DENDRITIC CELLS 
 uninfected +M.tb  uninfected +M.tb  
 MFI* %+ MFI %+ fold 
increase ^ 
MFI %+ MFI %+ fold 
increase ^ 
MHC molecules 
          
CD14-PE  209.69 68.0 272.80 93.0   1.3 129.3 28.0 138.9 38.0 1.1 
IA6-FITC (class II) 110.0 12.6 126.0 14. 1.1 49.0 18.0 210.2 44.0 4.0 
hamster IgG-PE    10.52 2.5    20.6 2.3  
murine IgG-FITC   11.5 1.8    8.96 1.4  
Co-stimulatory 
molecules 
          
CD-80 (B7.1) 84 55.0 101.0 77. 1.2 67.0 58.0 113.4 68.0 1.7 
CD-86 (B7.2) 103.1 16.5 107.9 16.0 0.9 50.0 4.19 118.0 27.8 2.4 
hamster IgG-FITC   6.09 1.23    4.4 2.3  
rat IgG2a-FITC   6.24 0.2    4.9 0.58  
Adhesion molecule 
          
CD54 (ICAM-1) 128.0 36.0 129.0 38.0 1.0 62.0 45.0 245.0 93.0 3.9 
hamster IgG-FITC   6.51 0.7    4.4 1.9  
Table 1.  Cell Surface Phenotypes of DCs infected with M. tuberculosis. 
 
 
Purified bone marrow derived DCs and were infected with M. tuberculosis or uninfected and 
harvested 48 hours post-infection.  The cells were stained for H-2D-PE conjugated (MHC class 
I), IAb - FITC conjugated (MHC class II), CD54-FITC (ICAM), CD-80-FITC (B7.1),  CD-86-
FITC (B7.2), and CD14-PE antibodies, fixed, and analyzed by FACS analysis. Cells were gated 
on size (forward angle scatter) and density (side scatter) to exclude cellular debris and dead cells.  
The table shows a representative FACS experiment of 10 independent experiments. 
* Mean Fluorescence Intensity ^ MFI compared to the MFI of uninfected cell 
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Figure 6.  Phagocytic capability is decreased in M. tuberculosis-infected DC but not 
macrophages.   
Purified DC and MØ were cultured without (top panel) or with M. tuberculosis (bottom panel).  
After 72 hours, cells were incubated with 3 micron FITC-labeled latex beads for 2h at 4°C (1st 
and 3rd row) or 37°C (2nd and 4th row) and examined by flow cytometry.  Dead cells and free 
beads were excluded from gate and 1 X 104 cells were collected within the gate for each sample. 
Mean fluorescence intensity (MFI) is indicated in each histogram. Bar above histograph 
represents gate.  % gated: DC uninfected:4°C= 20%, 37°C= 76%; DC +M.tb: 4°C=5%, 
37°C=37%; MØ uninfected: 4°C = 33%, 37°C =93%, MØ +M.tb:4°C =14%, 37°C =83%.  
Experiment was repeated once. 
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early as 4 hrs in infected MØ, and increased over the course of infection (Figure 7A).  Infected 
MØ produced 2-5 fold more IL-12 than infected DCs. TNF-α  was produced by M. tuberculosis-
infected DCs and MØ by 4 hrs post-infection, with decreased production at later timepoints 
(Figure 7B).  Infected DCs consistently produced more TNF-α early compared with infected MØ 
but infected MØ produced more later and this did not decline as quickly.  This pattern matches 
the pattern of RNA expression (Figure 8B) .  Uninfected DC and MØ produce negligible 
amounts of TNF-α and IL-12 (Figure 8, time 0).  We also assessed TNF-α, IL-12, and IL-10 
gene expression by an RNAse Protection Assay. IL-12 gene expression was barely detectable in 
M. tuberculosis infected DCs and MØ until 24 hours; no gene expression was observed in 
uninfected cells.  There was a noticeable increase TNF-α gene expression over uninfected cells 
at all timepoints (Figure 8).  In addition, IL-1α and IL-1β gene expression increased with 
infection in both cells (not shown).  IL-10 was not detected in either uninfected or M. 
tuberculosis-infected cells at any of the time points examined, by ELISA or by intracellular 
cytokine staining (data not shown).  However, a low level of RNA was detected in M. 
tuberculosis-infected DC and MØ and this increased over time (Figure 8).   
Stimulation of T cell proliferation and cytokine production by antigen presenting cells.  
The differential effect of mycobacterial infection on expression of co-stimulatory molecules by 
DC and MØ suggested that they might differ in mycobacterial antigen presenting functions.  To 
assess the ability of infected DCs and MØ to stimulate T cell effector functions, T cells from M. 
tuberculosis-infected mice were cultured with either DCs or MØ as APCs.  Both uninfected and 
live M. tuberculosis-infected APCs were used.  M. tuberculosis-infected DCs induced substantial 
proliferation of T cells from infected mice (Figure 9A).  In contrast, uninfected DCs and MØ 
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Figure 7.  Cytokine secretion in response to M. tuberculosis-infected DCs and MØ. 
 
 
Supernatants from M. tuberculosis-infected unactivated DCs (black circles) and ΜØ (white 
squares) were assayed in duplicate for cytokine production  IL-12 (ELISA for IL-12p70) or TNF.  
Time 0 represents cytokine production from the cells prior to infection.  Recombinant murine 
cytokines were used as standards in each assay.  A representative experiment of 4 experiments is 
shown for IL-12 and 2 experiments for TNF-α. 
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Figure 8.  Cytokine gene expression in response to M. tuberculosis-infected DCs and MØ.  
 
Analysis of gene expression by RNase protection assay. 6 µg of RNA from either uninfected or 
M. tuberculosis-infected DC (black circles, dotted line)  and MØ (solid line, white squares) at 
various time points was used in the assay and specific genes of interest were standardized to 
GAPDH by densitometerization of the autoradiograph.  A representative experiment of 2 
experiments is shown.   
IL-12 TNF-α IL-10 
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Figure 9.  Stimulation of T cell proliferation and cytokine production by antigen presenting cells.  
 
T cell enriched splenocytes from C57BL/6 mice were cultured for 3 days with bone marrow 
derived DC or MØ, either infected with M. tuberculosis (MOI 4) or left uninfected, at 1:50 ratio 
of APC:T cells.  (A) Proliferation was measured by 3H-thymidine incorporation and is 
represented as the stimulation index. Stimulation with Con A resulted in ~18,000 cpm and 
stimulation with infected DCs resulted in ~16,000 cpm. DCs, MØ or T cells alone incorporated 
fewer than 2000 cpm.  (B) Supernatants of the cultures described above were collected at the end 
of the culture period and concentration of IFN-γ was measured by sandwich ELISA. A 
representative experiment (of 3 experiments) is shown.
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and, surprisingly, even infected MØ were very poor stimulators of T cells from infected mice 
(Figure 9A). T cells, DCs or MØ alone did not proliferate to a significant extent (data not 
shown).  A correlation was observed between stimulation of T cell proliferation and IFN-
γ production.  M. tuberculosis-infected DCs readily stimulated secretion of IFN-γ by T cells from 
infected mice, at levels comparable to that induced by Con A (Figure 9B). However, little IFN-γ 
secretion was observed when infected MØ, or uninfected DCs and MØ were used as APCs 
(Figure 9B). 
 
Discussion: 
 DC readily internalized M. tuberculosis bacilli, and subsequently displayed phenotypic and 
functional changes, including upregulation of various cell surface molecules important in 
initiating immune responses and downregulation of phagocytic ability, as well as producing 
inflammatory cytokines.  These DCs were superior to macrophages in stimulating proliferation 
and IFN-γ production of mycobacteria-specific T cells in this study (97) (14).  M. tuberculosis-
infected DC and macrophages have recently been suggested to differentially polarize naïve T 
cells (87).  M. tuberculosis-infected DC biased a  Type 1 (IFN-γ producing) response (TH1) 
response whereas macrophages did not (87).  In order to develop a protective immune response 
to M. tuberculosis a Type 1 T cell response must be initiated; therefore these data suggest that 
the DC is a critical link to protection from disease. 
Mouse bone marrow derived DC infected with M. tuberculosis for 48 hours demonstrated 
increased cell surface expression of ICAM-1, B7.1 and B7.2 molecules (both % positive cells 
and MFI), while decreasing their phagocytic ability and this differed from M. tuberculosis 
infection of macrophages.  These data are consistent with our previous work with M. 
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tuberculosis infection of human PBMC-derived DCs, although upregulation of cell surface 
molecules was less profound in the murine system, and with the results reported by Tascon, et al, 
using the tsDC cell line (14).  Although levels of B7 expression were similar between our 
primary DCs and the tsDC line, we also observed an increase in ICAM-1 after infection, which 
was not observed using the tsDC cell line (14).  A consistent up or down regulation of MHC I or 
II was not observed in our studies.  It may be that levels of MHC class I and II are susceptible to 
variables such as MOI, percentage of infected cells, and the number of live (or dead) bacilli per 
cell.  We also did not observe down regulation of MHC Class II on macrophages following 
infection, in either this study or in our study with human DCs and MØ (22), in contrast to 
published reports (176-178).  
Inflammatory cytokine production by DCs would be expected to influence the T cell 
phenotype primed in the lymph node (179).  M. tuberculosis-infected DCs produced low to 
moderate amounts of IL-12, which would skew the primed T cell response toward a TH 1 (IFN-
γ producing) response.  The IL-12 produced directly by DC has been shown to be important in 
Mycobacterium leprae infection (149).  Production of this cytokine was lower in DCs than in our 
M. tuberculosis infected MØ.  IL-12 production by DCs following infection with microbial 
pathogens has been reported, although down regulation of constitutive IL-12 production by DC 
following infection with certain pathogens has also been reported (180, 181).  DCs infected with 
Toxoplasma gondii have a refractory period where IL-12 production is low, but upon 
restimulation, IL-12 production can increase (182).  In the human in vitro system human DCs 
infected with M. tuberculosis also produced a low but reproducible amount of IL-12 (147), (22). 
However, in vitro the human macrophages infected with M.tuberculosis did not produce any 
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detectable levels of IL-12 which makes the small amount of IL-12 produced by the DC even 
more critical.   
TNF-α production following M. tuberculosis infection was initially higher in DC 
compared to MØ, but MØ did not decrease TNF-α production as quickly.  This is similar to the 
pattern seen with M. tuberculosis infection of human DCs (22).  IL-10 production was not 
observed in infected DC or macrophages up to 60 hours post-infection.  Low levels of mRNA 
are detected and increased by 24 hours (Fig 4C). This down regulatory cytokine may be 
produced later in infection, or may be produced primarily by T cells during this infection.  
Recently Giacomini et. al showed that human-derived DCs produced IFN-γ inducing cytokines 
such, as IL-12 and IFN-α; whereas macrophages produced more pro-inflammatory cytokines 
such as TNF-α, IL-1, and IL-6, as well they produced IL-10 whereas the DC did not (147).  
Although the cytokine profile seems to be more distinctive between the human macrophages and 
DCs in their system the hypothesis is that DC and macrophages play very separate functions in a 
M. tuberculosis infection and we also observe this phenomenon.  Giacomini et. al. believe based 
on these cytokine differences that macrophages induce granulomatous inflammatory response 
while DCs induce an anti-mycobacterial T cell immune response.  As well we have shown that 
DC are better at stimulating T cells and respond to M.tuberculosis infection in different ways, 
such as surface marker changes and cytokine production then macrophages.   
We believe that the ability of DC excel at presenting mycobacterial antigens is important 
since they are capable of migrating from the site of a mycobacterial infection, most likely the 
lung, to the lymph nodes which drain the lung to stimulate a naïve population of T cells.  DC 
have been shown to reside in murine lungs in the tissue, airways, and interstitium (183).  
Although the DC in the lung are only estimated to be less than 1% of the pulmonary 
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mononuclear cellular population they have been shown to be very effective APCs in the lung 
(183). Alveolar macrophages in particular have been shown to be suppressive in a mycobacterial 
infection, and resident lung macrophages are believed to be less likely to migrate from the lungs 
following infection.  Therefore, it has been unclear as to how protective immunity is generated in 
a M. tuberculosis infection.  We believe that DC are the missing link and will provide valuable 
information as to help protective immunity is generated.   
DC have been shown to be good candidates for vaccine development against 
mycobacterial infections (149).  Although this may not be the most practical approach for 
developing a vaccine against this pathogen, studies using infected DC have shown that they can 
generate protection from tuberculosis.  IL-12-transfected DC were shown to protect against 
Leishmania donovani challenge within mice.  BCG-infected-DC generated a more rapid 
induction of cellular immunity in mice than vaccination with BCG alone but both types of 
vaccination resulted in the same level of protection (184).  Mice injected with DC infected with 
M. tuberculosis were shown to be protected after challenge with M. tuberculosis to a higher 
degree than the current vaccine, BCG (14).  However vaccination with DC given immune 
stimulating cell components of M.tuberculosis, such as LAM, were not as effective at generating 
immunity as BCG in their system.  These data reinforce the importance of DC in generating an 
immune response in infection. The data also suggest that DCs harboring live, rather than killed, 
bacteria can stimulate a better immune response.  We next examined the intracellular viability if 
M. tuberculosis within DCs (Chapter 2).  
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CHAPTER 2 
DC inhibit the intracellular growth of Mycobacterium tuberculosis 
 
 
 
 
 
 
 
 
 
 
 
 
This chapter has been modified from: 
Bodnar, K. A., N. V. Serbina, and J. L. Flynn. Fate of Mycobacterium tuberculosis within Murine 
Dendritic Cells.  Infection and Immunity.  69.  2:800-809. 
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Introduction 
The fate of a microbe within a DC may affect presentation of antigen by the DC to naïve 
T cells.  The bactericidal capabilities of DC might be expected to correspond to those of MØ, 
given the similarity in progenitor cell, but studies examining the fate of microorganisms within 
DC are rare.  The production of nitric oxide by DC is dependent on activation with IFN-γ and a 
second signal (185).  DCs encountering a pathogen in tissue, for example the lung, early in 
infection, are not likely to also encounter specific T cells secreting cytokines, such as IFN-γ, to 
activate the DC.  There have been relatively few studies on the effect of DC, particularly 
activated DC, on intracellular bacteria.  DC, due to their antigen-processing ability, have means 
to kill microbes, degrade them, proteolytically process their proteins for peptides to present  DC 
are capable of killing Chlamydia trachomatis and Chlamydia psittaci by phagosome-lysosome 
fusion, then processing and presenting these antigens to stimulate naive CD4+ cells (165).  
 DC are well established as potent antigen presenting cells (APC) and key to initiating a 
cell mediated immune response, which is particularly important for intracellular pathogens (186).  
Our lab and others have previously reported that DC can be infected with M. tuberculosis in 
vitro, and in response secrete inflammatory cytokines and shift to a more mature, antigen 
presenting phenotype.  M. tuberculosis-infected DC are better at stimulating T cell responses 
than infected MØ (23) (97) (14).  In this study we examined the ability of DC to control the 
growth of intracellular M. tuberculosis.  DC have been demonstrated to take up various 
microbes, including Salmonella (160, 187), E. coli (187), Listeria monocytogenes (188), Borrelia 
burgdorferi (161, 189), Bordetella bronchiseptica (159), BCG (158, 190), Leishmania (162, 163, 
191), and Chlamydia (164, 165, 192, 193), Histoplasma capsulatum (194), and Candida albicans 
(195).  Salmonella was reported to survive and replicate within unactivated murine DC (160).  
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The inability of the DC to clear B. bronchiseptica suggested that it may contribute to the natural 
infection and provide a reservoir for this bacteria (159).  We have reported that DC can infect 
human and murine DC, and we report here that unactivated DC permit the growth of M. 
tuberculosis and may also be a reservoir for the infection.  Leishmania parasites have been 
shown to persist within DC in lymph nodes, suggesting that DC are impaired in their ability to 
kill Leishmania (162, 163).  Recent studies indicate that certain parasitic infections, such as 
Trypanosoma cruzi and Plasmodium falciparum, downregulate inflammatory cytokine 
production and prevent maturation of the DC (181, 196). These parasites apparently manipulate 
DC as an immune evasion strategy.   
 DC, unlike MØ, are not typically considered to have effector functions against 
intracellular organisms.  Once a microbe is ingested by a phagocyte, such as a macrophage or 
DC, it is usually retained in a vacuole; many intracellular pathogens can replicate and survive in 
the phagosome.  However, it has long been known that upon activation with IFN-γ and a second 
signal, macrophages makes this environment quite hostile for microbes (24), (25), (26).  Upon 
activation macrophages can produce compounds, such as reactive oxygen intermediates (ROI) 
and reactive nitrogen intermediates (RNI), that have potent anti-microbial effects (40), (197).  
The vacuole containing the microbe will also proceed through the endocytic pathway to fuse 
with the lysosome and acidify this newly formed compartment (33).  In this acidic environment, 
activation of hydrolytic and reactive oxygen intermediate (ROI) producing enzymes is enhanced. 
Compounds such as ROI and RNI can also become more potent as their half lives increase, new 
compounds form, or they become more reactive (56).  Many viruses, bacteria, and parasites are 
susceptible to this environment.  But, many microbes have developed means to survive.  Listeria 
monocytogenes can escape the phagosome (198), (199), Legionella pneumophila prevents 
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phagosome-lysosome fusion in the host cell (200), Coxiella burnetti replicates only under acidic 
conditions (201), and M. tuberculosis can also prevent phagolysosome fusion (33) and (202) 
 M. tuberculosis is an intracellular pathogen that can often survive in the harsh 
environment of the macrophage. The nitric oxide produced by an activated macrophage via 
NOS2 dependent pathways has been shown to kill, at most, only half of the intracellular bacteria 
in a population of macrophages in vitro (61).  We directly compared the growth and killing of M. 
tuberculosis in DC and macrophages to determine whether these phagocytic cells had the same 
capacity to kill M .tuberculosis. DC produce RNI, which was suggested to downregulate a strong 
TH 1 T cell response or kill autoreactive T cells (55), (203).  Langerhans cells have been shown 
to produce RNI but its function was not determined  (204), (205).  We report here that the RNI 
produced by activated DC can prevent the growth of M. tuberculosis intracellularly.  The 
production of RNI by macrophages activated with IFN-γ and LPS is known to be a potent means 
to kill intracellular organisms.  RNI production by DC had not been reported to kill intracellular 
pathogens previously.  A recent study reported that RNI did not kill Candida albicans, although 
this organism was killed within a mature DC, supposedly by lysosomal hydrolyases after 
phagolysosomal fusion (195).   
 Our data supports the idea that DC have a state beyond that of mature, in which they 
produce anti-microbial compounds after exposure to IFN-γ and a second signal. A recent review 
of nitric oxide in the immune response discusses that Langerhans cells, murine bone-marrow 
DC, DC cells line produce RNI in response to IFN-γ and a second signal such as LPS (206).  The 
exception was rat thymic DC which appeared to produce RNI simply to self-antigens (203), 
(194).  The activation of DC to produce RNI suggests that there are roles for DC beyond that of 
the traditional role of an antigen presenting cell.  DC may be a critical link between the innate 
 70 
and the CMI (207),  especially in the lung (194).  The ability of DC to kill microbes such as 
Borrelia burgdorferi and Chylamdia species by phagolysosome fusion resulted in the direct 
processing and presentation by MHC II, resulting in CD4+ T cell stimulation.  Other studies have 
shown that the ability of the DC to stimulate T cells was enhanced when the microbe was not 
killed such as Leishmania major(162), Histoplamsa capsulatum (194), Candida albicans (195), 
and B. burgdorferi (161).  Therefore this different role for DC as an effector cell may be directly 
linked to its potency as an antigen presenting cell.  The data we present here suggest that DC 
play a role in an M. tuberculosis infection.  The differences in the ability to kill between the 
activated DC and MØ suggest that in this infection DC have functions which are distinct from 
that of MØ. 
   
Materials & Methods 
 
Mice 
Adult female (8-10) week old C57BL/6 mice (Jackson Laboratories, Bar Harbor, ME) 
were used.  NOS2-/- mice on a C57BL/6 background were generated by MacMicking, et al. (64) 
and kindly provided by Dr. Timothy Billiar (University of Pittsburgh School of Medicine).  All 
mice were maintained in a specific pathogen-free Biosafety Level 3 facility.   
  
Culture and purification of DC and ΜØ 
DCs and MØ were generated from the bone marrow cells of C57BL/6 mice.  Briefly, 
cells were extracted from the femur and tibia bones of mice in DMEM medium.  For the MØ 
cultures, cells were washed twice in DMEM and 2.5 X 106 cells were plated in LabTek PS petri 
dishes (Fisher Scientific, Pittsburgh PA) in 25 ml DMEM supplemented with 10% certified FBS, 
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1mM sodium pyruvate, 2mM L-glutamine (Life Technologies, Grand Island, NY), and 33% 
supernatant from L-cells fibroblasts cultured for 5-6 days.  All reagents were LPS-free and no 
antibiotics were used.  Medium was changed on day 3.  On day 5, adherent cells were washed 
twice with ice-cold PBS (Life Technologies, Grand Island, NY), incubated for 20 minutes on ice, 
and harvested using cell scrapers (Becton Dickinson Labware, Lincoln Park, NJ).  Cell 
concentration was adjusted to 1.0 x 106 cells/ml and cells were placed in Teflon jars (1 ml) 
(Savillex, Minnetonka, MN) or aliquoted into a 96 well plate (200µl/well) for infection.  
 
  For DC cultures, bone marrow cells were centrifuged at 1200 rpm for 7 minutes, and red 
blood cells were lysed with NH4Cl/Tris solution.  T cells (CD4+ and CD8+) were removed using 
Low-Tox–M rabbit complement (Accurate Chemical and Scientific Corporation, Westbury, NY) 
after incubation with anti-CD4 antibody (GK1.5 10µg/1 x 107 cells) and anti-CD8 antibody 
hybridoma supernatant (anti-CD8α, clone 83−15−5).  Cell concentration was adjusted to 1 x 106 
cells/ml and adherent cells were depleted by overnight culture in DC medium containing 
DMEM, 2 mM L-glutamine, and heat inactivated 5% mouse serum (Sigma, St. Louis, MO).  The 
non-adherent cells were cultured at 0.25 x 106 cells/ml in 24-well plates (Costar, Cambridge, 
MA) in DC medium containing 1000 Units/ml of rm-GM-CSF and rmIL-4 (Schering-Plough, 
Kenilworth, NH and kindly provided by Dr. Walter Storkus).  At day 5 cells, non-adherent cells, 
were harvested, adjusted to 1.0 x 106 cells/ml in DC media containing rmGM-CSF (1000 U/ml) 
and either dispersed into a 24 well plate (1 ml/well) or aliquoted into a 96 well plate (200µl/well) 
for infection.  
 
Bacteria 
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M. tuberculosis strain Erdman (obtained from the Trudeau Institute, Saranac Lake, NY) 
was passed through mice, grown once in liquid (7H9 Middlebrook, Difco) medium, and frozen 
in aliquots at –800C.  Aliquots were used to start cultures at a concentration of 2.5 x 106 /ml in 
7H9 medium; bacteria were grown in 5% CO2 at 37oC.  Cultures were used at day 6 or 7 to infect 
cells. The bacteria were washed and resuspended in DC or ΜØ media, sonicated 10s in a cup-
horn sonicator, then added to the cell cultures after estimation of bacterial numbers based on 
previous experience.  Enumeration of viable bacteria to confirm MOI was by plating for viable 
CFU on 7H10 Middlebrook medium and incubated for 18 days at 37 oC with 5% humified CO2.  
 
Infection of DCs and MØ 
After culture for 5 days, DCs (at 1 x 106/ml in DC media + rmGM-CSF, without IL-4) 
were infected in 24 or 96 well plates with M. tuberculosis at an estimated MOI of 3-5.  After 12 
hours, unincorporated bacteria were removed by pelleting the DCs at low speed (<1000 rpm) and 
reculturing with fresh media. In some experiments, MØ were cultured and infected in 96 well 
plates; monolayers were washed to remove extracellular bacteria and fresh medium was added.  
In experiments involving quantitative cultures of intracellular bacterial growth, stasis or killing, 
the MOI was reduced to 1 and extracellular bacteria were removed after 4 hours.  To estimate the 
percentage of infected cells for each experiment, DCs and MØ were either airdried on poly-L-
lysine coated slides or grown in parallel in glass culture well slides (Nalgene) and fixed in 1% 
paraformaldehyde at each time point.  Slides were stained by the Kinyoun method for acid–fast 
bacteria.  For phenotypic assays, DCs and MØ were cultured for an additional 48 hours. 
 
Anti-mycobacterial activity of MØ and DC 
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The anti-mycobacterial activity of DCs and MØ was assessed by metabolic labeling of 
intracellular M. tuberculosis with [3H]-uracil as previously described (104) (46).  DCs and MØ 
(2 x 105 cells/well, duplicate or triplicate wells for each condition) were primed with IFN-γ (100 
U/ml) (Genentech, Inc., San Francisco, CA) for 12-24 hours and then LPS (1µg/ml) (Sigma, St. 
Louis, MO) was added.  Activated and resting cells were infected with M. tuberculosis 
(sonicated in a cup horn sonicator 20 seconds to reduce clumping) at an MOI of 3-5. 
Aminoguanidine (AG), an NOS2 enzyme inhibitor, was added to some conditions of the IFN-γ-
treated and untreated cells, 4 hours prior to LPS addition and infection to inhibit NOS2 activity.  
24 hours post infection cells were pulsed with 2.5 µCi of [3H]-uracil, which is incorporated 
predominantly by the bacteria and not by MØ or DCs.  Supernatants were removed 8-16 hours 
later, the cell pellets were lysed with 1% saponin and TCA precipitated onto GF/C glass fiber 
filters (Fisher Scientific, Pittsburgh, PA.) and radioactive incorporation was measured by β-
scintillation counter. The percent inhibition was calculated as 100-[(cpm activated cells/cpm 
resting cells) X 100].  
For determination of actual intracellular colony forming units (CFU), DCs and MØ 
cultures were prepared as above, and cell lysates at each time point were cultured on 7H10 plates 
(10-fold dilutions in PBS + 0.05% Tween). The number of extracellular bacteria was determined 
by plating the undiluted sonicated supernatant of each timepoint.  The number of initial 
intracellular bacteria was determined at 4 hours post-infection, and reduction of input was based 
on that number. CFU were counted after incubation of plates at 37°C for 18 days.  
 
Determination of nitrite accumulation 
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Nitrite (NO2-) accumulation in the supernatant of cultured cells was measured as an 
indicator of NO production by a Griess Assay, with a sodium nitrite standard, as previously 
described (208). Supernatants from 2 x 105 cells (100 µl) of each condition were assayed in 
duplicate or triplicate and absorbency was measured at 570 nm using an Emax precision 
microplate reader (Molecular Devices, Sunnyvale, CA). 
 
Transmission electron microscopy 
Uninfected and M. tuberculosis-infected DCs were cultured as described above for 72 
hours post-infection. Cells (4 x 105) were gently pelleted at 2000 rpm for 2 minutes in microfuge 
tubes, washed twice in PBS, and then fixed in 1.5% paraformaldehyde and 1.0% glutaraldehyde 
in PBS.  Cells were post-fixed in 1% osmium tetroxide in PBS, dehydrated through a graded 
series of alcohols and embedded in Epon (Energy Beam Sciences, Agawam, MA).  Thin (60nm) 
sections were cut using a Reichert Ultracut S (Leica, Deerborn, MI), mounted on 200 mesh 
copper grids, counterstained with 2% aqueous uranyl acetate for 7 minutes and 1% aqueous lead 
nitrate for 2 minutes, and observed using a JEOL 1210 transmission electron microscope 
(Peabody, MA). 
 
Statistics 
For statistical analysis of samples, paired and  unpaired student t tests were used (Instat, 
v. 2.03, GraphPad Software, San Diego, CA and StatView, Abacus Concepts, Berkeley, CA).  P 
values <0.05 were considered significant. 
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Results 
Activated DCs inhibited the proliferation of M. tuberculosis in vitro. 
M. tuberculosis can grow within unactivated macrophages, and this is a major site for 
bacterial replication in vivo.  However, murine MØ activated by IFN-γ and either TNF-α or LPS 
inhibit intracellular growth of M. tuberculosis and kill a proportion of the bacteria via NOS2-
dependent reactive nitrogen intermediate (RNI) production (61).  It has been reported that murine 
DCs can produce NO in response to LPS and/or IFN-γ (55).  We examined the ability of DCs, 
either unactivated or activated with IFN-γ and LPS, to support or inhibit the growth of 
intracellular M. tuberculosis.  Intracellular mycobacterial proliferation was assessed using 3H-
uracil incorporation into M. tuberculosis, which measures bacterial growth but does not 
determine whether the bacteria are killed (61, 209).  M. tuberculosis in unactivated DCs or 
macrophages incorporated 3H-uracil, indicating replication of intracellular bacteria (Figure 9A).  
DCs and MØ activated with IFN-γ and LPS inhibited the growth of intracellular M. tuberculosis, 
compared to unactivated cells, and the inhibition was comparable (76% inhibition for DCs 
compared to 75% inhibition for MØ). The inhibition correlated with RNI production by activated 
DCs or MØ (Figure 9B).  Addition of an NOS2 inhibitor, aminoguanidine (AG), to both DCs 
and MØ prior to infection abrogated the effect on intracellular M. tuberculosis (Figure 9A).   
Confirmation of the importance of RNI production in anti-mycobacterial activity of DCs 
was obtained using DCs and MØ generated from NOS2-/- mice.  IFN–γ and LPS activated 
NOS2-/- DCs failed to inhibit M. tuberculosis proliferation (Figure 10), similar to activated 
NOS2-/- MØ (Figure 10). There was consistently a higher incorporation of 3H-uracil into M. 
tuberculosis within DCs, as compared to MØ (Figure 11), although similar infection levels were  
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Figure 10.  Activated DCs and MØ are comparable in the inhibition of M. tuberculosis growth 
via RNI production.  
 
(A) Incorporation of 3H-uracil into M. tuberculosis within DC and MØ was assessed in untreated 
and IFN-γ/LPS activated DC and MØ.  The lysates of 3H-uracil labeled uninfected, M. 
tuberculosis-infected, or IFN-γ/LPS activated M. tuberculosis-infected wild type DCs and MØ 
were TCA precipitated, collected on glass filters, and counted in a β-scintillation counter.  An 
inhibitor of NO production, aminoguanidine (AG) was added to the cells prior to infection as 
indicated. (B) Griess assay were performed from supernatants of M. tuberculosis-infected DCs 
and MØ and read at 570 nm.  The standard curve was generated using NaNO2. 
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Figure 11.  Killing of intracellular M. tuberculosis is dependent on nitric oxide in DC and 
macrophages.   
 
Lysates of 3H-uracil-labeled uninfected, M. tuberculosis-infected, or IFN-γ/LPS-activated M. 
tuberculosis-infected NOS2-/- DCs  and MØ were TCA precipitated and counted using liquid 
scintillation. Samples were tested in triplicate and a representative experiment from 3 
experiments is shown. For statistical analysis for all panels, IFN-γ/LPS or IFN-γ/LPS + AG 
samples were compared to untreated cells * p<0.02. 
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Figure 12.  Tritiated-uracil incorporation and availability into mammalian and bacterial cells. 
(A.)  1 X106 bacilli were given various concentrations of tritiated-uracil (0.004-2.5µCi/ml).  
Then the cells were precipitated were TCA precipitated and counted using liquid scintillation.  
Cpms are reported.  Experiment was repeated twice.  (B.)  DCs and macrophages obtained as 
detailed in Materials and Methods were given 2.5µCi/ml then lysed with 0.1% saponin, counted 
using liquid scintillation.  Cpms are reported. Experiment was repeated four times. 
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obtained, as judged by AFB staining and intracellular CFU determination (see below) of each 
culture.  To determine whether there was a differential uptake of 3H-uracil by DCs as compared 
to macrophages, cells were pulsed with 3H-uracil, washed, centrifuged, and quantitated by liquid 
scintillation.  There was a two-fold increase in 3H-uracil uptake in DC as compared to MØ 
(Figure 11B).  DCs have a high fluid phase uptake and the additional 3H-uracil inside the cell 
may have resulted in increased incorporation into the.  Varying the concentration of 3H-uracil in 
a cell free M. tuberculosis proliferation assay indicated that incorporated CPM declined linearly 
with the dilutions of 3H-uracil (Figure 3A).  These results confirmed that availability of 3H-uracil 
affects incorporation into the bacteria. Thus, the observed differences in total CPM between M. 
tuberculosis in DCs and MØ probably reflects availability of 3H-uracil, rather than any 
differences in bacterial growth within the cells. 
 
Mycobacterial growth and killing within DC and MØ. 
 DCs encountering M. tuberculosis in the lung might not be activated initially, and thus 
the intracellular bacteria would be able to multiply, and perhaps use this cell to gain access to the 
lymph node.  The ability of DCs to produce RNI and prevent bacterial replication suggests a 
potential role for DCs as an effector cell.  Therefore, the anti-microbial effects of activated DCs 
were studied further.  IFN-γ/LPS activated DCs clearly inhibited growth of intracellular M. 
tuberculosis, similar to IFN-γ/LPS activated MØ, as described above.  However, the ability of 
DCs to actually kill the organism was unknown.  To address this, intracellular CFU at various 
times post-infection were determined by plating lysates from an equal number of unactivated and 
activated infected DCs and MØ (Figure 12).  Initial (4 hours post-infection) intracellular CFU 
were similar between DCs and MØ (p = 0.63).  M. tuberculosis grew equally well within  
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Figure 13.  Dendritic cells inhibit the growth of, but do not kill intracellular M. tuberculosis.   
 
Cell pellet lysates of M. tuberculosis-infected DCs or MØ (MOI 1), unactivated or activated with 
IFN-γ/LPS, were serially diluted in PBS+0.5% Tween-80 and plated on 7H10 plates which were 
incubated for 18 day at 37OC and 5% CO2. Three wells per condition were assessed at each time 
point, and the mean intracellular CFU are reported at various time points after infection. (A) 
Intracellular CFU in resting DCs (black circles) and resting MØ (open squares).  (B) Intracellular 
CFU in activated DC (black bars) and activated macrophages (white bars).  At each time point, 
<1% of total CFU was found in the supernatant.  In panel A, CFU within unactivated DCs and 
MØ at each time point revealed no statistical differences (p >0.5).  In panel B, bacterial numbers 
within DC were not significantly reduced (p = 0.2) compared to intracellular CFU at 4 hours 
(input).  Comparison of CFU within MØ at each time point to the CFU at 4 hours revealed 
statistically significant reductions over time (**p<0.01, *p< 0.02).  Error bars show standard 
error.  A representative experiment of 6 experiments is shown. 
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MØ 
time 
(hour) 
CFU (1 X 10-5) a fold change  
in CFUs b 
NO2- c 
(nmol) 
 untreated IFNγ/LPS untreated IFNγ/LPS untreated IFNγ/LPS 
4 1.73 +/- 0.05 1.70 +/- 0.13   10.97 105.50 
24 4.18 +/- 0.06 1.43 +/- 0.10 +2.4 - 1.1 23.80 76.80 
36 6.20 +/- 0.64 1.01 +/- 0.07 +3.6 -1.6 50.50 142.70 
48 7.65 +/- 0.07 0.89 +/- 0.15 +4.5 -1.9 43.5 130.5 
 
DCS 
time 
(hour) 
CFU (1 X 10-5) a fold change  
in CFUs b 
NO2- c 
(nmol) 
 untreated IFNγ/LPS untreated IFNγ/LPS untreated IFNγ/LPS 
4 1.75 +/- 0.05 1.74 +/- 0.06   0 37.5 
24 3.14 +/- 0.26 1.91 +/- 0.11 +1.8 +1.1 0.14 90.9 
36 4.64 +/- 0.50 1.83 +/- 0.30 +2.6 +1.1 2.31 150.6 
48 6.90 +/- 0.07 2.15 +/- 0.16 +4.3 +1.2  1.74 135.3 
Table 2.  Activated macrophages kill M. tuberculosis whereas activated DCs inhibit the growth 
of M . tuberculosis.   
a the mean of the triplicate intracellular CFU of the untreated (resting) and IFNγ/LPS 
(activated) cells. 
 b fold change of intracellular CFU at each timepoint compared to the intracellular CFU at 4   
hours (input).   
c nitrite in the supernatant of these samples as determined by a Griess assay.   
Shown is a representative experiment of 6 performed. 
These data are graphically represented in Figure 4. 
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unactivated DC and MØ over 60 hours (Figure 12, Table 2) confirming the ability of DCs to 
support the growth of intracellular M. tuberculosis. In activated MØ (treated with IFN-γ and 
LPS) there was a differential uptake of 3H-uracil by DCs as compared to MØ, both cell types, the 
number of viable bacteria was reduced by ~50% by 48 hours post-infection, compared to 4 hours 
post-infection (p = 0.02) (Figure 12B, Table 2).  The number of viable bacteria in activated DCs 
did not increase over time, confirming that these cells can inhibit mycobacterial replication.  
However, in contrast to activated MØ, the number of intracellular M. tuberculosis in activated 
DCs were not reduced over the course of the infection in six independent experiments (4 hours 
vs. 48 hours, p = 0.21), demonstrating a lack of killing of intracellular bacteria (Figure 4B, Table 
1).  Examination of the viability of the DC and MØ cultures over the course of infection was 
performed by staining parallel cultures of infected cells in chamber slides, and staining with 
trypan blue or for acid fast bacilli.  At 48 hours, there was no difference in the viability of the 
DCs and MØ, although at later time points (72-90 hours) there was a marked deterioration of 
both cell types.  For this reason, we compared intracellular killing only up to 48 hours post-
infection.  In addition, the culture supernatants at each time point were plated to determine the 
number of bacteria that had escaped the cells, perhaps due to cell death.  In all cases up to 48 
hours, very few bacteria (<1% of total bacterial numbers) were present in the supernatants, and 
there was no difference between DC and MØ cultures.  Thus, the discrepancy in killing 
intracellular organisms between DCs and MØ cannot be attributed simply to differences in cell 
viability.  
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Figure 14.  Activated DCs have bacteriostatic effects on intracellular M. tuberculosis whereas 
activated macrophages are bactericidal.   
 
DCs (A, B) and macrophages (C, D ) activated with IFN-γ and LPS then infected with M. 
tuberculosis were fixed, embedded, sectioned, and examined by transmission electron 
microscopy (EM).  Arrows indicate multi-membrane. 
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Figure 15.  M. tuberculosis within activated macrophages is killed.  
 
M. tuberculosis within IFN-γ and LPS activated DC (A) and macrophages (B) examined by 
transmission electron microscopy (EM).  DC and macrophages were activated with, infected, 
then fixed, embedded, and sectioned.  Arrows indicate multi-membrane structures that suggest 
bacterial killing.  This figure is a representative experiment from at least 10 individual cells at 
several timepoints. 
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Electron microscopic comparison of activated DC and macrophages infected with M. 
tuberculosis.   
Although activated DCs can prevent intracellular growth of M. tuberculosis the 
intracellular bacteria were not killed, as discussed above. We used electron microscopy to DC 
appeared viable whereas in activated MØ there were clear indications that there had been 
bacteria killing (Figure 13 & 14).  In activated MØ we saw multi-membranous structures 
surrounding the bacilli and these were not observed in activated infected DC (Figure 13 & 14, 
arrows shows multi-membranes).  The build-up of these membranes is probably due to the high 
composition of lipids in the mycobacteria.  Structures such as this have been reported after 
phagocytosis of cells, where the lipid debris from the cells swirl around the membrane of the 
aged organelles (210).  Alveolar macrophages, which are responsible for the surfactant turn-over 
have similar structures from the lamellar phospholipid material (210).  We did not observe any 
other striking differences in terms of compartmentalization with activated DC compared to 
activated MØ.  We did observed that bacilli resided singly in both resting DC and MØ, but post-
activation the bacteria were seen in a communal vacuole as previously reported (32).  NOS2-/- 
mice (and macrophages) cannot produce RNI and do not kill M. tuberculosis.  In NOS2-/- bone-
marrow derived macrophages, there was no detectable killing of the bacteria by electron 
microscopy (Figure 16 C,D) and there was observable killing in the WT bone-marrow derived 
macrophages (Figure 16 A, B).   
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Figure 16.  Activated macrophages have bactericidal effects on intracellular M. tuberculosis 
which is abrogated in macrophages from NOS2-/- mice.   
 
Macrophages from WT mice (A, B) and NOS2-/- mice (C, D) were activated with IFN-γ and 
LPS then infected with M. tuberculosis, fixed, embedded, sectioned, and examined by 
transmission electron microscopy (EM).  Black arrows indicate bacteria and red arrows indicate 
multi-membrane structures that suggest bacterial killing.  This figure is a representative 
experiment from at least 20 individual cells at 24 hours post-infection. 
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Discussion 
Macrophages are the known host cell for M. tuberculosis, however, we demonstrated 
previously that both human and mouse DC were easily infected with M. tuberculosis (22) 
(Chapter 1). In this chapter, we demonstrate that M. tuberculosis bacilli replicated equally well 
within unactivated DCs and MØ.  Thus, maturation of the DC in response to M. tuberculosis 
infection had little effect on intracellular survival and growth of the microbe (Figure 13, Table 
4).  Although it has been reported that untreated murine bone-marrow-derived DC were as 
permissive for M. tuberculosis growth as bone-marrow derived macrophages others have 
reported that the bacteria did not grow in an untreated DC cell line (14).  The disparity in results 
may be due to differences between primary DC and an immortalized line.  Infection of human 
dendritic cells with a MOI of 0.1-12.5 of M. tuberculosis resulted in 15% to 93% infection (148).  
M. tuberculosis continued to grow in these unactivated cells for up to seven days post-infection 
(148). The average doubling time for M. tuberculosis within these cells was 26 hours.  These 
data suggest that DC may harbor and be a reservoir for M. tuberculosis in vivo.  As well this has 
been suggested for murine DC infected with B. bronchiseptica(159) and Leishmania major 
(163).  DC may contribute to the longevity of a M. tuberculosis infection.  A mature DC would 
be expected to traffic to the lymph nodes, and our data suggest that such a DC would be carrying 
live M. tuberculosis bacilli.  This may be a mechanism by which M. tuberculosis gains access to 
the lymph node.  Studies in the Leishmania murine model suggest that DC persist in the lymph 
node even when infected (163).  Viable parasites from DC isolated from in vivo infection of 
Leishmania major have been isolated and used to re-infect mice and cause lesions (163).  We 
show DC infected with M. tuberculosis cannot kill and eliminate the bacteria but do prevent its 
growth, thus allowing DC to proceed to the lymph nodes with viable bacteria (Figure 13, table 
2). 
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It has been hypothesized that the host’s ability to control an infection is a complex 
balance between a low number of persistent organisms and the specific effector cells in the 
immune system (155, 163, 211).  Therefore, a continuous supply of antigen from a living 
bacterium may be advantageous for the priming and maintenance of an effective immune 
response.  In experiments using Histoplasma capsulatum (194) and Candida albicans (195) there 
is much better stimulation of CD4+ cells by DC which are infected with live microbes as opposed 
to the heat killed.  An important consideration for vaccine development and design may be 
targeting DC in vivo.  In two recent studies, mice vaccinated with BCG- or M. tuberculosis-
infected DC were shown to generate a protective immune response and reduce the bacterial 
burden after challenge with M. tuberculosis (14, 184).  Those studies suggest that targeting DC 
in vivo will be an important consideration for vaccine development and design. M. tuberculosis-
infected DC were shown to generate a more protective immune response then BCG vaccination, 
however DC pulsed with immuno-stimulatory mycobacterial components did not generate more 
protection than BCG vaccination in mice (184).  These data reinforce that live M. tuberculosis 
within DC is important for the generation of good protection.   
In an environment where T cells or other cells are producing IFN-γ, DC would be 
expected to be activated in a manner similar to MØ.  Activated MØ have been shown by various 
groups to inhibit the growth of intracellular M. tuberculosis bacilli (61, 62, 212) and, more 
importantly, kill at least 50% of the intracellular mycobacteria (61) via NOS2 dependent 
mechanisms.  In our studies, activation of MØ with IFN-γ and LPS also resulted in a 50% 
reduction in intracellular M. tuberculosis by 48 hours post-infection, as determined by CFU in 
cell lysates (Figure 13, Table 2).  Electron microscopy of M. tuberculosis within activated DC as 
compared to activated macrophages support that DC retain live viable bacteria.  The bacilli in 
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activated macrophages are sometimes surrounded by multi-membraneous structures which are an 
indication of cellular breakdown by phagocytic cells.  In many cases the bacilli itself appears to 
be degraded (Figure 14 & 15).  This is not seen within activated DC and is also not readily 
detectable in macrophages derived from NOS2-/- mice which do not kill M. tuberculosis due to 
lack of RNI production (Figure 16). DC treated with IFN-γ and LPS were capable of restricting 
the growth of intracellular M. tuberculosis, and this was dependent on NOS2 activity (Figure 10 
and 11). However, in contrast to MØ, activated DC were unable to reduce the intracellular 
bacterial numbers over time, despite essentially similar levels of RNI production between DC 
and MØ.  In some experiments there were differences in RNI production at 4 hours post-
infection (Table 2).  Initially we speculated that more RNI produced by activated MØ early in 
the infection compared to activated DC could be responsible for the differential ability of the 
cells to kill M. tuberculosis.  However, analysis of data from a series of experiments indicated 
that regardless of the RNI production by DC at 4 hours, including experiments where the output 
was similar to that of MØ, the DC did not reduce the number of input bacteria over time.  It is 
possible that M. tuberculosis within DC avoids the killing effects of RNI by persisting within 
special vacuoles of DC.  Other possibilities for the lack of mycobacterial killing include 
differences in phagosome pH, lysosomal enzymes, and reactive oxygen production in DC 
compared to MØ. Investigations into the mechanisms by which DC and macrophages differ are 
presented in chapter 3. 
 We hypothesize that the ability of M. tuberculosis to survive, although perhaps not 
replicate, within activated DC may be beneficial in priming a T cell response by mature DC in 
the lymph node.  Live bacteria are capable of secreting antigens, which are believed to be 
important in the protective T cell response against tuberculosis.  It has been suggested that M. 
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tuberculosis forms a pore within the phagosomal membrane which allows access to the 
cytoplasm for mycobacterial peptides; presumably priming of MHC Class I restricted CD8 T cell 
responses would be more efficient in DC harboring live, rather than dead, tubercle bacilli (133).  
An alternative hypothesis is that M. tuberculosis has evolved a strategy to evade killing by the 
DC, and uses this cell as a vehicle for disseminating from the lung to lymph nodes and other 
organs. As previously mentioned viable Leishmania parasites were isolated from the DC within 
the lymph nodes of infected mice.  Although DC are the major APC in anti-leishmanial 
immunity in vitro (213)and in vivo (214), the ability to persist and to migrate to the lymph node 
may be a factor which prolongs this infection and lends to it’s chronicity.  The interactions 
between M. tuberculosis and the immune system is a constant battle, in which those traits 
beneficial to the generation of protection may also lend to the chronicity of the infection.  DC 
may also have multifaceted roles as a reservoir, as an effector cell that is capable of hindering 
growth, and an APC which is capable of initiating a necessary cell mediated response. 
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CHAPTER 3 
Anti-Microbial Mechanisms of Murine DC 
Why is Mycobacterium tuberculosis not killed? 
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Introduction:  
 The interaction of dendritic cells (DC) with Mycobacterium tuberculosis may play an 
important role in protection and one that is distinct from macrophages (MØ).  In this study we 
examined anti-microbial mechanisms of IFN-γ/LPS-activated DC that play a role in M. 
tuberculosis infection.  DC, unlike MØ are not typically considered to have effector functions 
against intracellular organisms.  However, activation of murine bone-marrow derived DC with 
IFN-γ and LPS prevents the intracellular growth of M. tuberculosis. Unexpectedly, this 
activation does not appear to kill the organisms (Chapter 2).  In contrast, similar activation of 
MØ leads to the killing of intracellular M. tuberculosis  (Chapter 2). It is well established that the 
ability of activated murine MØ to kill intracellular M. tuberculosis is dependent on reactive 
nitrogen intermediate (RNI) production (61). Activated DC and MØ produce a comparable 
amount of RNI but there is a clear difference in the DC’s ability to kill the organism.  
Differences in NOS2 expression at the protein and RNA level do not result in a difference in the 
level of nitrites produced.  These data suggest that overall RNI production is not directly 
responsible for the differences in the ability of DC and MØ to kill M. tuberculosis.  
The production of ROI by human derived-DC only has been reported after infection with 
the fungus, Candida albicans (195).  Polymorphonuclear cells kill C. albicans predominately by 
the production of toxic oxygen metabolites, but in the human DC the production of ROI did not 
result in killing of this organism (195). The role of reactive oxygen intermediates (ROI) in a 
mycobacterial infection has been controversial.  ROI are also produced by M. tuberculosis-
infected MØ and a number of ROI including superoxide (•O2-) and hydrogen peroxide (H2O2) 
can interact with nitric oxide (•NO) to form the noxious compound ONOO- (61) (57).  There are 
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data that argue against an important role for ROI in killing or hindering the growth of M. 
tuberculosis and other data has supported a role for ROI in protection.  In macrophage lines 
deficient in ROI production, there in no difference in the killing of M. tuberculosis compared to 
wild-type macrophages (215).  M. tuberculosis wall component,  lipoarabinomannan (LAM), is 
proficient at scavenging ROI generated by the respiratory burst of infected macrophages. (215).  
Other mycobacterial components such as sulfatides and phenolglycolipid I (PGL-1) have also 
been suggested to interfere with ROI-dependant anti-microbial mechanisms within macrophages 
(215).  M. tuberculosis can produce both superoxide dismutase (42) and catalase (43) which 
could interfere with toxic oxygen radical production.  On the other hand, patients with the rare 
genetic disorder, human chronic granulomatous disease (CGD), that renders cells unable to 
produce reactive oxidants (ROI) production via a defect in the NADPH oxidase complex have a 
higher incidence of mycobacterial infections (40).  The mouse model for this disease,  p47phox-/-  
or p91phox-/-  mice, show an initial increase in bacteria but later can control the infection (216).  
Peroxynitrite is a strong oxidizing compound formed by the simultaneous production of 
superoxide and NO (56), which we show that both occur in macrophages and DC after M. 
tuberculosis infection.  Peroxynitrite production was shown to be present in blood-derived 
human monocytes (PBMC) and in a human monocyte derived cell line, U937 (217).  
Peroxynitrite can kill several intracellular pathogens, such as Rhodococcus equi(218), 
Escherichia coli (219), Salmonella enterica (68), Salmonella typhimurium (220), Mycoplasma 
pulmonis(221), and Candida albicans (222);  but many organisms are more susceptible to NO 
alone and not susceptible the products of ROI and NO such as Leishmania major (223), Giardia 
lamblia (224),  Cryptococcus neoformanis (225), and M. tuberculosis (49).  Leishmania major 
was shown to be completely resistant to high doses of peroxynitrite (49).  It has been suggested 
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that the addition of superoxide lowers the NO concentration and reduces peroxynitrite formation 
which would reduce the toxicity against organisms such as Leishmania major (223), Giardia 
lamblia (224), Cryptococcus neoformanis (225), and M. tuberculosis (49).  Recent studies show 
that some bacteria, including M. tuberculosis, possess peptide methionine sulfoxide reductase 
that can protect bacteria from the oxidative damage of RNI, such as peroxynitrite.  Helicobacter 
pylori protects itself from the bactericidal effects of peroxynitrite damage by carbon dioxide 
production (226).  Pathogens may have evolved defenses mechanisms specifically for the 
protection from peroxynitrite.  In a recent study by Yu et. al.it was demonstrated that virulent 
strains of M. tuberculosis, such as Erdman and clinical isolates, were completely resistant to 
peroxynitrite, yet susceptible to nitric oxide and nitrogen dioxide killing.  However, non-virulent 
and non-pathogenic strains were highly susceptible to peroxynitrite, nitric oxide, and nitrogen 
dioxide killing (49).  Based on these data we hypothesized that macrophages may produce more 
peroxynitrite, and therefore less of other, more toxic RNI, compared to DC.  This is tested in the 
experiments detailed in this chapter. 
An importance feature of the activated state of macrophages is that the endosomal 
compartment, which contains the pathogen (phagosome), proceeds through a pathway of 
maturation that ultimately leads to the fusion of the phagosome with the lysosome.  This fusion 
creates an acidified environment which then activates many degrading enzymes and may 
enhance anti-microbial compounds resulting in the death of many pathogens within this phago-
lysosome (28).  Data has shown that M. tuberculosis will be killed in acidified phagosome (201).  
However, the bacteria has been shown to be capable of preventing this acidification, the 
activation of cells is thought to overcome this inhibition in mycobacterial phagosomes (227), 
(28).  Acidification will also contribute to the potency of compounds such as, ROI, NO, and 
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peroxynitrite and increase their half-lives (56).  Here we examine intracellular acidification of 
DC compared to macrophages. This may contribute to the inability of DC to kill M. tuberculosis 
and possibly other organisms.  
Material & Methods 
Mice 
Adult female (8-10) week old C57BL/6 mice were obtained from Jackson Laboratories 
(Bar Harbor, ME). NOS2-/- mice on a C57BL/6 background were generated by MacMicking, et 
al. (64) and breeding pairs were kindly provided by Dr. Timothy Billiar (University of Pittsburgh 
School of Medicine); mice were bred in our facility as homozygotes.  B6.129S6-Cybbtm1 mice , 
(C57BL/6 background)  have a genetic disruption of the p91 phox-/- gene in the NADPH complex 
(228), and were obtained from Jackson Laboratories (Jackson Laboratories, Bar Harbor, ME).  
All mice were maintained in a specific pathogen-free Biosafety Level 3 facility.   
 
Bacteria: 
M. tuberculosis strain Erdman (obtained from the Trudeau Institute, Saranac Lake, NY) 
was passed through mice prior to freezing. ∆-icl-M. tuberculosis was derived from strain Erdman 
(229)and generously provided by Dr. John D. McKinney (Howard Hughes Medical Institute, 
Rockefeller University, New York, NY).  Mycobacterium smegmatis strain MC2155 was kindly 
provided by Dr. Graham Hatfull (Department of Biological Sciences, University of Pittsburgh), 
and BCG Tice strain obtained from Organon Teknika (Durham, NC).  GFP-labeled M. 
tuberculosis strain Erdman was generously provided by Dr. Joel Ernst (University of California 
San Francisco School of Medicine, San Francisco, CA).  These strains were grown in liquid 
(7H9 Middlebrook, Difco) medium, and frozen in aliquots at –800C.  Aliquots were used to start 
 96 
cultures at a concentration of 2.5 x 106 /ml in 7H9 medium; bacteria were grown in 5% CO2 at 
37oC.  Cultures were used at day 6 or 7 to infect cells. The bacteria were washed and 
resuspended in DC or ΜØ media, sonicated 10s in a cup-horn sonicator, then added to the cell 
cultures after estimation of bacterial numbers based on previous experience.  Enumeration of 
viable bacteria to confirm MOI was by plating for viable CFU on 7H10 Middlebrook medium 
and incubated for 18 days (3 days for M. smegatis) at 37 oC with 5% humified CO2..  
 
Culture and purification of DC and ΜØ 
DCs and MØ were generated from the bone marrow cells of C57BL/6, NOS2-/-, and 
B6.129S6-Cybbtm1 p91 phox-/- mice.  Briefly, cells were extracted from the femur and tibia bones 
of mice in DMEM medium.  For the MØ cultures, cells were washed twice in DMEM and 2.5 X 
106 cells were plated in LabTek PS petri dishes (Fisher Scientific, Pittsburgh PA) in 25 ml 
DMEM supplemented with 10% certified FBS, 1mM sodium pyruvate, 2mM L-glutamine (Life 
Technologies, Grand Island, NY), and 33% supernatant from L-cells fibroblasts cultured for 5-6 
days.  All reagents were LPS-free and no antibiotics were used.  Medium was changed on day 3.  
On day 5, adherent cells were washed twice with ice-cold PBS (Life Technologies, Grand Island, 
NY), incubated for 20 minutes on ice, and harvested using cell scrapers (Becton Dickinson 
Labware, Lincoln Park, NJ).  Cell concentration was adjusted to 1.0 x 106 cells/ml and cells were 
placed in Teflon jars (1 ml) (Savillex, Minnetonka, MN) or aliquoted into a 96 well plate 
(200µl/well) for infection.  For DC cultures, bone marrow cells were centrifuged at 1200 rpm for 
7 minutes, and red blood cells were lysed with NH4Cl/Tris solution.  T cells (CD4+ and CD8+) 
were removed using Low-Tox–M rabbit complement (Accurate Chemical and Scientific 
Corporation, Westbury, NY) after incubation with anti-CD4 antibody (GK1.5 10µg/1 x 107 cells) 
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and anti-CD8 antibody hybridoma supernatant (anti-CD8α, clone 83−15−5).  Cell concentration 
was adjusted to 1 x 106 cells/ml and adherent cells were depleted by overnight culture in DC 
medium containing DMEM, 2 mM L-glutamine, and heat inactivated 5% mouse serum (Sigma, 
St. Louis, MO).  The non-adherent cells were cultured at 0.25 x 106 cells/ml in 24-well plates 
(Costar, Cambridge, MA) in DC medium containing 1000 Units/ml of rm-GM-CSF and rmIL-4 
(Schering-Plough, Kenilworth, NH and kindly provided by Dr. Walter Storkus).  At day 5 cells, 
non-adherent cells, were harvested, adjusted to 1.0 x 106 cells/ml in DC media containing 
rmGM-CSF (1000 U/ml) and either dispersed into a 24 well plate (1 ml/well) or aliquoted into a 
96 well plate (200µl/well) for infection.  
 
Infection of DCs and MØ 
After culture for 5 days, DCs (at 1 x 106/ml in DC media + rmGM-CSF, without IL-4) 
were infected in 24 or 96 well plates with either M. tuberculosis, ∆-icl-M. tuberculosis, M. 
smegmatis, or BCG at an estimated MOI of 0.5-5.  After 12 hours, unincorporated bacteria were 
removed by pelleting the DCs at low speed (<1000 rpm) and reculturing with fresh media. In 
some experiments, MØ were cultured and infected in 96 well plates; monolayers were washed to 
remove extracellular bacteria and fresh medium was added.  In experiments involving 
quantitative cultures of intracellular bacterial growth, stasis or killing, the MOI was reduced to 1 
and extracellular bacteria were removed after 4 hours, except for M. smegmatis where we used a 
lower MOI and removed bacteria at 1 hour post-infection.  To estimate the percentage of infected 
cells for each experiment, DCs and MØ were either airdried on poly-L-lysine coated slides or 
grown in parallel in glass culture well slides (Nalgene) and fixed in 1% paraformaldehyde at 
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each time point.  Slides were stained by the Kinyoun method for acid–fast bacteria.  For 
phenotypic assays, DCs and MØ were cultured for an additional 48 hours. 
 
Reactive Oxygen Intermediate Assay  
  Day 5  bone-marrow derived DC and MØ (1 X 106) cells per ml were activated with 250 
units/ml IFN-γ overnight and 1 µg/ml LPS. The assay was performed as described in (230).  
Briefly, cells were washed twice with Kreb's Ringer Phosphate Buffer with Glucose (KRPG) 
(15.6 mM Na Phospahte Buffer, 120 mM NaCl, 4.8 mM KCl, 0.54 mM CaCl2, 1.2 mM MgSO4, 
and 11mM Glucose), resuspended in KRPG at 2 X 106 cells per ml, and then 4 X 105 were 
placed in a cuvette with 250 µg ferrricytochrome C, 2.5 µg catalase, and 0.25 µg PMA. The 
control sample contained 12 µg/µl SOD to inhibit the reduction of ferrricytochrome C (Sigma, 
St. Louis).  Readings were taken at 550 nm every 30 seconds for 1 hour on a 14DS UV/visible 
spectrometer (Aviv instrument, New Jersey).  
 
Peroxynitrite assay 
 Day 5 bone-marrow derived DC and MØ were activated with 250 units/ml mouse 
recombinant IFN-γ overnight and 1 µg/ml LPS.  Peroxynitrite assay was performed essentially as 
described in (68).  Briefly, the activated cells were then stimulated with 400 ng PMA and 
incubated in Hank's balanced salt solution at 4 X 106 cells in 24-well plates in the presence of 
1mM 4-hydroxyphenlacetic acid (4-HPA) with or without Cu, Zn superoxide dismutase (0.1 
µg/ml) (Oxis Research, Eugene, OR) for 4 hr at 37°C.  Supernatants were filtered (0.45 µM 
filters) and assayed for NO2-HPA at 420nm on a 14DS UV/visible spectrometer (Aviv 
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instrument, New Jersey).  Peroxynitrite concentrations were determined using the conversions 
for NO2-HPA reported in (68). 
 
Determination of nitrite accumulation: 
Nitrite (NO2-) accumulation in the supernatant of cultured cells was measured as an 
indicator of total RNI production by a Griess Assay, with a sodium nitrite standard, as previously 
described (208)(Chapter 2). Supernatants from 2 x 105 cells (100 µl) of each condition were 
assayed in duplicate or triplicate and absorbency was measured at 570 nm using an Emax 
precision microplate reader (Molecular Devices, Sunnyvale, CA). 
 
Intracellular growth for mycobacteria 
For determination of actual intracellular colony forming units (CFU), DCs and MØ 
cultures were prepared and activated as above, and cell lysates (lysed in 0.1% saponin) at each 
time point were cultured on 7H10 plates (10-fold dilutions in PBS + 0.05% Tween). The number 
of extracellular bacteria was determined by plating the undiluted sonicated supernatant of each 
timepoint.  The number of initial intracellular bacteria was determined at 1 or 4 hours post-
infection (M. smegmatis and BCG, or M. tuberculosis, respectively), and reduction of input was 
based on that number.  CFU were counted after incubation of plates at 37°C for 3 days for M. 
smegmatis) and 18 days for BCG and M. tuberculosis. 
 
RNAse protection assay (RPA) 
Determination of the levels of mRNA for the genes of interest at various time intervals 
after the infection was performed using a multiprobe RNAse protection assay (Pharmingen, San 
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Diego, CA). Total RNA was extracted from DC and MØ, cultured and uninfected or infected 
with M. tuberculosis as detailed before, using Trizol reagent (Life Technology, Grand Island, 
NY).  The extracted RNA was subjected to RPA according to manufacturer's instructions. 
Protected [32P]UTP-labeled probes were resolved on a 6% urea polyacrylamide gel and analyzed 
by autoradiography.  Cytokine analysis was performed using a custom made probe set (Mck3) 
specific for NOS2, IL-12p40, IL-1α, IL-1β, IFN−γ, and IL-10.  The expression of specific genes 
was quantified densitometrically (Image Quant, Molecular Dynamics, Sunnyvale, CA) relative to 
the abundance of housekeeping genes glyceraldehyde-3-phosphate dehydrogenase (GAPDH) or 
L32. 
 
Western Blot Analysis  
DCs and MØ, uninfected or infected (MOI 3) as described above, were plated in 24 well 
plates at 1 x 106 cells/well. Four hours post infection, DC were collected and centrifuged at 1200 
RPM for 7 minutes, and supernatant was retained.  Supernatants were collected from MØ and 
both supernatants were used in Griess Assays. 250 µl of Western lysis buffer [1X TBS, 1% 
Nonidet P-40 (Pierce, Rockford, IL), protease inhibitor cocktail (10 µM phenylmethylsulfonyl 
fluoride (PMSF), 10 µg/ml aprotinin, 10 µg/ml leupeptin, Sigma, St. Louis, MO)] was added to 
lyse the cell pellets (DC) or cell monolayer (MØ). Lysates were heated at 90°C for 15 minutes to 
kill mycobacteria.  Lysates then were incubated on ice for 20-30 minutes, cellular debris was 
pelleted out for 15 minutes at 14,000 rpm at 4oC.  Protein concentration was determined by Bio-
Rad DC assay per manufacturer's instructions (BioRad, Hercules, CA).  40 µg protein were added 
to an equal volume of 1X sample buffer (100 mM Tris pH6.8, 0.2%, bromophenol blue, 20 % 
glycerol, 4 % SDS, 200 mM dithiothreitol), boiled 5 minutes, then separated on both 7.5% and 
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12.5 % SDS-PAGE gels (Running buffer: 25mM Tris, 192mM glycine, 0.1% SDS) and either 
stained with Coomassie Brilliant Blue (Sigma, St. Louis, MO) or transferred to nitrocellulose 
(Micron Separations Inc., Westboro, MA) at 100V for 1 hour at 4oC in Western transfer buffer 
(25 mM Tris, 192 mM glycine, and 20% Methanol, pH 8.3).  The nitrocellulose membrane was 
stained with Ponceau S (Sigma, St. Louis, MO) to visualize transferred proteins, rinsed with de-
ionized water, then blocked 1 hr at room temperature with either 3% blocking reagent (Upstate 
Biotechnologies, Lake Placid, NY) in PBS (for anti-nitrotyrosine Ab) or 5% milk in TBS (for 
anti-NOS2 Ab) while gently rocking.  The membrane was washed twice with TBS+ 0.1% Tween 
20 (Sigma, St. Louis), then anti-NOS2 antibody (clone 2) (Transduction Laboratories, San 
Diego, CA) was added at 1:2000 dilution (in 20 ml of 5% milk in TBS + 0.1% Tween 20) or 
anti-nitrotyrosine antibody at 2µg/ml [in 10 ml of 3% Blocking Reagent (Upstate 
Biotechnologies, Lake Placid, NY) in PBS] for 1 hour at room temperature while gently rocking. 
The membrane was washed with TBS/0.1% Tween-20, and goat anti-rabbit IgG peroxidase 
conjugated secondary antibody (Sigma, St. Louis, MO) was added at 1:5000 for 1 hour at RT.  
The membrane was washed, then ECL (Amersham Lifescience, Piscataway, NJ) and 
autoradiography were used to visualize anti-NOS2 and anti-Nitrotyrosine reactive proteins.  
Molecular weights for proteins were determined from the pre-stained broad range MW standards 
(Bio-Rad, Hercules, CA) which were run on the gels.   
Controls include nitrotyrosine immunoblotting control (Upstate Biotechnology, Lake 
Placid, NY) which consists of nitrated bovine superdismutase (SOD, ~16 kDa), nitrated bovine 
serum albumin (BSA, ~66 kDa), and nitrated rabbit muscle myosin (~215 kDa); and mouse 
macrophage lysate (Transduction Laboratories, San Diego, CA) which contains 130 kDa NOS2.  
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Immunoprecipitation 
Bone-marrow derived macrophages were cultured as described above. At day 5 the 
medium was removed, cells were washed twice with warm PBS, and DMEM without methionine 
and cysteine plus 10 µM HEPES and 2mM glutamine was added for 1 hr at 37oC with 5% CO2 
humidification.  Cells were then labeled with [35S]-methionine at 100 µCi/ml for 2.5 hrs in a 
volume of 2 ml.  Cells were washed with PBS, lysed with Western lysis buffer (see above), and 
heated at 90 oC for 15 minutes to kill the M. tuberculosis.  Lysates were incubated on ice for 30 
minutes and transferred to a microfuge tube and spun at 13,000 rpm at 4 oC; supernatants were 
collected.  5µl of a 1:20 dilution of the polyclonal anti-nitrotyrosine (Upstate Biotechnologies, 
Lake Placid, NY) or anti-NOS2 antibody (Transduction Laboratories, San Diego, CA) was added 
to 95 µl of lysates and incubated on ice for 4hr, then an equal volume of 20% protein A-agarose 
Sepharose beads (BioRad, Hercules, CA) in lysis buffer was added, samples were vortexed for 
30 mins, pelleted, washed 3 times in lysis buffer, resuspended in 30 µl of 1X sample buffer (100 
mM Tris pH6.8, 0.2%, bromophenol blue, 20 % glycerol, 4 % SDS, 200 mM dithiothreitol 
(DTT)), boiled 5 minutes to elute proteins  The labeled proteins were separated on 7.5 and 12.5% 
SDS-PAGE gels with pre-stained molecular weight standards (Bio-Rad, Hercules, CA).  The gel 
was treated with Amplify (Amersham Pharmacia Biotech, UK) for 30 minutes, dried under 
vacuum at 80 oC, exposed to X-ray film.  
 
Intracellular Acidification 
The acidotropic dye Lysotracker Red DND-99 (Molecular Probes, Eugene, OR) was 
diluted in DMEM (1:10,000) for co-localization experiments with GFP-labeled M. tuberculosis 
(kindly provided by Dr. Joel Ernst, University of San Francisco, CA).  Bone-marrow derived DC 
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or macrophages were cultured in glass culture well slides (Nalgene) at 2 X 105 cells/well.  The 
cells were pre-loaded with lysotracker for 2 hrs prior to activation and infection with GFP-M. 
tuberculosis as described above.  When extracellular bacteria were removed 4 hr post-infection 
fresh media and lysotracker was added overnight, then the cells were washed in PBS, fixed in 
1% PFA, and mounted with coverslips using Gelvatol or Slow Fade (Molecular Probes, Eugene, 
OR).  Images were obtained using a Leica TCS NT Confocal Scanning Microscope over 5 fields 
per sample were viewed. 
 
Statistics 
For statistical analysis of samples, paired and  unpaired student t tests were used (Instat, 
v. 2.03, GraphPad Software, San Diego, CA and StatView, Abacus Concepts, Berkeley, CA).  P 
values <0.05 were considered significant. 
 
Results 
Expression of NOS2 mRNA in DC and macrophages after infection with M. tuberculosis.  
The message for NOS2 was examined in untreated or IFN−γ and LPS activated M. 
tuberculosis-infected-DC and macrophages by RPA using a template for NOS2 to determine 
whether there were differences at 4 hours (Figure 17).  We have previously reported that at 4 hr 
post-infection in some, but not all, experiments, a detectable difference in nitrite levels after 
infection was observed (Chapter 2).  Macrophages usually produced more nitrite at this 
timepoint, although in some experiments DC production of nitrite was higher (see Table 3). It 
was possible that this early burst of RNI production contributed to the ability of MØ to kill M. 
tuberculosis.  However, even in experiments where DC produced more nitrite at the 4 hr 
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timepoint, the intracellular bacilli were still not killed (Table 3).  Despite similar levels of RNI 
production by IFN-γ and LPS-activated M. tuberculosis-infected DC and macrophages, there was 
a difference in the intracellular killing of M. tuberculosis (23).  DC were unable to kill 
intracellular M. tuberculosis, yet controlled the growth by a NOS2 dependent mechanism.  In 
contrast, activated macrophages could kill 50% of all intracellular M. tuberculosis by a NOS2 
dependent mechanism.   
NOS2 is the enzyme necessary for the production of nitric oxide via the arginine pathway 
and therefore it was of interest to compare the mRNA for this enzyme in DC and macrophages.  
The activated infected DC actually had higher levels of NOS2 mRNA at 4hr, whereas at other 
timepoints the levels were similar to, or slightly lower (24hr) than the NOS2 mRNA expressed in 
macrophages (Figure 17).  Regardless of the higher levels of NOS2, the activated DC do not 
usually produce more nitrite in response to activation than the macrophages, and they were 
consistently incapable of killing the intracellular M. tuberculosis (Table 3). 
 
Expression of NOS2 protein in DC and macrophages early in M. tuberculosis infection.   
We used Western Blot analysis to examine NOS2 on the protein level to determine if the 
higher expression mRNA at 4 hrs in DC resulted in more protein expression (Figure 18).  We 
examined lysates from uninfected, M. tuberculosis-infected, IFN-γ and LPS-activated M. 
tuberculosis-infected DC and macrophages over a timecourse of 72 hours post-infection.  
Western blot of DC and MØ proteins demonstrated that the amount of NOS2 protein was higher 
in activated DC than in activated MØ at the 4 hr time point (Figure 18), as well at later time 
points (data not shown).  Although there is more NOS2 protein in the DC, the output of nitrite is 
higher in macrophages cultures (Figure 18B).  NOS2 protein may not be fully functional in DC  
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Figure 17.  Expression of NOS2 mRNA in DC and macrophages after infection with M. 
tuberculosis. 
 
 
RNA from uninfected or M. tuberculosis-infected unactivated (U) or IFNγ/LPS activated ( +) DC 
and macrophages at different time points post-infection was incubated with a 32-[P] labeled probe 
made from the custom designed mck-3 template as directed by the manufacture (Pharmingen, 
NJ).  (U) unactivated M. tuberculosis-infected; (+) IFNγ/LPS activated M. tuberculosis-infected 
cells.  Levels of NOS2 were standardized to the levels of GAPDH by densitometry (data not 
shown). 
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Figure 18.  Expression of NOS2 protein in DC and macrophages early in M. tuberculosis 
infection.  
 
 A.  Cell lysates of either uninfected, untreated M.tuberculosis-infected, IFN-γ and LPS activated 
M. tuberculosis-infected bone-marrow derived DC and macrophages were collected 4 hours 
post-infection and separated by SDS-PAGE, transferred to a nitrocellulose membrane, blocked 
with milk, and then incubated with an antibody directed against NOS2 (Upstate Biotechnologies, 
NY) and a secondary antibody conjugated with horseradish peroxidase (Sigma, St. Louis).  
Bands were visualized by ECL chemilluminescence (Amersham Lifescience, Piscataway, NJ).  
B.  Supernatants from these cells were tested for nitrite production by a Greiss assay.  Black bars, 
DC; white bar, macrophage. 
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IFN-γ/LPS MØ IFN-γ/LPS DC 
*nmol  
nitrite 
b fold 
change 
nmol  
nitrite 
fold 
change 
105 -1.9 37.5 +1.2 
27 -1.9 109 +0.8 
50 -1.9 25 +1.5 
20 -1.2 0 +2.0 
1.9 -1.2 19 +1.5 
1.9 -1.2 19 +1.5 
Table 3.  Differences in nitrite production by activated DC and MØ. 
*Supernatants from murine bone-marrow derived DC and MØ with IFN-γ and LPS 
and infected with  M. tuberculosis were examined by a Greiss Assay for nitrite 
production (as detailed in Materials & Methods).  
*The standard curve was generated using NaNO2. 
b fold change of intracellular CFU at 48 hours compared to the intracellular CFU at 4 
hours (input).   
 
 
 
 
 
 
 
 
 108 
 
compared to macrophages, due to unique post-translational modification or availability of 
substrate, arginine.  These data indicate that although RNI production is necessary for the 
intracellular bacteriostatic and bactericidal effects on M. tuberculosis, inadequate NOS2 
expression or total RNI production do not appear to be the underlying reason for inability of DC 
to kill intracellular M. tuberculosis.    
 
DC are capable of producing larger quantities of reactive oxygen intermediates (ROI).   
The production of ROI by DC has not been investigated fully.  Human-derived DC were 
shown to produce ROI in response to a Candida albicans infection (195).  To explore an 
underlying mechanism for the inability of DC to kill M. tuberculosis despite similar RNI 
production as activated MØ, we investigated production of ROI.  ROI are a known anti-
microbial mechanism, typically used by macrophages to kill intracellular pathogens, although the 
role in killing M. tuberculosis is controversial. ROI concentration was measured using an assay 
based on the reduction of ferricytochrome C (230).  Surprisingly, we observed that IFN-γ+LPS-
activated DC stimulated with phorbol 12-myristate 13-acetate (PMA) produced larger quantities 
of ROI than IFN-γ+LPS-activated MØ stimulated with PMA (Figure 19A).  ROI and RNI are 
triggered by different stimulus in macrophages.  Stimulation of these cells with PMA is typical 
and necessary in this assay to enhance the ROI production which, has a very low absorbency 
reading; it does not alter the pattern of production (230).   
Since the effect of ROI on M. tuberculosis is not well understood, the higher production 
of ROI from DC does not necessarily indicate a more potent anti-microbial effect against M. 
tuberculosis for DC. We examined the production of nitrites in the supernatants of these samples 
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(Figure 19B) and observed that despite difference in the ROI production the nitrite production 
was similar between activated DC and macrophages.  
 
Activated DC produced more peroxynitrite than activated MØ.   
Peroxynitrite (ONNO-) is formed by the interaction of nitric oxide (NO) and superanion 
(O2-) as represented in the equation:    
 
Increased production of ROI may lead to increased ONOO- as it is the limiting factor in 
the production of peroxynitrite (68).  Peroxynitrite is a strong oxidant and has the ability to kill 
many microorganisms, yet direct evidence of peroxynitrite killing M. tuberculosis has never been 
shown. In fact, a recent publication provided evidence that peroxynitrite is not toxic to M. 
tuberculosis, although other RNI can kill this organism (49). We compared the amount of 
peroxynitrite production by activated DC and MØ using a spectrometeric assay that measures the 
Cu, Zn superoxide dismutase nitration of 4-hydroxyphenlacetic acid (4-HPA) to 4-NO2HPA by 
peroxynitrite in the supernatants of cells (68).  Activated DC produced approximately 2-fold 
more peroxynitrite than activated MØ both uninfected (Figure 20A) and infected with 
Mycobacterium smegmatis (Figure 20B), a non-pathogenic species of mycobacteria which does 
not require Biosafety Level 3 containment and can be used in this assay.    
 
 
 
 
O2-  + NO-         ONNO- 
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Figure 19. Activated DC are capable of producing  larger quantities of ROI than activated MØ.   
 
A.  ROI production was quantitated by assaying the reduction of ferricytochrome C at 550 nm on 
a UV vis spectrometer as described in the Material & Methods. Activated DC (light gray line 
with circles); activated MØ (black line with diamonds); controls: activated DC and MØ with 
SOD (gray line with squares). (230) B.  Nitrite (NO2-) accumulation from the supernatant of 
these cultured cells (4 X 105 cells) was measured as an indicator of NO production by a Greiss 
Assay, with a sodium nitrite standards, as previously described (208).  
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Figure 20.  Activated DC produced more peroxynitrite than activated MØ. 
 
(A) Untreated or (B) Mycobacterium smegmatis infected DC (black) and macrophages (white) or 
activated DC (gray)  and macrophages (light gray) were cultured and activated as previously 
described then incubated with 4-hydroxyphenlacetic (4-HPA) for 4 hours in  the absence or 
presence of PMA.  Cu, Zn superoxide dismutase was added to these cells, the presence of 
peroxynitrite production in the supernatant will cause nitration of 4HPA resulting in the 
production of NO2-HPA which is assayed on a dual beam spectrometer at 420nm (68). 
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Nitrosylation of proteins did not occur in M. tuberculosis infected IFN-γ and LPS activated DC 
and macrophages within 72 hours.  
We attempted confirmation of peroxynitrite production in vivo by examining 
nitrosylation of protein within lysates of activated infected DC and macrophages.  Nitrosylation 
of proteins occur when peroxynitrite is present, and is referred to as a footprint of peroxynitrite. 
The nitration of tyrosine residues can render protein and enzymes inactivate (56).  In chronic 
infections, nitrosylated proteins are readily detectable as there has been sustained peroxynitrite 
production (231).   Nitrosylated proteins were easily detected in the lungs of mice infected with 
M. tuberculosis, where NOS2 expression is high (232). We used Western blot analysis with an 
anti-nitrotyrosine antibody to examine nitrosylated proteins in activated and infected 
macrophages at 4, 24, and 48 hrs post-infection and activated DC 4 hr post-infection (Figure 21, 
top).  We were consistently unable to detect the presence of any nitrosylated proteins in these 
lysates, despite high levels of proteins transferred to the membrane (observed after staining with 
a protein dye, Ponseau S).  A low amount of a positive control containing nitrosylated bovine 
superdismutase, nitrated bovine serum albumin, and nitrated rabbit muscle myosin, was readily 
detectable with the anti-nitrotyrosine antibody.  These same lysates did cross-react with anti-
NOS2 antibody, indicating that the cells were activated and expressed enzyme (Figure 21, 
bottom).  At all timepoints there were detectable levels of NOS2 (130 kDa)  (control indicated) 
and this matched the data from the Greiss assay showing that these cells were producing nitrite 
(data not shown).    
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Figure 21.  Nitrosylation of proteins did not occur in M. tuberculosis-infected, IFN-γ and LPS 
activated DC and macrophages within 72 hours 
.   
Cell lysates of IFN-γ and LPS activated M. tuberculosis-infected bone-marrow derived DC (4 hr 
post-infection) and macrophages (4, 24, and 72 hr post-infection) were separated by SDS-PAGE, 
transferred to a nitrocellulose membrane, blocked with de-nitrosylated milk (Upstate 
Biotechnology, NY), and then incubated with an antibody directed against nitrotyrosine (top) or 
NOS2 (bottom) (UpstateBiotechnologies, NY) and a secondary antibody conjugated with 
horseradish peroxidase (Sigma, St. Louis).  Bands were visualized by ECL chemilluminescence 
(Amersham Lifescience, Piscataway, NJ).  Controls:  top, nitrosylated proteins: rabbit muscle 
myosin (215 kDa), BSA (66kDa), SOD (16 kDa) (Upstate Biotechnologies, NY); bottom, NOS2 
protein (130kDa) (Upstate Biotechnologies, NY). 
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Nitrosylated proteins could not be immunoprecipitated from the IFN-γ and LPS-activated M. 
tuberculosis-infected DC and macrophages. 
  We used a more sensitive and specific technique in a further attempt to detect nitrosylated 
proteins within the lysates of activated infected DC and macrophages.  We radiolabeled IFN-γ 
and LPS-activated, M. tuberculosis-infected DC and macrophages with 35S-Met and performed 
immunoprecipitations using anti-nitrotyrosine antibody.  The immunoprecipitation technique 
allows for the extraction of the proteins bound to the antibody, in this case nitrosylated proteins, 
from the total pool of proteins; these were separated by SDS-PAGE and visualized by 
autoradiography. NOS2, which is expressed in these cells (Figure 22) was used as a positive 
control.  Total radiolabeled lysates were run to visualize the amount of metabolic labeling. A 
very long exposure of several weeks was required to detect the radiolabeled lysates, suggesting 
that the metabolic labeling of these cells was poor.  NOS2 was observed in all timepoints 
(130Kda), but there was no detectable nitrosylation.  We believe that the inefficient labeling may 
have hampered the detection of these proteins. This may be because the cells used were primary 
cells and not actively dividing, rather than a cell line.  Alternatively, early in infection there may 
not be detectable levels of nitrosylated proteins since the half live of peroxynitrite is extremely 
short (1s) and there may not be sufficient chronic exposure to peroxynitrite to nitrosylate 
proteins.  
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Figure 22.  Nitrosylated proteins could not be immunoprecipitated from the IFN-γ and LPS-
activated M. tuberculosis-infected DC and macrophages.  
 
Activated M. tuberculosis-infected DC and macrophages were incubated in Met-free media then 
labeled with 35[S]-Met.  Lysates were prepared and incubated with antibody recognizing 
nitrosylated proteins or NOS2 (positive control) (Upstate Biotechnology, NY), then incubated 
with Protein A sepharose beads. Beads were repeatedly washed, and the proteins were eluted by 
boiling for 10 minutes, and separated by SDS-PAGE.  NOS2 has a MW of 130kDA, which is 
indicated by a line.  35[S]- lysates were not incubated with antibody and represent total labeled 
proteins.  
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Mycobacterium smegmatis and Bacillus –Calmette Guerin (BCG) are killed within activated DC.   
Mycobacterium smegmatis and BCG have high or moderate susceptibility, respectively, to 
peroxynitite (49).  We tested the ability of activated DC, which produced more peroxynitrite than 
activated macrophages, to kill these susceptible mycobacterial species.  We observed that the 
intracellular bacterial numbers for both M. smegmatis (Figure 23) and BCG (Figure 24) were  
reduced below the input number of these bacteria in not only the activated MØ but the activated 
DC as well, suggesting that these bacilli are being killed.  This differs from the results for 
virulent M. tuberculosis which was not killed by DC, possibly because virulent M. tuberculosis 
is not very susceptible to peroxynitrite.  In activated DC there was a 25% reduction of M. 
smegmatis at 24 hours post-infection (p.i.) then 30% reduction by 48 hours p.i.; this was 
comparable to macrophages where there was a 40% reduction at 24 hours p.i. and 27% at 48 
hours.  In activated DC there was a 15% reduction of BCG at 24 hours p.i. and 43% reduction by 
48 hours p.i.; in activated macrophages infected with BCG there was a 29% reduction at 24 hour 
pi then only a 15% reduction by 48 hr.  In a few experiments the activated DC infected with 
BCG had 1.5 - 3 fold difference in killing (compared to activated macrophages) possibly related 
to more peroxynitrite production.  Importantly,  in activated M. tuberculosis-infected DC no 
reduction was observed, in contrast to the results obtained with these avirulent mycobacterial 
species.  M. tuberculosis was reported to be resistant to peroxynitrite whereas M. smegmatis and 
BCG were susceptible to peroxynitrite (49).  In activated macrophages infected with M. 
tuberculosis there is approximately 50% killing, we probably see less in the M. smegmatis and  
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Figure 23.  Mycobacterium smegmatis are killed within activated DC. 
 
A.  Cell pellet lysates of M. smegmatis-infected DC (black diamonds) and MØ  (white squares) 
(MOI=1), resting or activated with IFN-γ + LPS, were serially diluted in PBS + 0.05% Tween 80 
and plated on 7H10 plates, which were incubated for 3 days at 37°C and 5% CO2.  Three wells 
per condition were assessed at each timepoint, and the mean intracellular CFU values are 
reported at various time points after infection of DC and MØ.  At each timepoint, <1% of total 
CFU was found in the supernatant.  A representative of two experiments is shown.  Error bars 
show standard error.  B. Nitrite (NO2-) accumulation in the supernatant of the infected cells was 
measured by  Greiss Assay, with a sodium nitrite standards, as previously described (2).   
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Figure 24.  BCG is killed within activated DC. 
 
(A.)  Cell pellet lysates of BCG-infected DC (black diamonds) and MØ (white squares) 
(MOI=1), unactivated or activated with IFN-γ + LPS, were serially diluted in PBS + 0.05% 
Tween 80 and plated on 7H10 plates, which were incubated for 18 days at 37°C and 5% CO2.  
Three wells per condition were assessed at each timepoint, and the mean intracellular CFU 
values are reported at various time points after infection of DC and MØ.  At each timepoint, <1% 
of total CFU was found in the supernatant.  A representative of two experiments is shown.  Error 
bars show standard error.  (B.) Nitrite (NO2-) accumulation in the supernatant was measured by 
Greiss Assay, with a sodium nitrite standards, as previously described (2).  DC (black diamonds) 
and MØ (white squares). 
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BCG infection since the bacterial burden was 100-150 times higher.   The amount of nitrite in the 
supernatants of these cultured cells was comparable (as measured by Greiss Assay)(Fig. 23B, 
24B).  There was little to no RNI produced by the resting cells. 
 
M. tuberculosis growth within activated DC and macrophages from reactive oxygen  
intermediates (ROI)-deficient mice.   
We observed the growth of M. tuberculosis in DC and macrophages obtained from 
B6.129S6-Cybbtm1 (phox-/-) mice in which the gene encoding the 91 kD subunit of oxidase 
cytochrome b (p91phox) was disrupted (Jackson Laboratories, Bar Harbor,and disrupts the 
production ROI (228).  This mouse is a model for Chronic Granulomatous Disease.  It was 
reported that infection of these mice with M. tuberculosis led to initially higher bacterial burdens, 
although at later time points, CFU were similar to wild  type  mice (216).  The deficiency in ROI 
production in the p91phox-/- mice severely limits the amount of peroxynitrite that can form, 
although other RNI are present (Figure 26).  In the activated DC from p91phox-/- mice there was a 
reduction of bacilli below the input level at 4 hr (Figure 25B).  In contrast, in the wild-type DC 
(Figure 25A) as reported previously, the bacteria were not able to grow but were not killed.   
Unexpectedly, in the activated macrophages we observed a reversal of killing in the 
p91phox-/- mice.  The bacteria were not growing as readily as in the resting macrophages (compare 
Figure 25 B to A) but there was no reduction in the intracellular bacilli as compared to the input 
(4hr); indeed there may even a slight increase in bacteria.  This suggests a role for ROI in killing 
of M. tuberculosis within activated macrophages, and this role would appear not to be dependent 
on the formation of peroxynitrite.  Since there is uncompromised total RNI nitrite production by  
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Figure 25.  M. tuberculosis growth within activated DC and macrophage from ROI-deficient 
mice.   
Cell pellet lysates of M.tuberculosis-infected DC (squares) and MØ (circles) (MOI=1) isolated 
from the bone-marrow of (A.) C57Bl6 mice (B.) p91 phox-/- mice (Jackson Laboratory, ME), were 
left unactivated (filled) or activated (open) with IFN-γ-LPS, then serially diluted in PBS plus 
0.05% Tween 80 and plated on 7H10 plates, which were incubated for 18 days at 37°C and 5% 
CO2.. Three wells per condition were assessed at each timepoint, and the mean intracellular CFU 
values are reported at various time points after infection. DC (squares) and MØ (circles).  At the 
input 4 hr timepoint <1% of total CFU was found in the supernatant.  A representative of three 
experiments is shown.  Error bars show standard error.   
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Figure 26.  Activated DC and activated MØ from p91phox-/- mice did not produce substantial 
amounts of peroxynitrite.   
 
 
(A.) Untreated DC (black) and MØ (white) and IFN-γ/LPS activated DC (gray) and macrophages 
(dots) from WT and  p91phox mice were cultured and activated as previously described.  The 
peroxynitrite production was measure using an assay previously described in Material and 
Methods and (68). (B).  Griess assay were performed on the supernatants from these IFN-γ/LPS 
activated DC (black) and macrophages (white) derived from WT and p91phox mice  and read at 
570 nm.  The standard curve was generated using NaNO2 
 
 
 
 
 122 
the p91phox-/- cells, as compared to wild type (see Figure 26), this suggests that the macrophages 
may need ROI to efficiently use the RNI, or that ROI may have their own role.   Yet it does 
appear that activated DC benefit from the lack of ROI since the RNI available in the absence of 
ROI appear to kill intracellular M.tuberculosis.    
 
M. tuberculosis growth within activated DC and macrophage from RNI-deficient mice.  
To establish the potentially different contribution of ROI in activated DC and macrophages to 
controlling the intracellular growth of M. tuberculosis, we examined the growth of the bacteria 
within RNI-deficient mice (NOS2-/-) (Figure27).  In this system the RNI are eliminated from 
playing a role in killing of the bacteria although ROI are still present.  Mice with the gene for 
NOS2 disrupted are very susceptible to M. tuberculosis, highlighting the necessity of RNI in 
control of infection (64) [Scanga  in press]. In untreated NOS2-/- DC and macrophages, the 
bacteria grew readily.  Upon activation, the NOS2-/- DC and macrophages were deficient in 
inhibition of growth and killing the intracellular M. tuberculosis.  This was expected, and agrees 
with our previous data, since RNI production was impaired.  The ROI alone were not sufficient 
to inhibit the growth of the bacteria in the cells.  
 
Acidification within activated DC and macrophages. 
The apparent lack of effectiveness of RNI, peroxynitrite, and ROI in killing M. 
tuberculosis within activated DC could be due to a microenvironment (e.g. the phagosome or 
phagolysosome) that is not sufficiently acidic.  It has been demonstrated that M. tuberculosis and 
some other mycobacteria can inhibit acidification of the phagosome.  To investigate this 
possibility, we first attempted to use Lysotracker, an acidotrophic fluorescent dye which flows  
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Figure 27.  M. tuberculosis growth within activated DC and macrophage from RNI-deficient 
mice.   
Cell pellet lysates of M.tuberculosis-infected DC (squares) and MØ (circles) (MOI=1) isolated 
from (A)  C57Bl/6 mice or (B) NOS2-/- mice (kindly provided by Dr. Timothy Billiar), were 
unactivated (filled symbols) or activated (open symbols) with IFN-γ + LPS, then serially diluted 
in PBS plus 0.05% Tween 80 and plated on 7H10 plates, which were incubated for 18 days at 
37°C and 5% CO2. Three wells per condition were assessed at each timepoint, and the mean 
intracellular CFU values are reported at various time points after infection DC (squares) and MØ 
(circles).  At the input timepoint <1% of total CFU was found in the supernatant.  Representative 
of three experiments is shown.  Error bars show standard error.   
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Figure 28.  Lysotracker staining in unactivated and activated macrophages.   
Bone-marrow derived macrophages were left untreated (A, B) or pretreated with Lysotracker 
Red (C, D) (Molecular Probes, Eugene, OR) then infected with GFP-labeled M. tuberculosis 
(green)  (A, C) or given 3 micron Fitc-labeled beads (Polysciences, Warrington, PA) (B,D), 
washed 24 hours post-infection, fixed, and imaged with confocal microscopy.  A representative 
field and experiment is shown. Repeated at least 10 times. Magnification 100X (A, C) and 60 X 
(B, D). 
 
 125 
freely into the vacuoles and compartments of cells but is retained in acidified vacuoles and 
compartments due to protonatation of the dye, causing acidic compartments to fluoresce 
(Molecular Probes,Eugene, OR).  The intensity of the dye is proportionately related to the pH 
(the more fluorescence, the lower the pH).  A strain of M. tuberculosis that expresses Green 
Fluorescent Protein (GFP) was used in these experiments.  We activated DC and macrophages as 
described previously, incubated with Lysotracker Red, infected with GFP-M. tuberculosis, and 
viewed cells at several timepoints ranging from 1 hr to 96 hrs post-infection using confocal 
microscopy (Figure 28, 24 hr pi).  We used untreated and uninfected cells as our negative control 
(not shown).  This control determines the level of autofluorescent background, which can be very 
high in phagocytes even in the rhodamine wavelengths.  Since our cells were infected with 
virulent M. tuberculosis, they must be fixed prior to viewing.  The level of autofluorescence in 
cells without lysotracker was very high and appeared punctuate, which appears as positive 
staining for lysosomes thus hampering our ability to determine actual pH staining (Figure 28 A, 
C).  Even after several protocol changes, troubleshooting, and various microscopes, such as 
epifluorescent and live cell (with fixed cells), we were unable to eliminate background and 
identify real staining and hence unable to compare conditions.  Using a technique based on 
Grating  Imaging Systems for Optic Sectioning (233) we identified actual staining by recreating 
an image without the background (data not shown), but this technique can only recreate one cell 
at a time, and is very time-consuming, making it unrealistic for our studies.   
As a positive control, macrophages were incubated with 3 micron FITC-labeled latex 
beads.  Macrophages phagocytose these beads, then proceed through the endocytic pathways to 
fuse with the lysosome (28), and therefore lyostracker staining co-localizes with the beads and 
serve as a positive control.  However, even in this control scattered staining not associated with 
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beads was observed, as well as in cells without beads (Figure 28D).  In summary, this was not a 
clean enough system is to detect differences in pH, and probably would be completely useless for 
detecting subtle pH differences (as seen in Figure 28), as might be the case between DC and 
macrophages.  We hope to eliminate problems with background autofluorescence by using live 
cell microscopy with other non-P3 level mycobacteria.  There is an additional reason why this 
technique may not workin our system for measuring pH.  M. tuberculosis resides in phagosomes 
which are tightly apposed to the bacilli;  this does not allow for much fluid within the vacuole 
and may alter the effects of this dye and contribute to the problems with this technique in our 
system.  
 
∆icl-M. tuberculosis- growth within activated DC and macrophage.   
As an indirect method for testing the hypothesis that defective acidification of vacuoles 
could be partially responsible for the inability of DC to kill intracellular M. tuberculosis, we 
used a mutant strain of M. tuberculosis, which has a targeted knockout in the gene for isocitrate 
lyase (∆-icl).  This strain does not survive well in macrophages activated with a low dose of IFN-
γ, which causes acidification but does not trigger production of NO (229). The intracellular 
growth of ∆icl-M. tuberculosis within low dose IFN-γ-activated DC and macrophages was 
compared to the growth of wild-type M. tuberculosis.  There was a decrease in number of 
surviving ∆icl-M. tuberculosis in activated cells, compared to the wild-type strain.  The decrease 
in ∆icl-M. tuberculosis viability was much higher in activated macrophages compared to 
activated DC.  This supports that hypothesis that DC may not acidify their 
phagosome/phagolysosomes to the same degree as  
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Figure 29.  ∆icl-M. tuberculosis- growth within activated DC and macrophage.   
Cell pellet lysates of ∆icl-M.tuberculosis-infected (filled) or M.tuberculosis-(open) low dose (50 
units) IFN-γ-activated DC (squares) and MØ (circles) (MOI=1), were serially diluted in PBS 
plus 0.05% Tween 80 and plated on 7H10 plates, which were incubated for 18 days at 37°C and 
5% CO2.  Three wells per condition were assessed at each timepoint, and the mean intracellular 
CFU values are reported at various time points after infection DC (squares), MØ (circles), ∆icl-
M.tuberculosis, (filled), M.tuberculosis (open).  At the input timepoint <1% of total CFU was 
found in the supernatant. A representative of three experiments is shown.   
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Figure 30.  Theoretical model for anti-microbial compound production in activated DC and 
macrophages.   
 
This diagram depicts a very oversimplified view to how the activation of DC and macrophages 
can lead to differential production of peroxynitrite which does not kill M. tuberculosis, and leave 
different quantities of toxic nitric oxide behind which can kill.  We hypothesize that these ratios 
are important for differences in killing between these cells.  
Note this model excludes all other ROI and RNI production for simplicity 
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activated macrophages, since they cannot as efficiently kill ∆icl-M. tuberculosis, which is very 
sensitive to acidfication. 
Discussion  
DC are most commonly thought of as APC. Indeed, M. tuberculosis-infected DC are 
better APC than infected MØ, in terms of priming and restimulation of T cell responses (23), 
(97), (14),  (124), (data not shown).  Recently CD40-CD40L interaction was shown to be a 
potent stimulus for DC in response to a mycobacterial infection (14).  DC are capable of 
initiating a protective immune response to M. tuberculosis since upon infection they contribute 
important components of immunity, such as inflammatory cytokine production and T cell 
interaction (14).  We investigated whether DC also acted as an effector cell, and therefore could 
possibly contribute to control of the infection and participate in the direct killing of M. 
tuberculosis.   
DC have been demonstrated to take up and harbor various microbes, including 
Salmonella(160, 187), E. coli (187), Listeria monocytogenes (188), Borrelia burgdorferi (161, 
189), Bordetella bronchiseptica (159), BCG (158, 190), Leishmania (162, 163, 191), Chlamydia 
(164, 165, 192, 193), Candida albicans (195), and Histoplasma capsulatum (194).  DC have 
been shown to directly kill Chlamydia trachomatis and Chlamydia psittaci by phagosome-
lysosome fusion and this led to priming of Chlamydia-specific T cells (165).  DC have been 
shown to phagocytose Borrelia burgdorferi, which was later detected in the phagolysosome, then 
processed and loaded on MHC class II molecules (161). As well Histoplamsa capsulatum (194) 
and Candida albicans (195) are phagocytosed, killed by phagolysosome fusion, processed, and 
presented to T cells by human DC.  Interestingly, Histoplamsa capsulatum prevents 
phagolysosome in human macrophages but not in DC.   Candida albicans caused a large 
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reduction of phagolysosome fusion in the DC, as compared to Histoplamsa capsulatum, but 
hydrolases within the phagolysosome are ultimately hypothesized to kill the fungus, C. albicans 
was shown to trigger ROI production but this did not contribute to the killing of this organism 
(195).  Other anti-microbial mechanism of activated DC have not been investigated. 
We first investigated RNI production since it is known that murine macrophages use this 
mechanism to kill intracellular M. tuberculosis (61), (50), (52).  Murine DC have been shown to 
produce NO (55).  Thymic DC generate NO in response to self and allo-antigens and kill auto-
reactive T cells (203), including in the Experimental Allergic Encephalomyelitis (EAE) mouse 
model for Multiple Sclerosis (54), (53).  We reported previously that activated DC produce RNI 
and can prevent M. tuberculosis intracellular growth yet they do not appear to kill the bacilli (23) 
(Chapter2).  Despite these differences in killing there is comparable nitrite production by both 
activated DC and macrophages throughout 72 hrs post-infection (23).  We sometimes observed a 
difference in nitrite production early after infection (4hr).  The activated M. tuberculosis-infected 
DC actually had higher levels of NOS2 mRNA and protein but this did not result in higher nitrite 
production; regardless of the output of nitrite at 4 hrs the activated DC did not kill the 
intracellular bacteria.  Possibly DC may regulate the activity of the NOS2 enzyme post-
translationally, which inhibits NOS2 to prevent high levels of RNI output, or has a different 
availability of substrates for NOS2 (such as arginine).   
ROI and peroxynitrite following interaction with NO are potent oxidative compounds 
which are toxic to many pathogens such as Rhodococcus equi (218), Escherichia coli (219), 
Salmonella enterica (68), Salmonella typhimurium (220), Mycoplasma pulmonis (221), and 
Candida albicans (222).  The role of ROI, as discussed before, in M. tuberculosis infection is 
controversial, and so is the role for peroxynitrite.  Indeed although it was speculated that 
 131 
peroxynitrite could kill M. tuberculosis it has never been demonstrated.  In fact, the opposite has 
been reported: virulent strains of M. tuberculosis, such as the most prevalent New York clinical 
strain, Strain C, and the laboratory strain Erdman, are highly resistant to peroxynitrite. (49).  
When we investigated the production of these compounds from activated DC, surprisingly DC 
made more ROI than macrophages as well as peroxynitrite. The production of peroxynitrite is 
dependent on superanion, (O2-) which is formed via the NADPH-oxidase complex.  Mice which 
had a genetic disruption of the p91phox-/- subunit of this complex can no longer produce ROI and 
we show that this abrogates their ability to produce peroxynitrite as well (Figure 26A).   
Based on these data, we hypothesize that since activated DC make more peroxynitrite 
than activated macrophages, they are less efficient at killing M. tuberculosis, because the amount 
of effective RNI (such as NO) is diminished, due to the higher ROI levels, which pull away NO 
molecules to form peroxynitrite (Figure 30).  Leishmania major is susceptible to killing by NO 
production within macrophages but is resistant to both ROI and ONOO- killing (223).  We have 
also shown that activated DC can kill a non-pathogenic species, Mycobacterium smegmatis, and 
an a virulent strain of mycobacteria, BCG, which have been reported to be susceptible to 
peroxynitrite (Figure 23 & 24).  
In order for M. tuberculosis to survive in the lung they probably need defense mechanism 
against peroxynitrite (221).  Ruan, et. al. found a gene in M. tuberculosis, noxR3,  postulated to 
protect the bacteria from RNI and ROI.  When noxR3 from M. tuberculosis was expressed in 
Salmonella typhimurium it conferred resistance to these both oxidative and nitrosylative stress 
(233).  In addition, the lethal effects of NO can be modified.  M. tuberculosis has been shown to 
have peroxynitrite reductases, peroxiredoxins, which reduce the oxidizing and toxic effects of 
peroxynitrite (234).  These peroxidoxins’s reductase activity is based on the reversible oxidation 
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of their N-terminal Cys, therefore under conditions of chronic exposure or very high 
concentration of peroxynitrite their reductases activity is hindered since the active sites of Cys 
will remain oxidized  (234).  In the presence of small amounts of peroxynitrite or fluxes of 
production, possibly in acute infection, is probably when the peroxidoxins can work best.  
Interestingly, it was shown that small amounts of peroxynitrite may participate in signaling 
cascades which actually help the cell activate enzymes that repair tyrosine nitration  (234).  It has 
been reported that surfactant enhances peroxynitrite production possibly via SP-A, a surfactant 
protein, which has been suggested to mediate ROI release in the lungs (221)  It is likely that a 
defense mechanism against peroxynitrite is necessary for M. tuberculosis to survive long term in 
the lung.  These could explain why we were unable to detect the presence of nitrosylated 
proteins.  It was reported that an excess of ROI production may convert NO into NO3- by 
dioxygenase, which is inert and not anti-microbial (235).  Activated DC are capable of making 
more ROI therefore they in turn may make more NO3 and alter the lethal effects of their pool of 
RNI.   
We hypothesized that the excess production of ROI by activated DC leads more ONOO- 
and less tuberculocidial RNI, such as NO, contributing to the inability of DC to kill M. 
tuberculosis.  To address this further, the growth and killing of M. tuberculosis within p91 phox-/- 
murine macrophages, which cannot produce ROI, and NOS2-/- macrophages which cannot make 
NO were tested.  Neither mouse should be capable of peroxynitrite production since this is 
dependent upon 02 and NO (236).  We confirmed that p91 phox-/- did not produce significant 
levels of peroxynitrite as compared to WT cells (Figure. 26).  It was reported that p47 phox-/- mice 
are subtly impaired in the initial control of M. tuberculosis infection (216).  We report here that 
the activated DC from the p91 phox-/- mice could reduce the number of viable intracellular bacilli 
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below the input number (figure 25A), in contrast to activated DC from wild-type mice (Figure 
25B).  However, the activated macrophages from p91 phox-/- mice could not reduce the number of 
viable intracellular bacilli below input and even allowed for a small amount of bacterial growth; 
this differed from wild-type macrophages which can routinely kill 50% of intracellular M. 
tuberculosis (Figure25).  We hypothesize that p 91phox-/- DC can kill the intracellular M. 
tuberculosis because the NO needed for killing is not converted to peroxynitrite due to the 
relative absence of ROIs.  However, it appears macrophages use ROI in some capacity to make 
NO efficient at killing, which we believe is not the formation of peroxynitrite.  Roles for ROI in 
signaling within macrophages may lend to killing via cytokine production or undiscovered 
mechanisms that may contribute to killing of M. tuberculosis (216).  As well ROI themselves 
may be able to kill, it has been reported that M. tuberculosis in vitro was susceptible to hydrogen 
peroxide killing (47).  ROI have been implicated in non-phagocytic cells to contribute to signal 
transduction pathways which lead to apoptosis (237). 
Further support for the hypothesis is that ROI may contribute to killing within activated 
macrophages and not DC came from examining the growth of intracellular M. tuberculosis 
within NOS2-/- bone-marrow derived macrophages and DC (Figure 27).  In these cells the 
ability to kill M. tuberculosis is negated due to the inability to produce NO or RNI, but the 
activated macrophages do appear to slightly reduce the number of colonies below that of the 
unactivated (which do not produce ROI).  However in the NOS2-/- bone-marrow derived 
activated DC the growth of intracellular M. tuberculosis is either the same as or more than the 
unactivated cells which indicates that the ability to hinder the growth is completely abrogated.  
The only time the activated DC were capable of killing intracellular M. tuberculosis was under 
conditions where ROI were drastically diminished but NO was present as seen in the p91 phox-/- 
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mice.  Studies have shown that when ROI are depleted by superoxide dismutase there is a higher 
production of RNI.  We did not observe this;  there was a comparable level of RNI in wild-type 
and p91 phox-/- macrophages following activation.  Thus, differences in killing may be attributed 
to differences in the availability of NO. 
 M. tuberculosis can be killed in the acidic environment of a phagosome (238).  It was 
shown that Coxiella burnetti-containing phagosomes, which have a low pH, fused with M. 
tuberculosis containing phagosome thereby lowering the pH and killing the mycobacteria (201).  
Mycobacteria have been shown to prevent this acidification (239).  M. avium and M. tuberculosis 
can prevent the acidification of the phagosome by excluding ATPase pumps (30), (31).  
M.tuberculosis-containing phagosomes exclude Rab7, a late endosomal GTPase protein, thus 
indicating that these phagosomes did not fuse with the lysosome and acidify the phagosome (33).  
Even if M. tuberculosis containing-phagosomes express Rab 7 they still do not fuse with the 
lysosome suggesting interference with the function of Rab 7  (240).  In an activated macrophage 
fusion of the M .tuberculosis-containing phagosome to the lysosome is much more frequent, 
presumably increasing the amount of killing.  Therefore, if the activated DC is impaired in the 
ability to fuse with lysosomes and/or acidify the phagosome, then this would lead to an inability 
to kill.  DC infected with C. albicans showed a seventy percent  reduction of phagolysosome 
fusion, as compared to H. capsulatum infection of these cells, showing that DC can regulate the 
level of phagolysosome fusion during infections (195).  Acidification can also contribute to the 
potency and increase the half-live of NO, ONNO-, and ROI so a deficiency in acidification could 
reduce toxic effects of these compounds (56).  The ability of macrophages and DC to acidify the 
M. tuberculosis-containing phagosome was compared.   
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We first tried to assess acidification by a direct method, using a Lysotracker dye, but due 
to problems with high level of background autofluorescence we were unable to confidently 
assess acidification in activated DC and macrophages.  We had the same problems using an 
antibody against LAMP, a lysosomal marker,  to try to determine if there were differences in 
lysosomal fusion with phagosomes-containing M. tuberculosis in activated DC compared to 
activated macrophages (data not shown). The difficulties with Lysotracker dye and direct 
assessment of acidification led us to approach this question by an indirect method.  We compared 
the survival of a strain of M. tuberculosis with a mutation in the gene for isocitrate lyase (icl) in 
DC and macrophages. Isocitrite lyase is an important enzyme in the glyoxylate shunt in bacteria; 
when genetically disrupted in M. tuberculosis, ∆icl, the bacteria was reduced in persistence in 
mice and has much decreased viability in acidified macrophages (229).  In these experiments, the 
macrophages were activated with a low dose of IFN-γ and no second signal for NOS2; this 
resulted in fusion of phagosomes with lysosomes and subsequent acidification, but no RNI 
production. We compared the growth of ∆icl M. tuberculosis in IFN-γ-activated DC and 
macrophages to determine whether differences in the intracellular environment of the activation 
states of these cells results in differential viabilities of this acid-sensitive strain.  The growth of 
∆icl M. tuberculosis in low dose activated cells is much reduced below WT tuberculosis or ∆icl 
M. tuberculosis growth in unactivated cells.  Interestingly, in low IFN-γ dose activated DC there 
was much less killing of ∆icl M. tuberculosis as compared to macrophages (Figure 29).  This 
suggests that the activation state of the DC is different and possibly not as acidic as the 
macrophages.  Future plans include using immuno-EM with an antibody against DAMP, a 
molecule which accumulates in acidic compartments, on infected activated DC and macrophages 
given the DAMP, to quantitate difference in acidity between cells.   
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In vivo, only a small percentage of DC or macrophages are activated at any one time. M. 
tuberculosis likely grows within the unactivated cells, and thus the infection is not cleared.  Even 
within the activated state of a macrophage, only half the tubercle bacilli are killed, at least in 
vitro, and our data indicate that within a DC, killing does not occur.  M. tuberculosis manages to 
live within these hostile environment, yet the elimination of some portion of the population of M. 
tuberculosis is critical for the host-pathogen balance that is generally observed, i.e. latent 
infection.  We propose, based on the data presented here, that the role of the activated DC in 
maintaining a mycobacteriostatic, but not mycobactericidal environment may be crucial for 
protection, as it may enhance their potent antigen presenting properties.  Presentation of antigen 
from living microbes is more efficient than from killed organisms, and live M. tuberculosis 
matures DC better than killed bacilli (22).  This has been shown for Leishmania major and 
speculated by others to contribute to long-term immunity against an organism (163), (155).   
Early in infection, the DC may also contribute to protection by halting uncontrolled 
growth of the bacilli.  These data show that there are differences in the vacuolar environment 
between activated DC and macrophages, and this may contribute to an inability to kill M. 
tuberculosis. Our data also support that peroxynitrite does not kill M. tuberculosis.  However, 
ROI may play a role early in activated macrophages to help kill the intracellular microbes.  In an 
odd way ROI may contribute to protection in DC by allowing these cells to maintain viable 
bacteria. The differences in acidification of the vacuoles could lead to differences in how antigen 
is processed, loaded, and presented.  Low acidification, as we suspect in the DC, may be more 
beneficial for antigen presenting, whereas low pH favors killing of bacteria, as seen with 
macrophages.  We believe that DC play a distinct role in initiating the protective immune 
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response to M. tuberculosis, and the unique properties of this cell with respect to M. tuberculosis, 
described in this work, contribute to this function.  
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Summary 
Mycobacterium tuberculosis is responsible for the largest number of infections from a 
single organism, and is only second to HIV in the number of deaths per year from an infectious 
agent (1).  This high number of deaths occur despite effective antibiotic treatment, widespread 
vaccination with BCG, and the host’s ability to mount a protective immune response. It is 
estimated that only one of every ten immunocompetent people infected with M. tuberculosis 
develops active tuberculosis.  Numerous studies over the year have shown that cell-mediated 
immunity is necessary for protection (reviewed in (27)). Macrophages are the host cell for the 
bacilli and upon cytokine-induced activation kill M. tuberculosis.  Although, macrophages are 
APCs they have been shown to be suppressive in the lung (241).  Alveolar macrophages are 
inefficient APCs (242).  DC are potent APC and generate immunity in the airways after infection 
to a much larger extent than macrophages (140).  In this study we sought the effects of DC 
interacting with M. tuberculosis, both on the DC and on the intracellular bacteria.   
We first examined whether human peripheral blood derived DC and murine bone-marrow 
derived DC could be infected with M. tuberculosis.  Macrophages were previously the only 
known reservoir for this bacterium.  We determined that DC were readily infected with M. 
tuberculosis; and there was a comparable percentage of DC infected as compared to 
macrophages in an in vitro system.  The bacteria grow as rapidly within unactivated DC as 
macrophages (Chapter 1).  Thus DC may provide another repository for the bacteria in the host.  
Despite similarities in infection, these two cells responded differently to the bacteria (Chapter 1 
& 2).  DC downregulated their phagocytic ability and upregulated molecules important for 
antigen presentation and trafficking, such as B72, MHC I & II, and ICAM. This is a hallmark of 
DC development in which they shift from an antigen processing phenotype to antigen presenting 
phenotype in response to bacterial stimulus (186).  Macrophages expressed these markers but 
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they did not change significantly after infection nor did their phagocytic ability decrease after 
infection (Chapter 1).  Functionally we showed that M. tuberculosis-infected DC were better 
than macrophages at stimulating T cells from infected mice.  These studies suggested that DC 
play a role in initiating immunity (Chapter 1).  There have subsequently been reports in the 
literature to support this (14).   
DC in the lungs of mice have been shown to be infected (146) but it is still not known 
whether they are present in the granuloma or play a role in its formation.  DC secrete IL-12 in 
response to M. tuberculosis-infection and in other systems this is boosted upon interaction with T 
cells (151), (182).  IL-12 is important for the generation of a TH-1 T cell response that is 
necessary for protection in a M. tuberculosis infection.  In addition DC secrete inflammatory 
cytokines which are important for cell migration and granuloma formation (23), (147), (166).   
DC secrete TNF-α which is a crucial cytokine in activation of macrophage, inducing the 
inflammatory response, migration of cells, and organized granuloma formation (232).  DC also 
stimulate T cells to secrete IFN-γ which is a crucial cytokine in an M. tuberculosis infection.  
Mice deficient in this cytokine succumb to tuberculosis faster than any other single gene 
deficient mouse.  IFN- γ is necessary with a second signal to activate macrophages and DC (23) 
(Chapter 1).  These data show that DC produce protective immune responses and are better APC 
in the infection.  We believe these data support our hypothesis that DC in lung that are infected, 
mature, then traffic to the draining lymph node to prime naïve T cell against mycobacterial 
antigens. 
 In addition to characterizing what happens to the DC after infection we examined the fate 
what of M. tuberculosis in the intracellular environment, especially after activation with IFN- γ 
and LPS (Chapter 2 & 3).  There has not been much research in DC for anti-microbial 
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mechanism or compounds, with the exception of antigen processing mechanisms, such as late 
endosomal trafficking and fusion of the phagosome to the lysosome.  The production of such 
compounds may be necessary for protection and viability of the DC during infection, and the DC 
may limit harmful bacterial burdens in infections, such as M. tuberculosis.  Activation of 
macrophages by IFN- γ and a second signal leads to the production of NOS2 generated RNI, 
NADPH-catalyzed ROI, and phagolysosome fusion and acidification (reviewed in (27)).  We 
know that RNI  present in murine macrophages can kill M. tuberculosis.  The role for ROI in M. 
tuberculosis is debatable but its production by macrophages is known to play a role in many 
infections, including  M. microti (12).  The production of ROI was never investigated in DC.  
Although acidification has been shown to kill M. tuberculosis, it is questionable how often this 
happens in vivo since the mycobacteria can prevent acidification.  Macrophage activation allows 
endosomal procession to fusion with the lysosome, therefore under this circumstance some 
killing of M. tuberculosis would occur (33).  In vivo we know that not all cells are activated and 
those that are have a limited lifespan and may eventually die. The remaining  intracellular M. 
tuberculosis may be taken up by a unactivated macrophage, which will allow for its growth.  
Neither RNI production and/or acidification in the activated macrophage can clear this infection 
but they are important mechanisms in the stand-off between the bacterium and the host.   
We have found these anti-microbial mechanisms present in IFN-γ and LPS activated 
murine DC but we see a different outcome for the bacteria (Chapter 3).  This suggests that DC 
have an activated state that is different from the matured state.  We were not surprised to find 
that DC produce RNI since this had been reported previously (55), but despite an equal 
production of nitrites by the infected-activated DC, they only hinder the growth of M. 
tuberculosis and do not kill it.  In addition the activated DC produced a larger quantity of ROI 
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which leads to a higher production of peroxynitrite (Chapter 3), since ROI is the limiting factor 
in peroxynitrite formation from NO and O2-.  In spite of more of these compounds the activated 
DC cannot kill intracellular M. tuberculosis, but  can kill M. smegmatis and BCG which are non-
pathogenic (Chapter 3). Several species of bacteria and parasites are resistant to peroxynitrite 
killing, including M. tuberculosis and Leishmania major.  Protection to Leishmania major in 
mice has many similarities that of M. tuberculosis including the necessity of a TH1 response 
which is driving by the DC.  Leishmania major is also not killed within DC but remains viable 
while the DC traffic to the lymph node and was even found to remain viable within DC in the 
lymph node up to several days post-infection (162, 163).  Virulent strains of M. tuberculosis 
were found to be amazingly resistant to very high doses of peroxynitrite but susceptible to nitric 
oxide and nitrogen dioxide.  Avirulent strains were susceptible to peroxynitrite killing as well as 
nitrogen dioxide and nitric oxide killing (49).  Recent data has shown that peroxredoxins are 
present in cells, including bacteria such as M. tuberculosis, and prevent destructive oxidation, 
especially under low concentrations of peroxynitrite (234).  This could explain our lack of 
detection of nitrosylated proteins within M. tuberculosis-infected DC and macrophages (Chapter 
3).  Nitrosylation of protein occurs due to the presence of peroxynitrite (68). If M. tuberculosis 
can reduce the peroxynitrite then this would alleviate cell damage and nitroyslation.  In addition 
these reductases may be present and active in DC and macrophages.  
Our hypothesis, derived from these data, is that the higher quantity of ROI from DC 
utilizes the available NO to form peroxynitrite which is not toxic to this bacteria.  Therefore the 
DC uses up NO which is lethal for M. tuberculosis to produce a compound (OONO-) which 
which is not.  It is unclear whether the bacteria or DC adapted this strategy for its benefit.  We 
have tested this hypothesis by examining growth of M. tuberculosis within mice deficient in ROI 
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production, p91phox-/-, in which there are still RNI present but no peroxynitrite since it needs 
superanion to be produced.  We determined that DC from p91phox-/- mice were able to kill 
intracellular M. tuberculosis  (Chapter 3).  This is probably because RNI are available and not 
sequestered by production of peroxynitrite.  In mice which lack NOS2 and RNI production, DC 
were incapable of inhibiting the growth of intracellular M. tuberculosis, in contrast to DC from 
wild-type mice.  However, activated macrophages from NOS2 mice appeared to allow for a 
slight amount of M. tuberculosis growth suggesting the ability of macrophages to kill M. 
tuberculosis involves ROI (Chapter 3).  We believe this is not dependent on the formation of 
peroxynitrite since this compound does not kill M. tuberculosis.  It is possible that another 
compound is formed with some species of ROI and RNI within activated macrophages, and this 
may not occur in activated DCs.  ROI is involved in important signaling mechanisms within the 
macrophages (216) that may turn on a NOS2 independent mechanism for killing or simply turn 
on the production of certain cytokines such as TNF-α.  We did not examine cytokine production 
from these infected knock-outs.  Data have shown roles for ROI-mediated signaling in cytokine 
production and in cell trafficking (216).  NOS2-independent mechanisms are believed to exist 
and not yet identified in activated macrophages. 
 Importantly a reduction in acidification in the phagosomes of DC could greatly affect 
their ability to kill.  Studies have shown that phagolysosome fusion occurs in DC.  This has been 
shown to kill Chlamydia species and Borrelia burgdorferi has been identified in the 
phagolysosome then processed and presented on MHC class II (165), (161).  It is known that 
antigens which are presented by MHC class II must proceed through to the late endosomal 
compartments so that they can fuse to class II containing compartments (243).  Therefore DC 
possess to ability to kill microbes for presentation by acidification via the lysosome or class II 
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compartment and this is the best studies anti-microbial mechanism in DC.  The amount of 
acidification has never been directly compared to that of a macrophage.  We have data 
suggesting the activated DC may not have as acidic of a phagosome environment.  A mutant 
strain of M. tuberculosis, ∆icl, has been shown to be sensitive to killing within the acidified state 
of a macrophage, which is achieved by low dose IFN- γ activation (229).  Therefore indirectly, 
this mutant is an indicator of pH within the phagosome.  ∆icl M. tuberculosis is susceptible to 
killing within an low dose IFN- γ  activated DC, whereas the wild-type strain is not and the ∆ icl 
M. tuberculosis is not killed within unactivated DC.  However, the low dose IFN- γ activated DC 
does not come close to killing as much ∆icl M. tuberculosis as the activated macrophage can.  
This suggests that there is an acidification difference between these activated cells.  It confirms 
what our other data has shown that the activation state of these cells is different.  This difference 
in pH could limit the toxicity of anti-microbial compounds such as ROI, NO, and peroxynitrite 
and hinder their ability to kill.  The killing effect of these compounds on microbes is usually 
determined from activated macrophages where the pH is very low.  In vitro assays have shown 
that low pH increase the half-lives of these compounds (68) and this could contribute to 
difference in killing.  As well it may be of interest to investigate gene expression of M. 
tuberculosis within activated DC and macrophages, as these environment are different there may 
be unique gene expression within the bacteria.   
   We believe that the bacteriostatic effects of the DC contribute to their ability to be a 
potent APC in this infection.  It has long been known that live M. tuberculosis and presumably 
secreted antigens from this bacilli can generate more immunity than dead bacilli (133), (12).  To 
sustain an immune response to chronic infection such as M. tuberculosis and Leishmania major, 
it is believed that the DC would have to harbor live antigens which could continually be secreted 
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(163), (155).  These studies help establish that DC are important in the initiation of an immune 
response. They also identify DC as being effector cells and preventing bacterial growth as well 
as producing compounds which can kill microbes.  This research will lead to further 
investigation of the differences between the activated states of DC and macrophages, as well as 
elucidate the different role these cells play in infection.  Understanding DC and how they process 
mycobacterial antigen and generate immunity will be very beneficial toward understand how to 
protect the host during infection. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 145 
 
Bibliography 
 
1. The World Health Report 1999.  Making a Difference. World Health Organization, 
Geneva, p. 116. 
2. Raviglione, M. C., D. E. Snider, and A. Kochi. 1995. Global epidemiology of 
tuberculosis: Morbidity and mortality of a global epidemic. JAMA 273:220. 
3. Okhiambo, J. A., M. Borgdorrf, F. Kiambih, D. Kibuga, D Kwamanga, L. Ng'ang'a, R. 
Agwanda, N. Kalisvaart, O. Misljenovic, N. Nagelkerke, M. Bosman. 1999. Tuberculosis 
and the HIV epidemic: increasing annual risk of tuberculous infection in Kenya 986-
1996. Am. J. Publ. Health 89:1078. 
4. Alpert, P. L., Munsiff,S.S., Gourevitch, M. N., Greensburg, B., and Klein, R.S. 1996. A 
prospective study of tuberculosis and human immunodeficiency virus infection. Clin.,. 
Infect. Dis 24:661. 
5. Goletti, D., Weissman, D., Jackson, R.W.,Graham, N.M., Vlahov, D., Klein, R.S., 
Munsiff, S. S., Ortona, L., Cauda, R., Fauci, A. S. 1996. Mycobacterium tuberculosis on 
HIV replication: role of immune activation. J. Immunol 157:1271. 
6. Nakata, K., Rom, W.N., Honda, Y., Condos, R., Kanegaskai, S., Cao, Y., Weiden, M. 
1997. Mycobacterium tuberculosis enhances human immunodeficiency virus type-1 
replication in the lung. Am. J. Respir. Crit. Care Med. 155:996. 
7. Freiden, T. R., Sterling, A., Pablos-Mendez, A., Kilburn, J.O., Cauthen, G.M., and 
Dooley, S.W. 1993. The Emergence of drug-resisitant tuberculosis in New York. N. Engl. 
J. Med 328:521. 
8. 1999. Tuberculosis Treatment Interuptions-Ivanovo Oblast, Russian Federation. JAMA 
285:1953. 
9. Kubin, M., Prikazsy, V., Havelkova, M., Svandova, E., Levina, K., Kurve, A, and 
Leimans, J. 1999. Present State of tuberculosis in the Czech Republic and in central 
European and Baltic countries. Central European Journal of Public Health 7:109. 
10. Iseman, M. D., and J.A. Sbarbaro. 1992. The increasing prevalence of resistance to anti-
tuberculosis chemtherapeutic agents:  implications of global tuberculosis control. Curr. 
Clin. Top. Infect. Dis. 12:188. 
11. Banatvala, N. a. G., P. 1999. Tuberculosis, Russia, and the Holy Grail. The Lancet 
353:999. 
12. Bloom, B. R., and P.E.M. Fine. 1994. In Tuberculosis: Pathogenesis, Protection, and 
Control, Vol. in press. B. R. Bloom, ed. American Society for Microbiology, 
Washington, D.C. 
13. Huygen, K., Content, J., Denis, O., Montgomery, A.M., Yawman, Deck, R.R., Dewitt, 
C.M., Drene, I.A., Baldwin, S., D'Souza, C., Drowart, A., Lozes, E., Vandenbusshe, P., 
van Vooren, J.P., Liu, M.A., and Ulmer, J.B. 1996. Immunogenic and protective efficacy 
of tuberculosis DNA vaccine. Nat. Med. 2:888. 
14. Tascon, R. E., C. s. Soares, S. Ragno, E. Stavropoulos, E. M. A. Hirst, M. J. Colston. 
2000. Mycobacterium tuberculosis-activated dendritic cells induce protective immunity 
in mice. Immunol. 99:473. 
15. Tascon, R. E., E. Stavropoulos, K. V. Lukacs, M. J. Colston. 1998. Protection against 
Mycobacterium tuberculosis infection by CD8 T cells requires production of gamma 
interferon. Infect. Immun. 66:830. 
 146 
16. Ngeyen, H. T., Trach. D., Man, N., Ngoan, T., Dunia, M., Ludrosky-Diawara, M., and 
Benedetti, E. 1979. Comparative ultrastructure of mycobacterium leprae and 
Mycobacterium lepraemurium cell envelops. J. Bacteriol. 138:552. 
17. Silva, M. T., P.M. Macebo. 1983. The interpretation of the ultrastructure of 
mycobacterial cells in transmission electron microscopy of ultrathin sections. Int. J. Lepr. 
51:225. 
18. Chan, J., X.-D. Fan, S.W. Hunter, P.J. Brennan, B.R. Bloom. 1991. Lipoarabinomannan, 
a possible virulence factor involved in persistence of Mycobacterium tuberculosis within 
macrophages. Infect. Immun. 59:1755. 
19. McNeil, M. R. a. B., P.J. 1991. Structure, fuction and biogenesis of the cell envelop of 
mycobacteria in relation to bacterial physiology, pathogenesis and drug resistance; some 
thoughts and possibilities arising from recent structural information. Res. Microbiology 
142:451. 
20. Minnikin, D. E. 1991. Chemical principles in the organization of lipid components in the 
mycobacterial cell envelop. Res. Microbiol. 142:423. 
21. Ernst, J. D. 1998. Minireview:  Macrophage receptors for Mycobacterium tuberculosis. 
Infect. Immun. 66:1277. 
22. Henderson, R. A., S. C. Watkins, and J. L. Flynn. 1997. Activation of human dendritic 
cells following infection with Mycobacterium tuberculosis. J. Immunol. 159:635. 
23. Bodnar, K., Serbina, N. V., and Flynn, J. L. 2001. Fate of Mycobacterium tuberculosis 
within Murine Dendritic Cells. Infection and Immunity 69:800. 
24. Lurie, M. 1942. Studies on the mechanism of immunity in tuberculosis.  The fate of 
tubercle bacilli ingested by mononuclear phagocytes derived from normal and immunized 
animals. J. Exp. Med. 75:247. 
25. Suter, E. 1952. The multiplication of tubercle bacilli within normal phagocytes in tissue 
cultures. J. Exp. Med. 96:137. 
26. Mackaness, G. 1969. The influence of immunologically committed lynphoid cells on 
macrophage  activation in vivo. J. Exp. Med. 129:973. 
27. Flynn, J. L., J. Chan. 2001. Immunology of tuberculosis. Ann Rev Immunol 19:19. 
28. Deretic, V., Fratti, RA. 1999. Mycobacterium tuberculosis phagosome.  Mol. Microbiol. 
31:1603. 
29. Mellman, I., Fuchs, R, Helenius, A. 1986.  Acidification of the endocytic and exocytic 
pathways. Ann. Rev. Biochem. 55:663. 
30. Sturgill-Koszycki, S., Schlesinger, PH, Chakraborty, P, Haddix, PL, Collins, HL, Fok, 
AK, Allen, RD, Gluck, SL, Heuser, J, Russell, DG. 1994. Lack of acidification in 
Mycobacterium phagosomes produced by exclusion of the vesicular proton-ATPase. 
Science 263:678. 
31. Xu, S., Cooper, A, Sturgill-Koszycki, S, van Heyningen, T, Chatterjee, D, Orme, I, Allen, 
P, Russell, DG. 1994. Intracellular trafficking in Mycobacterium tuberculosis and 
Mycobacterium avium-infected macrophages. J. Immunol. 153:2568. 
32. Sturgill-Koszycki, S., Schaible, UE, Russell, DG. 1996. Mycobacterium-containing 
phagosomes are accessible to early endosomes and reflect a transitional state in normal 
phagosome biogenesis. EMBO J. 15:6960. 
33. Deretic, V., Via, LE, Fratti, RA, Deretic, D. 1997. Mycobacterial phagosome maturation, 
rab proteins, and intracellular trafficking. Electrophoresis. 18:2542. 
 147 
34. Gatfield, J., and J. Pieters. 2000. Essential role for cholesterol in entry of mycobacteria 
into macrophages. Science 288:1647. 
35. Ferrari, G., H. Langen, M. Naito, J.A. Pieters. 1999. Coat protein on phagosomes 
involved in the intracellular survival of mycobacteria. Cell 97:435. 
36. Gordon, A., D'Arcy Hart, P, Young, MR. 1980. Ammonia inhibits phagosome-lysosome 
fusion in macrophages. Nature 286:79. 
37. Reyrat, J.-M., Berthet, F-X, Gicquel, B. 1995. The urease locus of Mycobacterium 
tuberculosis and its utilization for the demonstration of allelic exchange in 
Mycobacterium bovis bacillus Calmette-Guerin. Proc. Natl. Acad. Sci. USA 92:8768. 
38. Clemens, D., Lee, B-Y, Horwitz, MA. 1995. Purification, characterization, and genetic 
analysis of Mycobacterium tuberculosis urease, a potentially critical determinant of host-
pathogen interaction. J. Bacteriol. 177:5644. 
39. Vazquez-Torres, A., Jones-Carson, J., Mastroeni, P., Ischiropoulos, H., and Fang, F.C. 
2000. Anti-microbial Action of the NADPH Phagocyte Oxidase and Inducible Nitric 
Oxide Synthase in Experimental Salmonellosis. I. Effects on Microbial Killing by 
Activated Peritoneal Macrophages in Vitro. J. Exp Med. 192:227. 
40. Adams, L., Dinauer, MC, Morgenstern, DE, Krahenbuhl, JL. 1997. Comparison of the 
roles of reactive oxygen and nitrogen intermediates in the host response to 
Mycobacterium tuberculosis using transgenic mice. Tuberc. Lung Dis. 78:237. 
41. Cooper, A. M., J. E. Pearl, J. V. Brooks, S., and I. M. O. Ehlers. 2000. Expression of the 
Nitric Oxide Synthase 2 Gene Is Not Essential for Early Control of Mycobacterium 
tuberculosis in the Murine Lung. Infect. Immun. 68:6879. 
42. Jackett, P. S., Aber V.R., and D.B. Lowrie. 1978. Virulence and resisitance to 
superoxide, low pH and hydrogen peroxide among strains of Mycobacterium 
tuberculosis. J. Gen. Microbiol. 104:37. 
43. Middlebok, G. 1954. Isoniazid-resisitant and catalase activity of tubercle. Am. rev. 
Tuberc 69:471. 
44. Melo, M. D., Catchpole, I.R., Haggar, G., and Stokes, R.W. 2000. Utilization of CD11b 
knock-out mice to characterize the role of complement receptor 3 (CR3, CD11b/CD18) 
in the growth of Mycobacterium tuberculosis in macrophages. Cellular Immunology 
205:13. 
45. Zabaleta J., A. M., Maya JR., and Garcia. 1998. Diminished adherence and/or ingestion 
of virulent Mycobacterium tuberculosis by monocyte-derived macrophages from patients 
with tuberculosis. Clinical & Diagnostic Laboratory Immunology. 5. 
46. Chan, J., K. Tanaka, D. Carroll, J. L. Flynn, and B.R. Bloom. 1995. Effect of nitric oxide 
synthase inhibitors on murine infection with Mycobacterium tuberculosis. Infect. Immun. 
63:736. 
47. Walker, L., D.B. Lowrie. 1981. Killing of Mycobacterium microti by immunologically 
activated macrophages. Nature 293:69. 
48. Lau, Y. L., G. C. Chan, S. Y. Ha, Y. F. Hui, K. Y. Yuen. 1998. The role of the 
phagocytic respiratory burst in host defense agasint Mycobacterium tuberculosis. Clin. 
Infect. Dis. 26:226. 
49. Yu, K., Mitchell, C., Xing, Y., Magliozzo, R.S., Bloom, B. R., and Chan, J. 1999. 
Toxicity of nitrogen oxides and related oxidants on mycobacteria:  M. tuberculosis is 
resistant to peroxynitrite anion. Tuberc Lung Dis 79:191. 
 148 
50. MacMicking, J., Xie, Q-W, Nathan, C. 1997. Nitric oxide and macrophage function. Ann. 
Rev. Immunol. 15:323. 
51. Chan, J., J. Flynn. 1999. Nitric oxide in Mycobacterium tuberculosis infection. In Nitric 
oxide and infection. F. Fang, ed. Plenum Publishers, New York, p. 281. 
52. Shiloh, M., Nathan, CF. 2000. Reactive nitrogen intermediates and the pathogenesis of 
Salmonella and mycobacteria. Curr. Opinion Microbiol. 3:35. 
53. Xu, L., Huang, Y., Yang, J., van Der Meide, P.H., Levi, M., Wahren, B., Link, H., and 
Xiao, B. 1999. Dendritic cell-derived nitric oxide is involved in IL-4-induced suppression 
of experimental allergenic encephalomyelitis (EAE) in Lewis rats. Clin. Exp. Immunol. 
118:115. 
54. Xiao, B. G., Huang, Y.M., Xu, L.Y., Ishikawa, M., Link, H. 1999. Mechanisms of 
recovery from experimental allergenic encephalomyelitis with myelin basic peptide 68-
86 in Lewis rats: a role for dendritic cells in inducing apoptosis of CD4 T cells. Journal 
of Neuroimmunology 97:25. 
55. Bonham, C. A., L. Lu, R. A. Hoffman, R. L. Simmons, A. W. Thomson. 1997. 
Generation of nitric oxide by mouse dendritic cells and its implications for immune 
response regulation. In Dendritic cells in fundamental and clinical immunology. P. 
Ricciardi-Castagnoli, ed. Plenum Press, New York. 
56. Beckman, J. S. a. W. H. K. 1996. Nitric Oxide, superoxide, and peroxynitrite:  the good, 
the bad, and the ugly. Am. J. Physiol. 271:C1424. 
57. Fang, F. 1997. Mechanisms of nitric oxide-related anti-microbial activity. J. Clin. Invest. 
99:2818. 
58. MacMicking, J., North, RJ, LaCourse, R, Mudgett, JS, Shah, SK, Nathan, CF. 1997. 
Identification of nitric oxide synthase as a protective locus against tuberculosis. Proc. 
Natl. Acad. Sci. USA 94:5243. 
59. Flynn, J. L., Scanga, C.A., Tanaka, K.E., and Chan, J. 1998. Effects of Aminoguadine on 
Latent Murine Tuberculosis. J. Immunol 160:1796. 
60. Denis, M. 1991. Killing of Mycobacterium tuberculosis within human monocytes: 
activation by cytokines and calcitriol. Clin. Exp. Immunol. 84:200. 
61. Chan, J., Y. Xing, R. Magliozzo, B.R. Bloom. 1992. Killing of virulent Mycobacterium 
tuberculosis by reactive nitrogen intermediates produced by activated murine 
macrophages. J. Exp. Med. 175:1111. 
62. Flesch, I., S. H. E. Kaufmann. 1991. Mechanisms involved in mycobacterial growth 
inhibition by gamma-interferon activated bone marrow macrophages: role of reactive 
nitrogen intermediates. Infect. Immun. 59:3213. 
63. Mohan, V. P., C. A. Scanga, K. Yu, H. M. Scott, K. E. Tanaka, E. Tsang, J. L. Flynn, J. 
Chan. 2001. Effects of Tumor Necrosis Factor alpha on host immune response in chronic 
persistent tuberculosis: possible role for limiting pathology. Infect. Immun. 69:1847. 
64. MacMicking, J. D., C. Nathan, G. Hom, N. chartrain, M. Trumbauer, K. Stevens, Q-w. 
Xie, K. Sokol, D. S. Fletcher, N. Hutchinson, H. Chen, J. S. Mudgett. 1995. Altered 
responses to bacterial infection and endotoxic shock in mice lacking inducible nitric 
oxide synthase. Cell 81:641. 
65. Scanga, C. A., V.P. Mohan, K. Tanaka, D. Alland, J. L. Flynn, J. Chan. , and I. I. 2001. 
The NOS2 Locus Confers Protection in Mice against Aerogenic  
  Challenge of Both Clinical and Laboratory Strains of Mycobacterium  
  tuberculosis. Infect. Immun. in press. 
 149 
66. Nicholson, S., M. Bonecini-Almeida, J.R. L. Silva, C. Nathan, Q-w Xie, R. Mumford, 
J.R. Weidner, J. Calaycay, J. Geng, N. Boechat, C. Linhares, W. Rom, J. L Ho. 1996. 
Inducible nitric oxide synthase in pulmonary alveolar macropahges from patients with 
tuberculosis. J. Exp. Med. 184:2293. 
67. Wang, C.-H., Liu, C-Y, Lin, H-C, Yu, C-T, Chung, KF, Kuo, HP. 1998. Increased 
exhaled nitric oxide in active pulmonary tuberculosis due to inducible NO synthase 
upregulation in alveolar macrophages. Eur. Respir. J. 11:809. 
68. Ischiropoulos, H., Zhu, L., and Beckman, J. 1992. Peroxynitrite Formation from 
Macrophage-Derived Nitric Oxide. Archives of Biochemistry and Biophysics 298:446. 
69. Zhu, L., C. Gunn, J.S. Beckman. 1992. Bactericidal activity of peroxynitrite. Arch. 
Biochem. Biophys. 298:452. 
70. Poole, R., and Hughes, M. 2001. New Functions for the ancient globulin famly:  bacterial 
responses to nitric oxide and nitrosative stess. Molecular Microbiology 36:775. 
71. Krutzik, S. R., Sieling P.A., and, Modlin R.L. 2001. The role of Toll-like receptors in 
host defense against microbial infection. Current Opinion in 
Immunology. 13(1):104-8,Feb. 
72. Sieling P, A., and Modlin R.L. 2001. Activation of toll-like receptors by microbial 
lipoproteins. Journal of Infectious Diseases.  33(2):97-100. 
73. Akira S., T. K., and Kaisho T. 2001. Toll-like receptors: critical proteins linking innate 
and acquired immunity. [Nature Immunology. 2(8):675-80. 
74. Aderem, A. 2001 Jul. Role of Toll-like receptors in inflammatory response in 
macrophages. Critical Care 
Medicine. 29(7 Suppl):S16-8. 
75. Imler J, L., and Hoffmann J,A. 2001 Jul. Toll receptors in innate immunity. Trends in 
Cell Biology.  11(7):304-11. 
76. Imler J, L., and Hoffmann J,A.  Toll and Toll-like proteins: an ancient family of receptors 
signaling infection. Reviews in Immunogenetics. 2(3):294-304, 2000. 
77. Muzio, M., and Mantovani, A. 2001 Feb. The Toll receptor family. Allergy. 56(2):103-8. 
78. Kaisho, T., and Akira, S. 2000. Critical roles of Toll-like receptors in host defense. 
Critical Reviews in 
Immunology. 20(5):393-405. 
79. Belvin, M., Anderson, KV. 1996. A conserved signaling pathway: the Drosophila toll-
dorsal pathway. Annu. Rev. Cell Dev. Biol. 12:393. 
80. Baeuerle, P., Henkel, T... 1994. Function and activation of NF-kappa B in the immune 
system. Annu. Rev. Immunol. 12:141. 
81. Brightbill, H. D., D. H. Libraty, S. R. Krutzik, R. B. Yang, J. T. Belisle, J. R. Bleharski, 
M. Maitland, M. V. Norgard, S. E. Plevy, S. T. Smale, P. J. Brennan, B. R. Bloom, P. J. 
Godowski, and R. L. Modlin. 1999. Host defense mechanisms triggered by microbial 
lipoproteins through toll-like receptors. Science 285:732. 
82. Means, T. K., S. Wang, E. Lien, A. Yoshimura, D. T. Golenbock, and M. J. Fenton. 
1999. Human toll-like receptors mediate cellular activation by Mycobacterium 
tuberculosis. J Immunol 163:3920. 
83. Sybille, T., Stenger, S., Takeeuchi, O, Ochoa, M., Engele, M., Siebling, P. Barnes, P., 
Rollinghoff, M., Bolcskel, P., Wagner, M., Akira, S., Norgard, M., Belisle, J., Godowski, 
P., Bloom, B., and Modlin, R. 2001. Induction of Direct Anti-microbial Activity Through 
Mammalian Toll-like Receptors. Science 291:1544. 
 150 
84. Puldendran, B., Palucka, k., and Banchereau, J. 2001. Sensing Pathogens and Tuning 
Immune Responses. Science 293:253. 
85. Hertz, C. J., Kiertscher, S.M., Godowski, P.J., Bouis, D.A., Norgard, M.V., Roth, M.D., 
and Modlin, R.L. 2001. Microbial lipopeptides stimulate dendritic cell maturation via 
Toll-like receptor 2. Journal of Immunology 166:2444. 
86. Henderson, R. A., M. T. Nimgaonkar, S. C. Watkins, P. D. Robbins, E. D. Ball, O. J. 
Finn. 1996. Human dendritic cells genetically engineered to express high levels of the 
human epithelial tumor antigen mucin (MUC-1). Cancer Research 56:3763. 
87. Hickman, S., Chan. J., and Salgame, P. 2001. Differential Polarization of naive T cells by 
Mycobacterium tuberculosis-infected Dendritic cells and Macrophages. in press. 
88. Ladel, C. H., G. Szalay, D. Reidel, S. H. Kaufmann. 1997. Interleukin-12 secretion by 
Mycobacterium tuberculosis-infected macrophages. Infect. Immun. 65:1936. 
89. Flynn, J. L., M. M. Goldstein, K. J. Triebold, J. Sypek, S. Wolf, and B.R. Bloom. 1995. 
IL-12 increases resistance of BALB/c mice to Mycobacterium tuberculosis infection. J. 
Immunol. 155:2515. 
90. Cooper, A. M., J. Magram, J. Ferrante, I. M. Orme. 1997. Interleukin 12 (IL-12) is 
crucial to the development of protective immunity in mice intravenously infected with 
Mycobacterium tuberculosis. J. Exp. Med. 186:39. 
91. Ottenhof, T. H., D. Kumararatne, J. L. Casanova. 1998. Novel human 
immunodeficiencies reveal the essential role of type-1 cytokines in immunity to 
intracellular bacteria. Immunol. Today 19:491. 
92. Lowrie D, B., Tascon R,E., Bonato V.L., Lima V.M., Faccioli L.H., Stavropoulos E., 
Colston M.J., Hewinson R.G., Moelling K., and Silva C.L. 1999 Jul 15. Therapy of 
tuberculosis in mice by DNA vaccination.  Nature.  400(6741):269-71. 
93. Lyadova, I., V. Yeremeev, K. Majorov, B. Nikonenko, S. Khaidukov, T. Kondratieva, N. 
Kobets, and A. Apt. 1998. An ex vivo study of T lymphocytes recovered from the lungs 
of I/St mice infected with and susceptible to Mycobacterium tuberculosis. Infec. Immun. 
66:4981. 
94. Lalvani, A., R. Brookes, R. Wilkinson, A. Malin, A. Pathan, P. Andersen, H. Dockrell, G. 
Pasvol, A. Hill. 1998. Human cytolytic and interferon gamma-secreting CD8+ T 
lymphocytes specific for Mycobacterium tuberculosis. Proc. Natl. Acad. Sci. USA` 
95:270. 
95. Orme, I., E. Miller, A. Roberts, S. Furney, J. Griffen, K. Dobos, D. Chi, B. Rivoire, P. 
Brennan. 1992. T Lymphocytes mediating protection and cellular cytolysis during the 
course of Mycobacterium tuberculosis infection. J. Immunol. 148:189. 
96. Orme, I. M., A.D. Roberts, J.P. Griffen, J. S. Abrams. 1993. Cytokine secretion by CD4 
T lymphocytes acquired in response to Mycobacterium tuberculosis infection. J. 
Immunol. 151:518. 
97. Serbina, N. V., J. L. Flynn. 1999. Early emergence of CD8+ T cells primed for 
production of Type 1 cytokines in the lungs of Mycobacterium tuberculosis-infected 
mice. Infect. Immun. 67:3980. 
98. Flynn, J. L., J. Chan, K.J. Triebold, D.K. Dalton, T.A. Stewart and B.R. Bloom. 1993. An 
essential role for Interferon-γ in resistance to Mycobacterium tuberculosis infection. J. 
Exp. Med. 178:2249. 
99. Cooper, A. M., D.K. Dalton, T.A. Stewart, J.P. Griffen, D.G. Russell, I.M. Orme. 1993. 
Disseminated tuberculosis in IFN-γ gene-disrupted mice. J. Exp. Med. 178:2243. 
 151 
100. Jouanguy, E., R. Doffinger, S. Dupuis, A. Pallier, F. Altare, and J. L. Casanova. 1999. IL-
12 and IFN-gamma in host defense against mycobacteria and salmonella in mice and 
men. Curr Opin Immunol 11:346. 
101. Jouanguy, E., F. Altare, S. Lamhamedi, P. Revy, J-F Emile, M. Newport, M. Levin, S. 
Blanche, E. Seboun, A. Fischer, J-L Casanova. 1996. Interferon-γ receptor deficiency in 
an infant with fatal Bacille Calmette-Guerin Infection. New Engl. J. Med. 335:1956. 
102. Fenhalls, G., A. Wong, J. Bezuidenhout, P. van Helden, P. Bardin, P.T. Lukey. 2000. In 
situ production of gamma interferon, interleukin-4, and tumor necrosis factor alpha 
mRNA in human lung tuberculous granuloma. Infect. Immun. 68:2827. 
103. Robinson, D. S., Ying, S., Taylor, I.K., Wangoo., A., Mitchell. D., Kay. A., Hamid, Q., 
and Shaw., R. 1994. Evidence for a Th1 like brochoalveolar T-cell subset and 
predominance of IFN-γ gene activition in pulmonary tuberculosis. Am Rev Respir Crit. 
Care. Med. 149:989. 
104. Rook, G. A., Champion, B.R., Steele, J., Varey, A.M., Varey,  and Stanford, J.L. 1985. I-
A restricted activation by T cell lines of anti-tuberculosis activity in murine macrophages. 
Clin. exp. Immunol. 59:414. 
105. Ting, L. M., A. C. Kim, A. Cattamanchi, and J. D. Ernst. 1999. Mycobacterium 
tuberculosis inhibits IFN-gamma transcriptional responses without inhibiting activation 
of STAT1. J. Immunol 163:3898. 
106. Flynn, J. L., M. M. Goldstein, J. Chan, K.J. Triebold, K. Pfeffer, C.J. Lowenstein, R. 
Schreiber, T.W. Mak, and B.R. Bloom. 1995. Tumor necrosis factor-α is required in the 
protective immune response against M. tuberculosis in mice. Immunity 2:561. 
107. Bean, A. G. D., D.R. Roach, H. Briscoe, M.P. France, H. Korner, J.D. Sedgwick, W.J. 
Britton. 1999. Structural deficiencies in granuloma formation in TNF gene-targeted mice 
underlie the heightened susceptibility to aerosol Mycobacterium tuberculosis infection, 
which is not compensated for by lymphotoxin. J. Immunol. 162:3504. 
108. Liew, F. Y., Y. Li, S. Millott. 1990. Tumor necrosis factor-α synergizes with IFN-γ in 
mediating killing of Leishmania major through the induction of nitric oxide. J. Immunol. 
145:4306. 
109. Flesch, I. E. A., and S.H.E. Kaufmann. 1990. Activation of tuberculostatic macrophage 
functions by gamma interferon, interleukin-4, and tumor necrosis factor. Infect. Immun. 
58:2675. 
110. Flynn, J. L., J. D. Ernst. 2000. Immune responses in tuberculosis. Curr. Opin. Immunol. 
12:432. 
111. Gong, J.-H., M. Zhang, R.L. Modlin, P.S. Linsley, D. Iyer, Y. Lin, P.F. Barnes. 1996. 
Interleukin-10 downregulates Mycobacterium tuberculosis-induced Th1 responses and 
CTLA4 expression. Infect. Immun. 64:913. 
112. Rojas, M., M. Olivier, P. Gros, L.F. Barrera, L.F. Garcia. 1999. TNF−α and IL-10 
modulate the induction of apoptosis by virulent Mycobacterium tuberculosis in murine 
macorphages. J. Immunol. 162:6122. 
113. North, R. J. 1998. Mice incapable of making IL-4 and IL-10 display normal resistance in 
infection with Mycobacterium tuberculosis. Clin. Exp. Immunol. 113:55. 
114. Muller, I., S. Cobbold, H. Waldmann, S.H.E. Kaufmann. 1987. Impaired resistance to 
Mycobacterium tuberculosis infection after selective in vivo depletion of L3T4+ and 
Lyt2+ T cells. Infect. and Immunol. 55:2037. 
 152 
115. Orme, I., and F. Collins. 1984. Adoptive protection of the Mycobacteria tuberculosis-
infected lung. Cell. Immun. 84:113. 
116. Orme, I., and F. Collins. 1983. Protection against Mycobacterium tuberculosis infection 
by adoptive immunotherapy. J. Exp. Med. 158:74. 
117. Caruso, A. M., N. Serbina, E. Klein, K. Triebold, B. R. Bloom, J. L. Flynn. 1999. Mice 
deficient in CD4 T cells have only transiently diminished levels of IFN-γ, yet succumb to 
tuberculosis. J. Immunol. 162:5407. 
118. Selwyn, P. A., D. Hartel, V.A. Lewis, E.E. Schoenbaum, S.H. Vermund, R.S. Klein, A.T. 
Walker, G.H. Freidland. 1989. A prospective study of the risk of tuberculosis among 
intravenous drug users with human immunodeficiency virus infection. New Engl. J. Med. 
320:545. 
119. Oddo, M., T. Renno, A. Attinger, T. Bakker, H.R. MacDonald, P.R.A. Meylan. 1998. Fas 
ligand-induced apoptosis of infected human macrophages reduces the viability of 
intracellular Mycobacterium tuberculosis. J. Immunol. 160:5448. 
120. Clarke, S. R. M. 2000. The critical role of CD40/CD40L in the CD4-dependent 
generation of CD8+ T cell immunity. J. Leuk. Biol. 67:607. 
121. Andreasen, S. O., J. E. Crhistensen, O. Marker, A. R. Thomsen. 2000. Role of CD40 
ligand and CD28 in induction and maintenance of antiviral CD8+ effector T cell 
responses. J. Immunol. 164:3689. 
122. Kalams, S. A., B. D. Walker. 1998. The critical need for CD4 help in maintaining 
effective cytotoxic T lymphocyte responses. J. Exp. Med. 188:2199. 
123. Feng, C., G., A. G. D. Bean, H. Hooi, H. Briscoe, W. J. Britton. 1999. Increase in gamma 
interferon-secreting CD8+, as well as CD4+ T cells in lungs following aerosol infection 
with Mycobacterium tuberculosis. Infect. Immun. 67:3242. 
124. Serbina, N. V., C.-C. Liu, C. A. Scanga, J. L. Flynn. 2000. CD8+ cytotoxic T 
lymphocytes from lungs of M. tuberculosis infected mice express perforin in vivo and 
lyse infected macrophages. J. Immunol. 165:353. 
125. Flynn, J. L., M.M. Goldstein, K.J. Triebold, B. Koller, and B.R. Bloom. 1992. Major 
histocompatibility complex class I-restricted T cells are required for resistance to 
Mycobacterium tuberculosis infection. Proc. Natl. Acad. Sci. USA 89:12013. 
126. Behar, S. M., C. C. Dascher, M. J. Grusby, C. R. Wang, and M. B. Brenner. 1999. 
Susceptibility of mice deficient in CD1D or TAP1 to infection with Mycobacterium 
tuberculosis. J. Exp. Med. 189:1973. 
127. Sousa, A. O., R. J. Mazzaccaro, R. G. Russell, F. K. Lee, O. C. Turner, S. Hong, L. Van 
Kaer, B. R. Bloom. 1999. Relative contributions of distinct MHC Class I-dependent cell 
populations in protection to tuberculosis infection in mice. Proc. Natl. Acad. Sci., USA 
97:4204. 
128. Silva, C. L., D. B. Lowrie. 2000. Identification and characterization of murine cytotoxic 
T cells that kill Mycobacterium tuberculosis. Infect. Immun. 68:3269. 
129. Dow SW, R. A., Vyas J, Rodgers J, Rich RR, Orme I, Potter TA. 2000. Immunization 
with f-Met peptides induces immune reactivity against Mycobacterium tuberculosis. 
Tubercle Lung Dis. 80:5. 
130. Porcelli, S. A., R. L. Modlin. 1999. The CD1 system: Antigen-presenting molecules for T 
cell recognition of lipids and glycolipids. Ann. Rev. Immunol. 17:297. 
 153 
131. Sieling, P. A., D. Chatterjee, S. A. Porcelli, T..I. Prigozy, R. J. Mazzaccaro, T. Soriano, 
B. R. Bloom, M. B. Brenner, M. Kronenberg, P. J. Brennan, R. L. Modlin. 1995. CD1-
restricted T cell recognition of microbial lipoglycan antigens. Science 269:227. 
132. McDonough, K. A., Y. Kress, and B. R. Bloom. 1993. Pathogenesis of Tuberculosis: 
Interaction of Mycobacterium tuberculosis with macrophages. Infect. Immun. 61:2763. 
133. Mazzaccaro, R. J., M. Gedde, E. R. Jensen, H. M. van Santem, H. L. Ploegh, K. L. Rock, 
and B. R. Bloom. 1996. Major histocompatibility class I presentation of soluble antigen 
facilitated by Mycobacterium tuberculosis infection. Proc. Natl. Acad. Sci. USA 
93:11786. 
134. Gong, J. L., McCarthy, K., Telford, J., Tamatani, T., Miyasaka, M., Schneeberger, E. 
1992. Intraepithelial Airway Dendritic Cells:  A Distinct Subset of Pulmonary Dendritic 
Cells Obtained by Microdissection. J. Exp Med. 175:797. 
135. Toews, G., Vial, W., Dunn, M., Guzzetta, P., Nunez, G., Stastny, P., and Lipscomb, M. 
1984. The accessory function of human alveolar macrophages in specific T cell 
proliferation. Journal of Immunology 132:181. 
136. Lipscomb, M., Lyons, C., Nunez, G., Ball, E., Statny, Vial, W., Lem, V., Weissler, J., 
and Miller, L. 1986. Human alveolar macrophages: HLA-DR-positive macrophages that 
are poor stimulators of a primary mixed lymphocyte reaction. Journal of Immunology 
136:497. 
137. Lyons, C., Ball, E., Toews, B., Weissler, J., Stastny, P., and Lipscomb, M. 1986. Inability 
of human alveolar macrophages to stimulate resting T cells correlates with decreased 
antigen-specific T cell-macroophage binding. Journal of Immunolgy 137:497. 
138. Masten, B. a. L., M. 1999. Comparison of lung dendritic cells and B cells in stimulating 
naive antigen-specific T cells. Journal of Immunolgy 162:1310. 
139. Franke-Ulmann G., P., P., Walter, P., Steinmuller, C., Lohmann-Matthes, M., Kobzik, L. 
1996. Characteristic of murine lung interestitial macrophages in comparison with alveolar 
macrophages. Journal of Immunolgy 157:3097. 
140. Xia, W., C. Pinto, R. Kradin. 1995. The antigen-presenting activities of Ia+ dendritic 
cells shift dynamically from lung to lymph node after an airway challenge with soluble 
antigen. J. Exp. Med. 181:1275. 
141. McCombs, C., Michalski, J., Westerfield, B., and Light, R. 1982. Human alveolar 
macrophages suppress the proliferation response of peripheral blood lymphocytes. Chest 
82:266. 
142. Holt, P. G. 1979. Alveolar macrophages. II. Inhibition of lymphocyte proliferation by 
purified macrophages rat lung. Immunology 37:429. 
143. Bilyk, N. a. H., P. 1995. Cytokine modulation of the immunosuppressive phenotype of 
pulmonary alveolar macrophages populations. Immunology 86:231. 
144. Leemans, J., Juffermans, N., Floriquin, S., Rooijen, N., Vervoordeldonk, M., Verbon, A., 
van Deventer, S., and van der Poll, T. 2001. Depletion of Alveolar Macrophages Exerts 
Protective Effects in Pulmonary Tuberculosis in Mice. Journal of immunology 166:4604. 
145. Havenith, C., P. Miert, A. Breedijk, H. Beelen, E. Hoefsmit. 1993. Migration of dendritic 
cells into the draining lymph nodes of the lung after intratracheal instillation. Am. Res. 
Cell. Mol biol. 9. 
146. Gonzalez-Juarrero, M., O.C. Turner, J. Turner, P. Marietta, J.V.Brooks, I.M. Orme. 2001. 
Temporal and spatial arrangement of lymphocytes within lung granulomas induced by 
aerosol infection with Mycobacterium tuberculosis. Infect. Immun. 69:1722. 
 154 
147. Giacomini, E., Elisabetta, I., Lucietta, F., Minja, M., Lanfranco, F., Graziella, O., Iikka, 
J., Coccia, E. 2001. Infection of human macrophages and dendritic cells with 
Mycobacterium tuberculosis induces a differential cytokine gene expression that 
modulates T cell responses. Journal of Immunology 166:7033. 
148. Fortsch, D., Rollinghoff, M., and Stenger, S. 2000. IL-10 Converts Human Dendritic 
Cells into Macrophage-Like Cells with Increased Anti-bacterial Activitity Against 
Virulent Mycobacterium tuberculosis. Journal of Immunology 165:978. 
149. Demangel, C., and W. J. Britton. 2000. Interaction of dendritic cells with mycobacteria:  
where the action starts. Immunology and Cell Biology 78:318. 
150. Demangel, C., Umaimaithan, P., Feng, C., Heath, A.,  Bean, A., and W. J. Britton. 2001. 
Stimulation of Dendritic Cells via CD40 Enhances Immune Responses to Mycobacterium 
tuberculosis Infection. Infection and Immunity 69:2456. 
151. Schultz, O., A.D. Edwards, M. Schito, J. Aliberti, S. Manickasingham, A. Sher, C. Reis e 
Sousa. 2000. CD40 triggering of heterodimeric IL-12 p70 
production by dendritic cells in vivo requires a microbial priming signal. Immunity. 
152. Linsey, P. S. 2001. T cell activation: you can't get good help. Nature Immunol. 2:139. 
153. Gallucci S., L. M., and  Matzinger P. 1999.  Natural adjuvants: endogenous activators of 
dendritic cells. Nature Medicine. 5:1249. 
154. Toshinori, D., Masayuki, A., Takaaki, A., Moritaka, S., Sato, K, and Hiroshi, M. 1993. 
Resistance to Nitric Oxide in Mycobacterium avium Complex and its Implication in 
Pathogenesis. Infect. Immun. 61:1980. 
155. Matzinger, P. 1994. Memories are made of this? Nature 369:605. 
156. Chan, J., S.H. E. Kaufmann. 1994. Immune Mechanisms of Protection. In Tuberculosis: 
Pathogenesis, Protection and Control. B. R. Bloom, ed. American Society for 
Microbiology, Washington, D.C., p. 389. 
157. Leveton, C., S. Barnass, B. Champion, S. Lucas, B. De Souza, M. Nicol, D. Banerjee, G. 
Rook. 1989. T-cell mediated protection of mice against virulent Mycobacterium 
tuberculosis. Infect. Immun. 57:390. 
158. Havenith, C. E. G., A. J. Breedijk,  E. C. M. Hoefsmit. 1992. Effect of Bacillus Calmette-
Guerin inoculation on numbers of dendritic cells in bronchoalveolar lavages of rats. 
Immunobiol. 184:336. 
159. Guzman, C., Rohde, M., Bock, M., and Timmis, K.N. 1994. Invasion and intracellular 
survival of Bordetella bronchiseptica in mouse dendritic cells. Infect Immun 62:5528. 
160. Marriott, I., Hammond, T.G., Thomas, E.K., and Bost, K.L. 1999. Salmonella efficiently 
enter and survive within cultured CD11c+ dendritic cells initiating cytokines. Eur. J. 
Immunol. 29:1107. 
161. Filgueira, L., F. O. Nestle, M. Rittig, H. I. Joller, P. Groscurth. 1996. Human dendritic 
cells phagocytose and process Borrelia burgdorferi. J. Immunol. 157:2998. 
162. Moll, H., Fuchs, H., Blank, C., and Rollinghoff, M. 1993. Langerhans cells transport 
Leishmania major from the infected skin to the draining lymph node for presentation to 
antigen-specific T cells. Eur. J. Immunol. 23:1595. 
163. Moll, H., Flohe, S., and Rollinghoff, M. 1995. Dendritic cells in Leishmania major-
immune mice harbor persistent parasites and mediate an antigen-specific T cell immune 
response. Eur. J. Immunol. 25:693. 
 155 
164. Igietseme, J. U., Perry, L.L., Ananaba, A.G, Uriri, I.M., Ojior, O.O., Kumar, S.N., and 
Caldweld, H.D. 1998. Chlamydial infection in inducible nitric oxide synthase knockout 
mice. Infect. Immun. 66:1282. 
165. Ojcius, D. M., Bravo de Alba, Y., Kanellopoulos, J.M., Hawkins, R.A., Kelly, K.A., 
Rank, R.G., and Dautry-Varsat, A. 1998. Internalization of Chlamydia by dendritic cells 
and stimulation of Chlamydia-specific T Cells. J. Immunol. 160:1297. 
166. Rescigno, M., C. Winzler, D. Delia, C. Mutini, M. Lutz, and P. Ricciardi-Castagnoli. 
1997. Dendritic cell maturation is required for initiation of the immune response. J. Leuk. 
Biol. 61:415. 
167. Inaba, K., M. Inaba, N. Romani, H. Aya, M. Deguchi, S. Ikehara, S. Muramatsu, R.M. 
Steinmna. 1992. Generation of large numbers of dendritic cells from mouse bone marrow 
cultures supplemented with granulocyte/macrophage colony stimulating factor. J. Exp. 
Med. 176:1693. 
168. Steinman, R., and Swanson, J. 1995. The Endocytic Activity of Dendritic Cells. J. Exp. 
Med. 182:283. 
169. Sallusto, F., Cella, M., Danieli, C., and Lanzavecchia, A. 1995. Dendritic cells use 
macropinocytosis and the mannose receptor to concentrate macromolecules in the major 
histocompatibility complex class II compartment: downregulation by cytokines and 
bacterial products. J. Exp. Med. 182:389. 
170. Bloom, B. R., C. Murray. 1992. Tuberculosis: Commentary on a Reemergent Killer. 
Science 257:1055. 
171. Mahnke, K., Becher, E., Ricciardi-Castagnoli, P., Luger, TA., Schwarz, T., Grabbe, S. 
1997. CD14 is expressed by subsets of murine dendritic cells and upregulated by 
lipopolysaccharide. Adv. Exp Med & Biol. 417:145. 
172. Reise-Sousa, C., Stahl, P.D., and Austyn, J.M. 1993. Phagocytosis of antigens by 
Langerhans cells In Vitro. J. Exp. Med. 178:509. 
173. Sallusto, F., and A. Lanzavecchia. 1994. Efficient presentation of soluble antigen by 
cultured human dendritic cells is maintained by granulocyte/macrophage colony-
stimulating factor plus IL-4 and downregulated by tumor necrosis factor-α. J. exp. Med. 
179:1109. 
174. Riva, S., Nolli, M., Lutz, M., Citterio, S., Girolomoni, G., Winzler, C., and Ricciardi-
Castagnoli, P. 1996. Bacteria and bacteria cell wall constituents induce the production of 
regulatory cytokines in dendritic cell clones. J. Inflammation 46:98. 
175. Barnes, P. F., R. L. Modlin, J. J. Ellner. 1994. T-cell responses and cytokines. In 
Tuberculosis: Pathogenesis, Protection, and Control. B. R. Bloom, ed. American Society 
for Microbiology, Washington, D.C., p. 417. 
176. Hamma, Z., R. Gabathuler, W. A. Jefferies, G. de Jong, N. E. Reiner. 1998. Attenuation 
of HLA-DR expression by mononuclear phagocytes infected wtih Mycobacterium 
tuberculosis is related to intracellular sequestration of immature class II heterodimers. J. 
Immunol. 161:4882. 
177. Gercken, J., J. Pryjma, M. Ernst, H. D. Flad. 1994. Defective antigen presentation by 
Mycobacterium tuberculosis-infected monocytes. Infect. Immun. 62:3472. 
178. Noss, E. H., C. V. Harding, W. H. Boom. 2000. Mycobacterium tuberculosis inhibits 
MHC Class II antigen processing in murine bone marrow macrophages. Cell. Immunol. 
201:63. 
 156 
179. Lutz, M., Girolomoni, G., and Ricciardi-Castagnoli, P. 1996. The role of cytokines in 
functional regulation and differentiation of dendritic cells. Immunbiol. 195:431. 
180. Ahuja, S. S., Mummidi, S., Malech, H.L., and Ahuja, S.K. 1998. Human dendritic cell 
(DC)-based anti-infective therapy: Engineering DCs to secrete functional IFN-gamma 
and IL-12. J. Immunol. 161:868. 
181. van Overtvelt, L., N. Vanderheyde, V. Verhasselt, J. Ismaili, L. de Vos, M. Goldman, F. 
Willems, B. Vray. 1999. Trypanosoma cruzi infects human dendritic cells and prevents 
their maturation: inhibition of cytokines, HLA-DR, and costimulatory molecules. Infect. 
Immun. 67:4033. 
182. Cella, M., D. Scheidegger, K. Palmer-Lehmann, P. Lane, A. Lanzavecchia, G. Alber. 
1996. Ligation of CD40 on dendritic cells triggers production of high levels of 
interleukin-12 and enhances T cell stimulatory capacity: T-T help via APC activation. J. 
Exp. Med. 184:747. 
183. Holt, P., S. Haining, D. Nelson, and J. Sedwick. 1994. Origin and steady-state turnover of 
Class II MHC-bearing dendritic cells in the epithelium of the conducting airways. J. 
Immunolgy 153:256. 
184. Demangel, C., A. G. D. Bean, E. Marin, C. G. Feng, A. T. Kamath, W. J. Britton. 1999. 
Protection against aerosol Mycobacterium tuberculosis infection using Mycobacterium 
bovis Bacillus Camette Guerin-infected dendritic cells. Eur. J. Immunol. 29:1972. 
185. Bogdan, C., Y. Vodovotz, C. Nathan. 1991. Macrophage deactivation by interleukin 10. 
J. Exp. Med. 174:1549. 
186. Banchereau, J., Steinman, R.M. 1998. Dendritic cells and the control of immunity. 
Nature 392:245. 
187. Svensson, M., Stockinger, B., and Wick, M.J. 1997. Bone-marrow-derived dendritic cells 
can process bacteria for MHC-I and MHC-II presentation to T cells. Journal of 
Immunology 158:4229. 
188. Guzman, C. A., Domann, E., Rohde, M., Bruder, D., Darjii, A, Weiss, S., Wehland, J., 
Charraborty, T., and Timmis, K.N. 1996. Apoptosis of mouse dendritic cells is triggered 
by listeriolysin, the major virulence determinant of Listeria monocytogenes. Mol. 
Microbiol. 20:119. 
189. Mbow, M. L., Zeidner, N., Panella, N., Titus, R.G., and Piesman, J. 1997. Borrelia 
burdorferi-pulsed dendritic cells induce a protective immune response against tick-
transmitted spirochetes. Infect. Immun. 65:3386. 
190. Inaba, K., M. Inaba, M. Naito, and R.M. Steinman. 1993. Dendritic cell progenitors 
phagocytose particulates, including bacillus-Calmette Guerin organisms, and sensitize 
mice to mycobacterial antigens in vivo. J. Exp. Med. 178:479. 
191. Gorak, P. M., Engwerda, C.R., and Kaye, P.M. 1998. Dendritic Cells but not 
macrophages, produce IL-12 immediately following Leishmania donovani. European 
Journal of Immunology 28:687. 
192. Lu, H., Zhong, G. 1999. Interleukin-12 production is required for chlamydial antigen-
pulsed dendritic cells to induce protection against live Chlamydia trachomatis infection. 
Infection & Immunity 67:1763. 
193. Zhang, D., Yang, X., Lu, H., Zhong, G., Brunham, R.C. 1999. Immunity to Chlamydia 
trachomatis mouse pneumonitis induced by vaccination with live organisms correlates 
with early granulocyte-macrophage colony stimulating factor and interleukin-12 
production and with dendritic cell like maturation. Infect. Immun. 67:1606. 
 157 
194. Gildea, L., Morris, R., Newman, S. 2001. Histoplasma capsulatum yeasts are 
phagocytosed viua late antigen-5, killed, and processed for antigen presentation by 
human dendritic cells. J. Immunol 166:1049. 
195. Newman, S. a. H., A. 2001. Candida albicans is phagocytosed, killed, and processed for 
antigen presentation by human dendritic cells. Infect. Immun. 69:6813. 
196. Urban, B. C., D. J. P. Perfuson, A. Pain, N. Willcox, M. Plebanski, J. M. Austyn, D. J. 
Roberts. 1999. Plasmodium falciparum-infected erythrocytes modulate the maturation of 
dendritic cells. Nature 400:73. 
197. Ding, A. H., C. Nathan, D. Stuehr. 1988. Release of reactive nitrogen intermediates and 
reactive oxygen intermediates from mouse peritoneal macrophages. J. Immunol. 
141:2407. 
198. Goebel, W. a. K., M. 2000 Feb. Bacterial replication in the host cell cytosol. Current 
Opinion in Microbiology 3(1):49-53. 
199. Wehland, J. a. C. U. D. 1998 Mar. The sophisticated survival strategies of the pathogen 
Listeria monocytogenes. International Microbiology. 1(1):11-8. 
200. Segal, G. a. S., H,A. 1998 Jul. How is the intracellular fate of the Legionella 
pneumophila phagosome determined? Trends in Microbiology. 6(7):253-5. 
201. Gomes, M., Paul, S, Moreira, AL, Appelberg, R, Rabinovitch, M, Kaplan, G. 1999. 
Survival of Mycobacterium avium and Mycobacterium tuberculosis in acidified vacuoles 
of murine macrophages. Infect. Immun. 67:3199. 
202. Russell, D. 1995. Mycobacterium and Leishmania: stowaways in the endosomal network. 
Trends Cell Biol. 5:125. 
203. Aiello, S., Noris, M., Piccinini, G., Tomasoni, S., casiraghi, F., Bonazzola, S., Mister, M., 
Sayegh, M., and G. Remuzzi. 2000. Thymic Dendritic Cells Express Inducible Nitric 
Oxide Synthase and Generate Nitric Oxide in Response Self- and Alloantigens. Journal 
of Immunology 164:4649. 
204. Qureshi, A. A., et. al. 1996. Langerhans cells express inducible nitric oxide synthase and 
produce nitric oxide. J. Invest. Dermatol. 107:815. 
205. Ross, R. e. a. 1996. Involvement of NO in contact hypersensitivity. Int. Immunol. 10:61. 
206. Bogdan, C. 2001. Nitric oxide and the immune response. Nature Immunol. 2:907. 
207. Reis e Sousa, S., C., and Kaye, P. 1999. The role of dendritic cell in the induction of and 
regulation of immunity to microbial infections. Curr. Opin. Immunol. 11:392. 
208. Green, L. C., D.A. Wagner, J.A. Glogowske, P.L. Skipper, J.S. Wishnok, and S.R. 
Tannenbaum. 1982. Analysis of nitrite, nitrate, and [15N]-nitrate in biological fluids. 
Anal. Biochem. 126:131. 
209. Rook, G. A. W., S. Rainbow. 1981. An isotope incorporation assay for the anti-
mycobacterial effects of human monocytes. Ann. Immunol. 132D. 
210. Cross, P. a. M., K. 1993. Cell and Tissue Ultrastructure- a functional perspective. W.H. 
Freeman and Company, New York. 
211. Gray, D., Matzinger, P. 1991. T Cell memory is short-lived in the absence of antigen. J. 
Exp. Med. 174:969. 
212. Denis, M. 1991. Interferon-gamma-treated murine macrophages inhibit growth of 
tubercle bacilli via the generation of reactive nitrogen intermediates. Cell. Immunol. 
132:150. 
 158 
213. Konecny, P. S., AJ., Jebbari, H., et. al. 1999. Murine dendritic cells internalize 
Leishmania major promastigotes, produce IL-12 p40 and stimulate primary T cell 
proliferation in vitro. Eur. J. Immol. 29:1803. 
214. Ahuja, S. S., Reddick, R., and Sato, N. 1999. Dendritic cell (DC)-based anti-infective 
strategies: DCs engineered to secrete IL-12 are a potent vaccine in  a murine model of an 
intracellular infection. J. Immunol 163:3890. 
215. Chan, S. H., B. Perussia, J.W. Gupta, M. Kobayashi, M. pospisil, H.A. Young, S.F. Wolf, 
D. Young, S.C. Clark, G. Trinchieri. 1991. Induction of interferon-γ prodution by natural 
killer cell stimulatory factor: characterization of the responding cells and synergy with 
other inducers. J. Exp. Med. 173:869. 
216. Cooper, A., Segal, BH, Frank, AA, Holland, SM, Orme, IM. 2000. Transient loss of 
resistance to pulmonary tuberculosis in p47phox-/- mice. Infect. Immun. 68:1231. 
217. Jagannath, C., Actor, J., and R.L. Hunter. 1998. Induction of Nitric Oxide in Human 
Monocyte and Monocyte Cell Lines by Mycobacterium tuberculosis. Nitric Oxide 2:174. 
218. Darrah, P., Hondalus, M., Chen, Q., Ischiropoulos, H., and Mosser, D. 2000. Cooperation 
between Reactive and Oxygen and Nitrogen Intermediates in Killing of Rhodococcus 
equi by Activated Macrophages. Infect. Immun. 68:3587. 
219. Brunelli, L., Crow, J.P., and J.S. Beckman. 1995. The comparative toxicity of nitric oxide 
and peroxynitrite to Escherichia Coli. Archives of Biochemistry and Biophysics 316:327. 
220. DeGroote, M. A., Granger, D., Xu, Y., Cambell, G., Prince, R., and F.C. Fang. 1995. 
Genetic and redox determinants of nitric oxide cytotoxicity in Salmonella typhimurium 
model. Proc. Nat. Acad. Sci. USA 92:6399. 
221. Hickman-Davis, J., Gibbs-Erwin, J., Lindsey, J., S. Matalon. 1999. Surfactant protein A 
mediates mycoplasmacidal activity of alveolar macrophages by production of 
peroxynitrite. Proc. Nat. Acad. Sci. USA 96:4953. 
222. Vasquez-Torres, A., Jones-Carson, J., and E. Balish. 1996. Peroxynitrite contributes to 
the candidacidal activity of nitric oxide producing macrophages. Infect. Immun. 64:3127. 
223. Assreuy, J., Fernando, C., Epperlein, M., Noronha-Dutra, A., O'Donnell, C., Liew, F., 
and Moncada, S. 1994. Production of nitric oxide and superoxide by activated 
macrophages and killing of Leishmania major. Eur. J. Immol. 24:672. 
224. Fernando, C. a. J. A. 1997. Role of nitric oxide and superoxide in Giardia lamblia killing. 
Braz. J. Med. Biol. Res. 30:93. 
225. Tohyama, M., Kawakami, K., and Saito, A. 1996. Enhancing effect of oxygen radical 
scavengers on murine macrophages anti-cyrtococcal activity through production of nitric 
oxide. Clinical & Experimental Immunology. 103:436. 
226. Kuwahara, H., Miyamoto, Y., Akaike, T., Kubota, T., Sawa, T., Okomoto, S., H. Maeda. 
2000. Helicobacter pylori Urease Suppresses Bactricidial Activity of Peroxynitrite via 
Carbon Dioxide Production. Infect. Immun. 68:4378. 
227. Schaible, U., Sturgill-Koszycki, S, Schlesinger, PH, Russell, DG. 1998. Cytokine 
activation leads to acidification and increases maturation of  Mycobacterium avium -
containing phagosomes in murine macrophages. J. Immunol. 160:1290. 
228. Pollock, J. D., Williams, Gifford, M., Fisherman, D., Orkin, S., Doerschuk, C., M.C. 
Dinauer. 1995. Mouse model of X-linked chronic granulomatous disease, an inherited 
defect in phagocyte superoxide production. Nat. Genet. 9:202. 
229. McKinney, J. D., K. H. zu Bentrup, A. Miczak, B. Chen, W-T Chan, D. Swenson, J. C. 
Sacchettini, W. R. Jacobs Jr, D. G. Russell. 2000. Persistence of Mycobacterium 
 159 
tuberculosis in macrophages and mice requires the glyoxylate shunt enzyme isocitrate 
lyase. Nature 406:735. 
230. Pick, E. a. M., D. 1981. Rapid Microassays for the Measurement of Superoxide and 
Hydrogen Peroxide Production by Macrophages in Culture Using an Automatic Enzyme 
Immunoassay Reader. Journal of Immunological Methods 46:211. 
231. Beckman, J., Beckman, TW, Chen, J, Marshall, PA, Freeman, BA. 1990. Apparent 
hydroxyl radical production by peroxynitrite: Implications for endothelial injury from 
nitric oxide and superoxide. Proc. Natl. Acad. Sci. USA 87:1620. 
232. Scanga, C. A., V. P. Mohan, K. Yu, H. Joseph, K. Tanaka, J. Chan, J. L. Flynn. 2000. 
Depletion of CD4+ T cells causes reactivation of murine persistent tuberculosis despite 
continued expression of IFN-γ and NOS2. J. Exp Med. 192:347. 
233. Ruan, J., St. John, G, Ehrt, S., Riley, L., and Nathan, C. 1999. noxR3, a novel gene from 
Mycobacterium tuberculosis, protects Salmonella typhimurium from nitrosative and 
oxidative stress. Infect. Immun. 67:3276. 
234. Bryk, R., Griffin, P., and C. Nathan. 2000. Peroxynitrite reductase activity of bacterial 
peroxiredoxins. Nature 407:215. 
235. St. John, G., Brot, N., Ruan, J., Erdjument-Bromage, H., Tempst, P., Weissbach, H., and 
C. Nathan. 2001. Peptide methionine sulfoxide reductase from Esherichia Coli and 
Mycobacterium tuberculosis protect bacteria against oxidative damage from reactive 
nitrogen intermediates. Proc. Nat. Acad. Sci. USA 98:9901. 
236. Nathan, C. F., and J.B. Hibbs, Jr. 1991. Role of nitric oxide synthesis in macrophage anti-
microbial activity. Curr. Opin. Immunol. 3:65. 
237. Finkel, T. 1999. Signal transduction by reactive oxygen species in non-phagocytic cells. 
J. Leuk. Biol. 65:337. 
238. Applegate, R. a. I. R. O. 1993. Immunology 80:352. 
239. Crowle, A., Dahl, R, Ross, E, May, MH. 1991. Evidence that vesicles containing living, 
virulent Mycobacterium tuberculosis or Mycobacterium avium in cultured human 
macrophages are not acidic. Infect. Immun. 59:1823. 
240. Clemens, D., Lee, B., Horwitz, MA. 2000. Mycobacterium tuberculosis and Legionella 
pneumophila Phagosomes Exhibit Arrested Maturation despite Acquistion of Rab 7. 
Infect. Immun. 68:5154. 
241. Holt, P. G., Degebrodt, A., O'Leary, C.O., Krska, K., and Plozza, T. 1985. T cell 
activation by antigen-prsenting cells from tissue digests: suppression by endogenous 
macrophages. Clin. Exp. Immunol. 62:586. 
242. Holt, P. G., M.A. Schon-Hegrad. 1987. Localization of T cells, macrophages, and 
dendritic cells in rat respiratory tract tissue: implications for immune function studies. 
Immunol. 62:349. 
243. Heinz-Joachim, U., Beatty, W., and D. G. Russell. 2000. Interaction of Mycobacterium 
avium-containing Phagosomes with the Antigen Presentation Pathways. Journal of 
Immunology 165:6073. 
